Form 10-Q - Quarterly report [Sections 13 or 15(d)]

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024.

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to __________.

 

Commission File Number: 001-33899

 

Digital Ally, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada		20-0064269
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

 

14001 Marshall Drive, Lenexa, KS 66215

(Address of principal executive offices) (Zip Code)

 

[phone]

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of exchange on which registered
Common stock, $0.001 par value per share		DGLY		The Nasdaq Capital Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of Exchange Act.

 

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes ☐ No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

 

Class		Outstanding at May 17, 2024
Common Stock, $0.001 par value per share		2,879,826

 

 

 

 

 

FORM 10-Q

DIGITAL ALLY, INC.

MARCH 31, 2024

 

TABLE OF CONTENTS		Page(s)
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements.
Condensed Consolidated Balance Sheets – March 31, 2024 (Unaudited) and December 31, 2023		3
Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2024 and 2023 (Unaudited)		4
Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended March 31, 2024 and 2023 (Unaudited)		5
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and 2023 (Unaudited)		6
Notes to the Condensed Consolidated Financial Statements (Unaudited)		7-35
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.		36-53
Item 3. Quantitative and Qualitative Disclosures About Market Risk.		54
Item 4. Controls and Procedures.		54
PART II - OTHER INFORMATION
Item 1. Legal Proceedings.		54
Item 1A. Risk Factors.		55
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.		55
Item 3. Defaults Upon Senior Securities		55
Item 4. Mine Safety Disclosures		55
Item 5. Other Information.		55
Item 6. Exhibits.		55
SIGNATURES		56

 

2

 

 

PART I – FINANCIAL INFORMATION

 

Item 1 – Financial Statements.

 

DIGITAL ALLY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

MARCH 31, 2024 AND DECEMBER 31, 2023

 

		March 31, 2024 (Unaudited)				December 31, 2023
Assets
Current assets:
Cash and cash equivalents		$	927,861			$	680,549
Accounts receivable – trade, net of $234,727 allowance – March 31, 2024 and $200,668 – December 31, 2023			1,207,752				1,584,662
Other receivables, net of $25,000 allowance – March 31, 2024 and $5,000 – December 31, 2023			3,213,740				3,107,634
Inventories, net			3,148,689				3,845,281
Prepaid expenses			6,575,013				6,366,368
Total current assets			15,073,055				15,584,494
Property, plant, and equipment, net			6,207,795				7,283,702
Goodwill and other intangible assets, net			16,625,032				16,510,422
Operating lease right of use assets, net			925,128				1,053,159
Other assets			6,333,185				6,597,032
Total assets		$	45,164,195			$	47,028,809
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable		$	11,212,697			$	10,732,089
Accrued expenses			3,137,144				3,269,330
Current portion of operating lease obligations			225,960				279,538
Contract liabilities – current portion			3,299,714				2,937,168
Notes payable – related party – current portion			2,700,000				2,700,000
Debt obligations – current portion			2,403,029				1,260,513
Warrant derivative liabilities			1,718,629				1,369,738
Income taxes payable			—				61
Total current liabilities			24,697,173				22,548,437
Long-term liabilities:
Debt obligations – long term			4,875,831				4,853,237
Operating lease obligation – long term			749,718				827,836
Contract liabilities – long term			7,285,206				7,340,459
Lease Deposit			10,445				10,445
Total liabilities			37,618,373				35,580,414
Commitments and contingencies
Stockholders’ Equity:
Common stock, $0.001 par value per share; 200,000,000 shares authorized; shares issued: 2,879,826 shares issued – March 31, 2024 and 2,800,754 shares issued – December 31, 2023			2,880				2,801
Additional paid in capital			128,481,699				128,441,083
Noncontrolling interest in consolidated subsidiary			661,044				673,292
Accumulated deficit			(121,599,801	)			(117,668,781	)
Total stockholders’ equity			7,545,822				11,448,395
Total liabilities and stockholders’ equity		$	45,164,195			$	47,028,809

 

See Notes to the Unaudited Condensed Consolidated Financial Statements.

 

3

 

 

DIGITAL ALLY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE MONTHS ENDED

MARCH 31, 2024 AND 2023

(Unaudited)

 

		Three months ended March 31, 2024				Three months ended March 31, 2023
Revenue:
Product		$	1,565,846			$	2,453,810
Service and other			3,963,505				5,243,380
Total revenue			5,529,351				7,697,190
Cost of revenue:
Product			1,567,393				2,301,100
Service and other			2,438,259				3,851,298
Total cost of revenue			4,005,652				6,152,398
Gross profit			1,523,699				1,544,792
Selling, general and administrative expenses:
Research and development expense			487,466				934,939
Selling, advertising and promotional expense			761,118				1,847,489
General and administrative expense			3,914,149				4,935,170
Total selling, general and administrative expenses			5,162,733				7,717,598
Operating loss			(3,639,034	)			(6,172,806	)
Other income (expense):
Interest income			19,356				15,477
Interest expense			(648,567	)			(5,664	)
Other income			27,602				25,393
Change in fair value of warrant derivative liabilities			(348,891	)			—
Change in fair value of contingent consideration promissory notes and earn-out agreements			—				158,021
Gain on extinguishment of liabilities			682,345				—
Gain on sale of intangibles			5,582				—
Loss on sale of property, plant and equipment			(41,661	)			—
Total other income			(304,234	)			193,227
Income (loss) before income tax benefit			(3,943,268	)			(5,979,579	)
Income tax benefit			—				—
Net loss			(3,943,268	)			(5,979,579	)
Net (income) loss attributable to noncontrolling interests of consolidated subsidiary			12,248				(126,239	)
Net loss attributable to common stockholders		$	(3,931,020	)		$	(6,105,818	)
Net loss per share information:
Basic		$	(1.37	)		$	(2.22	)
Diluted		$	(1.37	)		$	(2.22	)
Weighted average shares outstanding:
Basic			2,861,229				2,751,662
Diluted			2,861,229				2,751,662

 

See Notes to the Unaudited Condensed Consolidated Financial Statements.

 

4

 

 

DIGITAL ALLY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

(Unaudited)

 

		Common Stock								Additional Paid In				Noncontrolling interest in consolidated				Accumulated
		Shares				Amount				Capital				subsidiary				deficit				Total
Balance, December 31, 2022			2,720,170			$	2,721			$	127,869,342				448,694			$	(91,980,234	)		$	36,340,523
Stock-based compensation			—				—				114,848				—				—				114,848
Restricted common stock grant			35,000				35				(35	)			—				—				—
Issuance due to rounding from reverse stock split			54				—				—								—				—
Net Income (loss)			—				—				—				126,239				(6,105,818	)			(5,979,579	)
Balance, March 31, 2023			2,755,224				2,756				127,984,155				574,933				(98,086,052	)			30,475,792
Balance, December 31, 2023			2,800,754			$	2,801			$	128,441,083			$	673,292			$	(117,668,781	)		$	11,448,395
Stock-based compensation			—				—				40,695				—				—				40,695
Restricted common stock grant			80,197				80				(80	)			—				—				—
Restricted common stock forfeitures			(1,125	)			(1	)			1				—				—				—
Net Income (loss)			—				—				—				(12,248	)			(3,931,020	)			(3,943,268	)
Balance, March 31, 2024			2,879,826			$	2,880			$	128,481,699			$	661,044			$	(121,599,801	)		$	7,545,822

 

See Notes to the Unaudited Condensed Consolidated Financial Statements.

 

5

 

 

DIGITAL ALLY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

THREE MONTHS ENDED MARCH 31, 2024 AND 2023

(Unaudited)

 

		Three months ended March 31, 2024				Three months ended March 31, 2023
Cash Flows from Operating Activities:
Net loss		$	(3,943,268	)		$	(5,979,579	)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation and amortization			550,991				543,110
Loss on sale of property, plant and equipment			41,661				—
Gain on sale of intangible			(5,582	)			—
Stock-based compensation			40,695				114,848
Amortization of debt issuance costs			360,330				—
Gain on extinguishment of liabilities			(682,345	)			—
Change in fair value of warrant derivative liabilities			348,891				—
Provision for inventory obsolescence			(56,072	)			80,434
Provision for doubtful accounts receivable			34,059				29,025
Provision for doubtful lease receivable			20,000				5,000
Change in fair value of contingent consideration promissory note			—				(158,021	)
Change in operating assets and liabilities (net of assets and liabilities acquired):
(Increase) decrease in:
Accounts receivable – trade			142,606				(211,201	)
Other receivable			(126,106	)			1,479,476
Inventories			793,664				837,893
Prepaid expenses			(154,645	)			684,403
Operating lease right of use assets			54,137				110,115
Other assets			263,847				(2,445,206	)
Increase (decrease) in:
Accounts payable			1,569,346				3,009,912
Accrued expenses			(132,185	)			(184,976	)
Operating lease obligations			(57,801	)			(110,115	)
Income taxes payable			(61	)			—
Lease deposit			—				10,445
Contract liabilities			19,293				967,561
Net cash used in operating activities			(918,545	)			(1,216,876	)
Cash Flows from Investing Activities:
Purchases of furniture, fixtures and equipment			(18,467	)			(23,657	)
Additions to intangible assets			(61,882	)			(46,988	)
Cash paid for acquisition of Country Stampede			(400,000	)			—
Proceeds from sale of intangible assets			90,535				—
Proceeds from sale of property, plant and equipment			550,644				—
Net cash provided by (used in) investing activities			160,830				(70,645	)
Cash Flows from Financing Activities:
Proceeds – Merchant Advances – Video Solutions Segment			700,000				—
Proceeds – Merchant Advances – Entertainment Segment			915,000				—
Proceeds – Commercial Extension of Credit – Entertainment Segment			275,000				1,000,000
Payments on Commercial Extension of Credit – Entertainment Segment			(87,928	)			(264,166	)
Payments on Merchant Advances – Video Solutions Segment			(702,000	)			—
Principal payment on EIDL loan			(810	)			—
Principal payment on contingent consideration promissory notes			(94,235	)			(120,789	)
Net cash provided by financing activities			1,005,027				615,045
Net increase (decrease) in cash, cash equivalents, and restricted cash			247,312				(672,476	)
Cash, cash equivalents, and restricted cash, beginning of period			778,149				3,532,199
Cash, cash equivalents, and restricted cash, end of period		$	1,025,461			$	2,859,723
Supplemental disclosures of cash flow information:
Cash payments for interest		$	158,517			$	6,348
Supplemental disclosures of non-cash investing and financing activities:
Restricted common stock grant		$	80			$	35
Restricted common stock forfeitures		$	1			$	—
Adjustments of accounts payable with the sale proceeds of property, plant and equipment		$	549,356			$	—
Assets acquired in business acquisitions		$	605,000			$	—
Goodwill acquired in business acquisitions		$	225,959			$	—
Liabilities assumed in business acquisitions		$	288,000			$	—
Amounts payable for Country Stampede acquisition		$	142,959			$	—
Commercial Extension of Credit repaid through accrued revenue – Entertainment Segment		$	205,357			$	26,977
ROU and lease liability recorded on extension (termination) of lease		$	(73,894	)		$	517,039

 

See Notes to the Unaudited Condensed Consolidated Financial Statements.

 

6

 

 

DIGITAL ALLY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1. NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations:

 

Digital Ally, Inc. was originally incorporated in Nevada on December 13, 2000 as Vegas Petra, Inc. and had no operations until 2004. On November 30, 2004, Vegas Petra, Inc. entered into a Plan of Merger with Digital Ally, Inc., at which time the merged entity was renamed Digital Ally, Inc. (such merged entity, the “Predecessor Registrant”).

 

On August 23, 2022 (the “Effective Time”), the Predecessor Registrant merged with and into its wholly owned subsidiary, DGLY Subsidiary Inc., a Nevada corporation (the “Registrant”), pursuant to an agreement and plan of merger, dated as of August 23, 2022 (the “Merger Agreement”), between the Predecessor Registrant and the Registrant, with the Registrant as the surviving corporation in the merger (such transaction, the “Merger”). At the Effective Time, Articles of Merger were filed with the Secretary of State of the State of Nevada, pursuant to which the Registrant was renamed “Digital Ally, Inc.” and, by operation of law, succeeded to the assets, continued the business and assumed the rights and obligations of the Predecessor Registrant immediately prior to the Merger. Under the Nevada Revised Statutes, shareholder approval was not required in connection with the Merger Agreement or the transactions contemplated thereby.

 

At the Effective Time, pursuant to the Merger Agreement, (i) each outstanding share of Predecessor Registrant’s common stock, par value $0.001 per share (the “Predecessor Common Stock”) automatically converted into one share of common stock, par value $0.001 per share, of the Registrant (“Registrant Common Stock”), (ii) each outstanding option, right or warrant to acquire shares of Predecessor Common Stock converted into an option, right or warrant, as applicable, to acquire an equal number of shares of Registrant Common Stock under the same terms and conditions as the original options, rights or warrants, and (iii) the directors and executive officers of the Predecessor Registrant were appointed as directors and executive officers, as applicable, of the Registrant, each to serve in the same capacity and for the same term as such person served with the Predecessor Registrant immediately before the Merger.

 

The business of the Registrant, Digital Ally, Inc. (with its wholly-owned subsidiaries, Digital Ally International, Inc., Shield Products, LLC, Digital Ally Healthcare, LLC (“Digital Ally Healthcare”), TicketSmarter, Inc. (“TicketSmarter”), Worldwide Reinsurance, Ltd., Digital Connect, Inc., BirdVu Jets, Inc., Kustom 440, Inc. (“Kustom 440”), Kustom Entertainment, Inc., and its majority-owned subsidiary Nobility Healthcare, LLC, collectively, “Digital Ally,” “Digital,” and the “Company”), is divided into three reportable operating segments: 1) the Video Solutions Segment, 2) the Revenue Cycle Management Segment and 3) the Ticketing Segment. The Video Solutions Segment is our legacy business that produces digital video imaging, storage products, disinfectant and related safety products for use in law enforcement, security and commercial applications. This segment includes both service and product revenues through our subscription models offering cloud and warranty solutions, and hardware sales for video and health safety solutions. The Revenue Cycle Management Segment provides working capital and back-office services to a variety of healthcare organizations throughout the country, as a monthly service fee. The Entertainment Segment acts as an intermediary between ticket buyers and sellers within our secondary ticketing platform, ticketsmarter.com, and we also acquire tickets from primary sellers to then sell through various platforms. The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information of those segments to be presented in financial statements. Such required segment information is included in Note 18.

 

Reverse Stock Split

 

On February 6, 2023, the Company filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada to effect a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the shares of its common stock. The Reverse Stock Split was effective as of time of filing. No fractional shares were issued in connection with the Reverse Stock Split. Any fractional shares of our Common Stock that would have otherwise resulted from the Reverse Stock Split were rounded up to the nearest whole number. In connection with the Reverse Stock Split, the board of directors of the Company approved appropriate and proportional adjustments to all outstanding securities or other rights convertible or exercisable into shares of the Company’s common stock, including, without limitation, all preferred stock, warrants, options, and other equity compensation rights. All historical share and per-share amounts reflected throughout the Company’s consolidated financial statements and other financial information in this Report have been adjusted to reflect the Reverse Stock Split as if the split occurred as of the earliest period presented. The par value per share of the Company’s common stock was not affected by the Reverse Stock Split.

 

7

 

 

Business Combination

 

In June 2023, the Company, entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Clover Leaf Capital Corp., a Delaware corporation (Nasdaq: CLOE) (“Clover Leaf”), CL Merger Sub, Inc., a Nevada corporation and a wholly owned subsidiary of Clover Leaf (“Merger Sub”), Yntegra Capital Investments LLC, a Delaware limited liability company, in the capacity as the representative from and after the Effective Time (as defined in the Merger Agreement) for the stockholders of Clover Leaf in accordance with the terms and conditions of the Merger Agreement, and Kustom Entertainment, Inc., a Nevada corporation, a wholly owned subsidiary of the Company, with a focus and mission to own and produce events, festivals, and entertainment alongside its evolving primary and secondary ticketing technologies (“Kustom”). Pursuant to the Merger Agreement, subject to the terms and conditions set forth therein upon the consummation of the transactions contemplated by the Merger Agreement (the “Closing”), Merger Sub will merge with and into Kustom, with Kustom continuing as the surviving corporation in the Merger and a wholly owned subsidiary of Clover Leaf. Upon the Closing which is subject to the approval of Clover Leaf’s shareholders and the satisfaction or waiver of certain other customary closing conditions, the common stock of the combined company is expected to be listed on the Nasdaq under a mutually agreed new ticker symbol that reflects the name “Kustom Entertainment”.

 

Basis of Presentation:

 

The unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.

 

The balance sheet at December 31, 2023 has been derived from the audited financial statements at that date, but does not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements.

 

For further information, refer to the audited financial statements and footnotes included in the Company’s annual report on Form 10-K for the year ended December 31, 2023.

 

Liquidity and Going Concern

 

During the second quarter of 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. This update provided U.S. GAAP guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. Under this standard, the Company is required to evaluate whether there is substantial doubt about its ability to continue as a going concern each reporting period, including interim periods. In evaluating the Company’s ability to continue as a going concern, management considered the conditions and events that could raise substantial doubt about the Company’s ability to continue as a going concern within 12 months after the Company’s financial statements were issued (May 15, 2023). Management considered the Company’s current financial condition and liquidity sources, including current funds available, forecasted future cash flows and the Company’s obligations due before May 15, 2024.

 

The Company has experienced net losses and cash outflows from operating activities since inception. For the three months ended March 31, 2024, the Company had a net loss attributable to common stockholders of $3,931,020, net cash used in operating activities of $918,545, $160,830 provided by investing activities and $1,005,027 provided by financing activities. The Company will have to restore positive operating cash flows and profitability over the next year and/or raise additional capital to fund its operational plans, meet its customary payment obligations and otherwise execute its business plan. There can be no assurance that it will be successful in restoring positive cash flows and profitability, or that it can raise additional financing when needed, and obtain it on terms acceptable or favorable to the Company.

 

The Company has implemented an enhanced quality control program to detect and correct product issues before they result in significant rework expenditures affecting its gross margins and has seen progress in that regard. The Company has also implemented a marketing and advertisement reduction plan for its entertainment segment, which will focus on reducing and alleviating current obligations from its media marketing agreements and place a hold on entering into any new agreements. The Company believes that its quality control, cost-cutting initiatives, and new product introduction will eventually restore positive operating cash flows and profitability, although it can offer no assurances in this regard.

 

Management has evaluated the significance of the conditions described above in relation to the Company’s ability to meet its obligations and concluded that, without additional funding, the Company will not have sufficient funds to meet its obligations within one year from the date the unaudited condensed consolidated financial statements were issued.

 

Basis of Consolidation:

 

The accompanying financial statements include the consolidated accounts of Digital Ally, its wholly-owned subsidiaries, Digital Ally International, Inc., Shield Products, LLC, Digital Ally Healthcare, LLC, TicketSmarter, Inc., Worldwide Reinsurance, Ltd., Digital Connect, Inc., BirdVu Jets, Inc., Kustom 440, Inc., and its majority-owned subsidiary Nobility Healthcare, LLC. All intercompany balances and transactions have been eliminated during consolidation.

 

8

 

 

The Company formed Digital Ally International, Inc. during August 2009 to facilitate the export sales of its products. The Company formed Shield Products, LLC in May 2020 to facilitate the sales of its Shield™ line of disinfectant/cleanser products and ThermoVu™ line of temperature monitoring equipment. The Company formed Nobility Healthcare, LLC (“Nobility Healthcare”) in June 2021 to facilitate the operations of its revenue cycle management solutions and back-office services for healthcare organizations. The Company formed TicketSmarter, Inc. upon its acquisition of Goody Tickets, LLC and TicketSmarter, LLC, to facilitate its global ticketing operations. The Company formed Worldwide Reinsurance Ltd., which is a captive insurance company domiciled in Bermuda. It will provide primarily liability insurance coverage to the Company for which insurance may not be currently available or economically feasible in today’s insurance marketplace. The Company formed Kustom 440, Inc. in 2022 to create unique entertainment experiences directly for consumers, and Kustom Entertainment, Inc. in 2023 to serve as the participant in the Business Combination.

 

Fair Value of Financial Instruments:

 

The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and subordinated notes payable approximate fair value because of the short-term nature of these items.

 

Revenue Recognition:

 

The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

 

The Company has two different revenue streams, product and service, represented through its three segments. The Company reports all revenues on a gross basis, other than service revenues from the Company’s entertainment and revenue cycle management segments, Revenues generated by all segments are reported net of sales taxes.

 

Video Solutions

 

The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situation where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e. when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement products. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

 

9

 

 

Service and other revenue is comprised of revenues from extended warranties, repair services, cloud revenue and software revenue. Revenue is recognized upon shipment of the product and acceptance of the service or materials by the end customer for repair services. Revenue for extended warranty, cloud service or other software-based products is over the term of the contract warranty or service period. A time-elapsed method is used to measure progress because the Company transfers control evenly over the contractual period. Accordingly, the fixed consideration related to these revenues is generally recognized on a straight-line basis over the contract term, as long as the other revenue recognition criteria have been met.

 

The Company’s multiple performance obligations may include future in-car or body-worn camera devices to be delivered at defined points within a multi-year contract, and in those arrangements, the Company allocates total arrangement consideration over the life of the multi-year contract to future deliverables using management’s best estimate of selling price.

 

Revenue Cycle Management

 

The Company reports revenue cycle management revenues on a net basis, as its primary source of revenue is its end-to-end service fees which is generally determined as a percentage of the invoice amounts collected. These service fees are reported as revenue monthly upon completion of the Company’s performance obligation to provide the agreed upon service.

 

Entertainment

 

The Company reports ticketing revenue on a gross or net basis based on management’s assessment of whether the Company is acting as a principal or agent in the transaction. The determination is based upon the evaluation of control over the event ticket, including the right to sell the ticket, prior to its transfer to the ticket buyer.

 

The Company sells tickets held in inventory, which consists of one performance obligation, being to transfer control of an event ticket to the buyer upon confirmation of the order. The Company acts as the principal in these transactions as the ticket is owned by the Company at the time of sale, therefore controlling the ticket prior to transferring to the customer. In these transactions, revenue is recorded on a gross basis based on the value of the ticket and is recognized when an order is confirmed. Payment is typically due upon delivery of the ticket.

 

The Company also acts as an intermediary between buyers and sellers through online secondary marketplace. Revenues derived from this marketplace primarily consist of service fees from ticketing operations, and consists of one primary performance obligation, which is facilitating the transaction between the buyer and seller, being satisfied at the time the order has been confirmed. As the Company does not control the ticket prior to the transfer, the Company acts as an agent in these transactions. Revenue is recognized on a net basis, net of the amount due to the seller when an order is confirmed, the seller is then obligated to deliver the tickets to the buyer per the seller’s listing. Payment is due at the time of sale.

 

Other

 

Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract and are reported separately as current liabilities and non-current liabilities in the Consolidated Balance Sheets. Such amounts consist of extended warranty contracts, prepaid cloud services and prepaid installation services and are generally recognized as the respective performance obligations are satisfied. During the three months ended March 31, 2024, the Company recognized revenue of $241,371 related to its contract liabilities. Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract and are reported separately as current liabilities and non-current liabilities in the Consolidated Balance Sheets. Such amounts consist of extended warranty contracts, prepaid cloud services and prepaid installation services and are generally recognized as the respective performance obligations are satisfied. Total contract liabilities consist of the following:

  

		March 31, 2024
		December 31, 2023				Additions/Reclass				Recognized Revenue				March 31, 2024
Contract liabilities, current		$	2,937,168			$	535,598			$	173,052			$	3,299,714
Contract liabilities, non-current			7,340,459				13,066				68,319				7,285,206
		$	10,277,627			$	548,664			$	241,371			$	10,584,920

 

		March 31, 2023
		December 31, 2022				Additions/Reclass				Recognized Revenue				March 31, 2023
Contract liabilities, current		$	2,154,874			$	562,809			$	92,813			$	2,624,870
Contract liabilities, non-current			5,818,082				868,211				370,646				6,315,647
		$	7,972,956			$	1,431,020			$	463,459			$	8,940,517

 

10

 

 

Sales returns and allowances aggregated $93,170 and $117,713 as of March 31, 2024 and December 31, 2023, respectively. Obligations for estimated sales returns and allowances are recognized at the time of sales on an accrual basis. The accrual is determined based upon historical return rates adjusted for known changes in key variables affecting these return rates.

 

Use of Estimates:

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management utilizes various other estimates, including but not limited to determining the estimated lives of long-lived assets, determining the potential impairment of long-lived assets, the fair value of warrants, options, the recognition of revenue, allowance for doubtful accounts, the estimate of fair value of the lease liabilities and related right of use asset, inventory valuation reserve, fair value of assets and liabilities acquired in a business combination, incremental borrowing rate on leases, the valuation allowance for deferred tax assets and other legal claims and contingencies. The results of any changes in accounting estimates are reflected in the financial statements in the period in which the changes become evident. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the period that they are determined to be necessary.

 

Cash and cash equivalents:

 

Cash and cash equivalents include funds on hand, in bank and short-term investments with original maturities of ninety (90) days or less. The following table shows the Company’s cash and cash equivalents by significant investment category as of March 31, 2024 and December 31, 2023:

  

		March 31, 2024
		Adjusted Cost				Realized Gains				Realized Losses				Fair Value
Demand deposits		$	769,982			$	—			$	—			$	769,982
Short-term investments with original maturities of 90 days or less (Level 1):
Money market funds			157,879				—				—				157,879
		$	927,861			$	—			$	—			$	927,861

 

		December 31, 2023
		Adjusted Cost				Realized Gains				Realized Losses				Fair Value
Demand deposits		$	545,207			$	—			$	—			$	545,207
Short-term investments with original maturities of 90 days or less (Level 1):
Money market funds			135,342				—				—				135,342
		$	680,549			$	—			$	—			$	680,549

 

The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At March 31, 2024 and December 31, 2023, the uninsured balance amounted to $296,799 and $29,700, respectively.

 

11

 

 

Restricted Cash:

 

Restricted cash of $97,600 and $97,600 was included in other assets as of March 31, 2024 and December 31, 2023, respectively. Restricted cash consists of bank deposits that collateralize our debt obligations.

 

The following table provides a reconciliation of cash and cash equivalents in the consolidated balance sheets to cash, cash equivalents and restricted cash in the consolidated statements of cash flows:

  

		March 31, 2024				December 31, 2023
Cash and cash equivalents		$	927,861			$	680,549
Long-term restricted cash included in other assets			97,600				97,600
Total cash, cash equivalents and restricted cash in the statements of cash flows		$	1,025,461			$	778,149

 

Accounts Receivable:

 

Accounts receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a weekly basis. The Company determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, and current economic conditions.

 

Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received. A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for more than thirty (30) days beyond terms. No interest is charged on overdue trade receivables.

 

Goodwill and Other Intangibles:

 

Goodwill - In connection with acquisitions, the Company applies the provisions of ASC 805, Business Combinations, using the acquisition method of accounting. The excess purchase price over the fair value of net tangible assets and identifiable intangible assets acquired is recorded as goodwill. In accordance with ASC 350, Intangibles - Goodwill and Other, the Company assesses goodwill for impairment annually as of December 31, and more frequently if events and circumstances indicate that goodwill might be impaired.

 

Goodwill impairment testing is performed at the reporting unit level. Goodwill is assigned to reporting units at the date the goodwill is initially recorded. Once goodwill has been assigned to reporting units, it no longer retains its association with a particular acquisition, and all of the activities within a reporting unit, whether acquired or internally generated, are available to support the value of the goodwill.

 

Traditionally, goodwill impairment testing is a two-step process. Step one involves comparing the fair value of the reporting units to its carrying amount. If the carrying amount of a reporting unit is greater than zero and its fair value is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount is greater than the fair value, the second step must be completed to measure the amount of impairment, if any. Step two involves calculating an implied fair value of goodwill. The Company has adopted ASU 2017-04 which simplifies subsequent goodwill measurement by eliminating step two from the goodwill impairment test. As a result, the Company compares the fair value of a reporting unit with its respective carrying value and recognized an impairment charge for the amount by which the carrying amount exceeded the reporting unit’s fair value.

 

12

 

 

The Company determines the fair value of its reporting units using the market approach. Under the market approach, we estimate the fair value based on multiples of comparable public companies and precedent transactions. Significant estimates in the market approach include: identifying similar companies with comparable business factors such as size, growth, profitability, risk and return on investment, and assessing comparable revenue and operating income multiples in estimating the fair value of the reporting unit.

 

Long-lived and Other Intangible Assets - The Company periodically assesses potential impairments of its long-lived assets in accordance with the provisions of ASC 360, Accounting for the Impairment or Disposal of Long-lived Assets. An impairment review is performed whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. The Company groups its assets at the lowest level for which identifiable cash flows are largely independent of the cash flows of the other assets and liabilities. The Company has determined that the lowest level for which identifiable cash flows are available is the operating segment level.

 

Factors considered by the Company include, but are not limited to, significant underperformance relative to historical or projected operating results; significant changes in the manner of use of the acquired assets or the strategy for the overall business; and significant negative industry or economic trends. When the carrying value of a long-lived asset may not be recoverable based upon the existence of one or more of the above indicators of impairment, the Company estimates the future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the sum of the expected future undiscounted cash flows and eventual disposition is less than the carrying amount of the asset, the Company recognizes an impairment loss. An impairment loss is reflected as the amount by which the carrying amount of the asset exceeds the fair value of the asset, based on the fair value if available, or discounted cash flows, if fair value is not available. The Company last assessed potential impairments of its long-lived assets as of December 31, 2023 and concluded that there was no impairment. Subsequent to completing our 2023 annual impairment test, no events or changes in circumstances were noted that required an interim goodwill impairment test.

 

Intangible assets include deferred patent costs, license agreements, trademarks and trade names. Legal expenses incurred in preparation of patent application have been deferred and will be amortized over the useful life of granted patents. Costs incurred in preparation of applications that are not granted will be charged to expense at that time. The Company has entered into several sublicense agreements under which it has been assigned the exclusive rights to certain licensed materials used in its products. These sublicense agreements generally require upfront payments to obtain the exclusive rights to such material. The Company capitalizes the upfront payments as intangible assets and amortizes such costs over their estimated useful life on a straight-line method.

 

Segment Reporting

 

The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information of those segments to be presented in financial statements. Operating segments are identified as components of an enterprise for which separate discrete financial information is available for evaluation by the chief operating decision maker (the Company’s Chief Executive Officer or “CODM”) in making decisions on how to allocate resources and assess performance. The Company’s three operating segments are Video Solutions, Revenue Cycle Management, and Entertainment, each of which has specific personnel responsible for that business and reports to the CODM. Corporate expenses capture the Company’s corporate administrative activities and are also to be reported in the segment information.

 

Contingent Consideration

 

In circumstances where an acquisition involves a contingent consideration arrangement that meets the definition of a liability under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity, the Company recognizes a liability equal to the fair value of the contingent payments the Company expects to make as of the acquisition date. The Company remeasures this liability each reporting period and records changes in the fair value through the consolidated statement of operations.

 

13

 

 

Non-Controlling Interests

 

Non-controlling interests in the Company’s Consolidated Financial Statements represent the interest in subsidiaries held by our venture partner. The venture partner holds a noncontrolling interest in the Company’s consolidated subsidiary Nobility Healthcare, LLC. Since the Company consolidates the financial statements of all wholly-owned and majority owned subsidiaries, the noncontrolling owners’ share of each subsidiary’s results of operations are deducted and reported as net income or loss attributable to noncontrolling interest in the Consolidated Statements of Operations.

 

New Accounting Standards

 

In November 2023, the FASB issued Accounting Standards Update No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The guidance is to be applied retrospectively to all prior periods presented in the financial statements. Upon transition, the segment expense categories and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in the period of adoption. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.

 

In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.

 

NOTE 2. INVENTORIES

 

Inventories consisted of the following at March 31, 2024 and December 31, 2023:

  

		March 31, 2024				December 31, 2023
Raw material and component parts– video solutions segment		$	2,938,434			$	3,044,653
Work-in-process– video solutions segment			26,091				20,396
Finished goods – video solutions segment			4,180,699				4,623,489
Finished goods – entertainment segment			489,854				699,204
Subtotal			7,635,078				8,387,742
Reserve for excess and obsolete inventory– video solutions segment			(4,315,132	)			(4,355,666	)
Reserve for excess and obsolete inventory – entertainment segment			(171,257	)			(186,795	)
Total inventories		$	3,148,689			$	3,845,281

 

14

 

 

Finished goods inventory includes units held by potential customers and sales agents for test and evaluation purposes. The cost of such units totaled $51,099 and $42,797 as of March 31, 2024 and December 31, 2023, respectively.

 

NOTE 3. DEBT OBLIGATIONS

 

Debt obligations is comprised of the following:

   

		March 31, 2024				December 31, 2023
Economic injury disaster loan (EIDL)		$	146,971			$	147,781
Contingent consideration promissory note – Nobility Healthcare Division Acquisition			64,826				129,651
Contingent consideration promissory note – Nobility Healthcare Division Acquisition			29,409				58,819
Revolving Loan Agreement			4,880,000				4,880,000
Commercial Extension of Credit- Entertainment Segment			69,643				87,928
Merchant Advances – Video Solutions Segment			1,348,000				1,350,000
Merchant Advances – Entertainment Segment			1,425,000				—
Unamortized debt issuance costs			(684,989	)			(540,429	)
Debt obligations			7,278,860				6,113,750
Less: current maturities of debt obligations			2,403,029				1,260,513
Debt obligations, long-term		$	4,875,831			$	4,853,237

 

Debt obligations mature as follows as of March 31, 2024:

 

		March 31, 2024
2024		$	2,402,188
2025			4,735,589
2026			3,542
2027			3,677
2028 and thereafter			133,864
Total		$	7,278,860

 

2020 Small Business Administration Notes.

 

On May 12, 2020, the Company received $150,000 in loan funding from the SBA under the Economic Injury Disaster Loan (“EIDL”) program administered by the SBA, which program was expanded pursuant to the recently enacted CARES Act. The EIDL is evidenced by a secured promissory note, dated May 8, 2020, in the original principal amount of $150,000 with the SBA, the lender.

 

Under the terms of the note issued under the EIDL program, interest accrues on the outstanding principal at the rate of 3.75% per annum. The term of such note is thirty years, though it may be payable sooner upon an event of default under such note. Monthly principal and interest payments began in November 2022, after being deferred for thirty months after the date of disbursement and total $731 per month thereafter. Such note may be prepaid in part or in full, at any time, without penalty. The Company granted the SBA a continuing interest in and to any and all collateral, including but not limited to tangible and intangible personal property.

 

15

 

 

The Company made principal payments of $810 during the three months ended March 31, 2024 and recorded interest expense of $1,383.

 

Contingent Consideration Promissory Notes

 

On June 30, 2021, Nobility Healthcare, a subsidiary of the Company, issued a contingent consideration promissory note (the “June Contingent Note”) in connection with a stock purchase agreement between Nobility Healthcare and a private company (the “June Seller”) of $350,000. The June Contingent Note has a three-year term and bears interest at a rate of 3.00% per annum. Quarterly principal and interest payments are deferred for six months and is due in equal quarterly installments on the seventh business day of each quarter. The principal amount of the June Contingent Note is subject to an earn-out adjustment, being the difference between $975,000 (the “June Projected Revenue”) and the cash basis revenue (the “June Measurement Period Revenue”) collected by the June Seller in its normal course of business from the clients existing on June 30, 2021, during the period from October 1, 2021 through September 30, 2022 (the “June Measurement Period”) measured on a quarterly basis and annualized as of the relevant period. If the June Measurement Period Revenue is less than the June Projected Revenue, such amount will be subtracted from the principal balance of this June Contingent Note on a dollar-for-dollar basis. If the June Measurement Period Revenue is more than the June Projected Revenue, such amount will be added to the principal balance of this June Contingent Note on a dollar-for-dollar basis. In no event will the principal balance of this June Contingent Note become a negative number. The maximum downward earn-out adjustment to the principal balance will be a reduction to zero. There are no limits to the increases to the principal balance of the June Contingent Note as a result of the earn-out adjustments.

 

The June Contingent Note is considered to be additional purchase price; therefore, the estimated fair value of the contingent liability is recorded as a liability at the acquisition date and the fair value is considered part of the consideration paid for the acquisition with subsequent changes in fair value recorded as a gain or loss in the Consolidated Statements of Operations. Management recorded the contingent consideration promissory note at its estimated fair value of $350,000 at the acquisition date. Total principal payments, since inception, on this contingent consideration promissory note totaled $261,543. The estimated fair value of the June Contingent Note at March 31, 2024 is $29,409, representing a reduction in its estimated fair value of $29,409 as compared to its estimated fair value as of December 31, 2023. This reduction only relates to the principal payments made for the three months ended March 31, 2024. Therefore, the Company recorded no gain or loss in the Consolidated Statements of Operations for the three months ended March 31, 2024.

 

On August 31, 2021, Nobility Healthcare, issued another contingent consideration promissory note (the “August Contingent Payment Note”) in connection with a stock purchase agreement between Nobility Healthcare and a private company (the “August Sellers”) of $650,000. The August Contingent Payment Note has a three-year term and bears interest at a rate of 3.00% per annum. Quarterly principal and interest payments are deferred for six months and is due in equal quarterly installments on the seventh business day of each quarter. The principal amount of the August Contingent Payment Note is subject to an earn-out adjustment, being the difference between the $3,000,000 (the “August Projected Revenue”) and the cash basis revenue (the “August Measurement Period Revenue”) collected by the August Sellers in its normal course of business from the clients existing on September 1, 2021, during the period from December 1, 2021 through November 30, 2022 (the “August Measurement Period”) measured on a quarterly basis and annualized as of the relevant period. If the August Measurement Period Revenue is less than the August Projected Revenue, such amount will be subtracted from the principal balance of this August Contingent Payment Note on a dollar-for-dollar basis. If the August Measurement Period Revenue is more than the August Projected Revenue, such amount will be added to the principal balance of this August Contingent Payment Note on a dollar-for-dollar basis. In no event will the principal balance of this August Contingent Payment Note become a negative number. The maximum downward earn-out adjustment to the principal balance will be to zero. There are no limits to the increases to the principal balance of the August Contingent Payment Note as a result of the earn-out adjustments.

 

The August Contingent Payment Note is considered to be additional purchase price, therefore the estimated fair value of the contingent liability is recorded as a liability at the acquisition date and the fair value is considered part of the consideration paid for the acquisition. Management has recorded the contingent consideration promissory note at its estimated fair value of $650,000 at the acquisition date. Principal payments, since its inception, on this contingent consideration promissory note totaled $617,082. The estimated fair value of the August Contingent Note at March 31, 2024 is $64,826, representing a decrease in its estimated fair value of $64,826 as compared to is estimated fair value as of December 31, 2023. This reduction only relates to the principal payments made for the three months ended March 31, 2024. Therefore, the Company recorded no gain or loss in the Consolidated Statements of Operations for the three months ended March 31, 2024.

 

16

 

 

2023 Commercial Extension of Credit

 

On February 23, 2023, the Company’s Entertainment segment entered into an extension of credit in the form of a loan to use in marketing and operating its business in accordance with the Private Label Agreement previously entered into with the Lender. The Lender agreed to extend, subject to the conditions hereof, and Borrower agreed to take, a Loan for Principal Sum of $1,000,000.

 

Lender shall retain 25% of each remittance owed to Borrower under the terms of the Private Label Agreement. Such remittances shall include regular weekly remittances and any additional incentive payments to which the Borrower may be entitled. The 25% withholding of the Borrower’s applicable remittance shall be deemed a “Payment” under the terms of this Note, and Payments shall continue until the earlier of (i) repayment of the Principal Sum, accrued Interest, and a fee of $35,000 or (ii) expiration of the Private Label Agreement on December 31, 2023.

 

During the three months ended March 31, 2024, the Entertainment segment Company’s Entertainment segment repaid the outstanding principal of $87,928 and did not renew this agreement.

 

2024 Commercial Extension of Credit

 

On January 22, 2024, the Company’s Entertainment segment entered into an extension of credit in the form of a loan to use in marketing and operating its business in accordance with the Ticket Solution Agreement. The Lender, Ticket Evolution, Inc., agreed to extend, subject to the conditions hereof, and Borrower agreed to take, a Loan for Principal Sum of $75,000 with monthly advances of $100,000.

 

The advances made are recoupable from client service fees with no more than $25,000 being recouped in any one week. The total advances received for the three months ended March 31, 2024 were $275,000 and payments made totaled $205,357. The outstanding balance as of March 31, 2024 was $69,643.

 

17

 

 

Convertible Note

 

On April 5, 2023, the Company entered into and consummated the initial closing (the “First Closing”) of the transactions contemplated by a Securities Purchase Agreement, dated as of April 5, 2023 (the “Purchase Agreement”), between the Company and certain investors (the “Purchasers”).

 

At the First Closing, the Company issued and sold to the Purchasers Senior Secured Convertible Notes in the aggregate original principal amount of $3,000,000 (the “Notes”) and warrants (the “Warrants”). The Purchase Agreement provided for a ten percent (10%) original interest discount resulting in gross proceeds to the Company of $2,700,000. No interest accrues under the Notes. The Warrants are exercisable for an aggregate 1,125,000 shares comprised of 375,000 warrants at an exercise price of $5.50 per share of the Company’s common stock, par value $0.001 (the “Common Stock”), 375,000 warrants at an exercise price of $6.50 per share of Common Stock, and 375,000 warrants at an exercise price of $7.50 per share of Common Stock.

 

Subject to certain conditions, within 18 months from the effectiveness date and while the Notes remain outstanding, the Purchasers have the right to require the Company to consummate a second closing of up to an additional $3,000,000 of Notes (the “Second Notes”) and Warrants on the same terms and conditions as the First Closing, except that the Second Notes may be subordinate to a mortgage on the Company’s headquarters building (the “Bank Mortgage”).

 

The Notes are convertible into shares of Common Stock at the election of the Purchasers at any time at a fixed conversion price of $5.00 (the “Conversion Price”) per share of Common Stock. The Conversion Price is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like, and subject to price-based adjustment in the event of any issuances of Common Stock, or securities convertible, exercisable or exchangeable for, Common Stock at a price below the then-applicable Conversion Price (subject to certain exceptions). Subject to certain conditions, including certain equity conditions, the Company may redeem some or all of the then outstanding principal amount of the Note for cash in an amount equal to 110% of the outstanding principal amount of the Notes (the “Optional Redemption Amount”). In addition, the Purchasers may, at their option, demand repayment at the Optional Redemption Amount upon five (5) business days’ written notice following (i) the closing by the Company of the Bank Mortgage, or (ii) a sale by the Company of Common Stock or Common Stock equivalents.

 

The Notes rank senior to all outstanding and future indebtedness of the Company and its subsidiaries, and are secured by substantially all of the Company’s assets, as evidenced by (i) a security agreement entered into at the Closing, (ii) a trademark security agreement entered into at the Closing, (iii) a patent security agreement entered into at the Closing, (iv) a guaranty executed by all direct and indirect subsidiaries of the Company pursuant to which each of them has agreed to guaranty the obligations of the Company under the Notes, and (v) a mortgage on the Company’s headquarters building in favor of the Purchasers.

 

Also at the Closing, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Purchasers. Pursuant to the terms of the Registration Rights Agreement, the Company has agreed to prepare and file with the SEC within the 10th business day following the First Closing (the “Filing Date”) a registration statement covering the resale of the shares of Common Stock issuable upon conversion of the Notes and exercise of the Warrants, and to use its best efforts to cause such Registration Statement to be declared effective under the Securities Act of 1933, as amended (the “Securities Act”), as promptly as possible, but in any event no later than 45 days following the Filing Date (the “Effectiveness Date”). If the Registration Statement is not filed by the Filing Date or is not declared effective by the Effectiveness Date, or under certain other circumstances described in the Registration Rights Agreement, then the Company shall be obligated to pay, as partial liquidated damages, to each Purchaser an amount in cash equal to 2% of the original principal amount of the Notes each month until the applicable event giving rise to such payments is cured. If the Company fails to pay any partial liquidated damages in full within seven days after the date payable, the Company will pay interest thereon at a rate of 10% per annum.

 

18

 

 

The Company recognized the full warrant derivative value, with the remaining amount being allocated to the debt obligation. As the warrant derivative value exceeded the net proceeds from the issuance, the excess amount is recognized as a loss on the date of the issue date. Thus, the Company recorded a loss of $576,380 as an interest expense on the date of issuance relating to the Notes. The following is the assumptions used in calculating the estimated grant-date fair value of the detachable warrants to purchase common stock granted in connection with the Notes:

  

		Terms at April 5, 2023 (issuance date)
Volatility - range			106.0	%
Risk-free rate			3.36	%
Dividend			0	%
Remaining contractual term			5.0 years
Exercise price		$	5.50 – 7.50
Common stock issuable under the warrants			1,125,000

 

On June 2, 2023, the Purchasers elected to convert $125,000 principal, at the fixed price of $5.00 per share of common stock, 25,000 shares valued at $119,750. The loss on conversion of convertible note into common shares, of $93,386, was recorded during the period.

 

On October 26, 2023, the Company entered into a Revolving Loan Agreement of which a portion of the net proceeds were used to repay the principal amount of the Convertible debt. The warrants associated with the convertible debt remain outstanding.

 

Revolving Loan Agreement

 

On October 26, 2023, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) by and between the Company, Digital Ally Healthcare, Inc., a Nevada corporation and wholly-owned subsidiary of the Company (“Digital Ally Healthcare” and, together with the Company, the “Borrower”), and Kompass Kapital Funding, LLC, a Kansas limited liability company (“Kompass”). In connection with the Loan Agreement, on October 26, 2023, the Company entered into a Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing (the “Mortgage”) by and between the Company, as grantor, and Kompass, as grantee, and issued a Revolving Note (the “Revolving Note”) to Kompass. The gross proceeds to the Company were $4,880,000 before repaying those certain Senior Secured Convertible Notes issued on April 5, 2023 in the aggregate amount of $3,162,500 and paying customary fees and expenses.

 

Pursuant to the Loan Agreement, Kompass agreed to make revolving loans (the “Revolving Loans”) available to the Borrower as the Borrower may from time to time request until, but not including, October 26, 2025, and in such amounts as the Borrower may from time to time request, provided, however, that the aggregate principal balance of the Revolving Loans outstanding at any time shall not exceed the lesser of $4,880,000 or an amount equal to eighty percent of the value of the mortgaged property, which consists of the real property owned by the Company having an address of 14001 Marshall Drive, Lenexa, KS 66215 (the “Mortgaged Property”). Under the Loan Agreement, the Revolving Loans made by Kompass may be repaid and, subject to customary terms and conditions, borrowed again up to, but not including October 26, 2025, unless the Revolving Loans are otherwise accelerated, terminated or extended as provided in the Loan Agreement. The Revolving Loans shall be used by the Borrower for the purpose of working capital and to retire existing debt. Under the Loan Agreement, the Borrower is required to provide written notice to Kompass prior to creating, assuming or incurring any debt or becoming liable, whether as endorser, guarantor, surety or otherwise, for any debt or obligation of any other party. While obligations remain outstanding under the Loan Agreement, the Borrower is required to maintain a minimum balance of $97,600 in a reserve account (the “Capital Reserve Account”). Under the Loan Agreement, the Borrower is prohibited from creating, assuming, incurring or suffering or permitting to exist any lien of any kind or character upon the collateral, which consists of the Mortgaged Property and the Company’s interest in the Capital Reserve Account. The Loan Agreement contains customary covenants, representations and warranties by the Borrower.

 

19

 

 

Pursuant to the Loan Agreement, the Company issued the Revolving Note to Kompass whereby the Company and Digital Ally Healthcare jointly and severally promise to pay to the order of Kompass the lesser of (i) $4,880,000.00, or (ii) the aggregate principal amount of all Revolving Loans outstanding under and pursuant to the Loan Agreement at the maturity or maturities and in the amount or amounts stated on the records of Kompass, together with interest (computed on the actual number of days elapsed on the basis of a 360 day year) at a floating per annum rate equal to the greater of (i) the Prime Rate plus four percent or (ii) eight percent, on the aggregate principal amount of all Revolving Loans outstanding from time to time as provided in the Loan Agreement.

 

The Company entered into the Mortgage to secure its obligations under the Loan Agreement. The property mortgaged under the Mortgage consists of the Mortgaged Property. The Mortgage contains customary covenants, representations and warranties by the Company. In addition, the Company recorded debt issuance costs of $188,255. During the three months ended March 31, 2024, the Company amortized $23,435 of debt discount under interest expense.

 

Merchant Cash Advances – Video Solutions Segment

 

In November 2023, the Company obtained a short-term merchant advance, which totaled $1,050,000, from a single lender to fund operations. These advances included origination fees totaling $50,000 for net proceeds of $1,000,000. The advance is, for the most part, secured by expected future sales transactions of the Company with expected payments on a weekly basis. The Company will repay an aggregate of $1,512,000 to the lender. The loan bears interest at 2.9% per week. During the three months ended March 31, 2024, the Company made repayments totaling $702,000 and received additional proceeds of $700,000. As of March 31, 2024 the outstanding balance was $1,348,000 which is expected to be repaid in 2024.

 

During the three months ended March 31, 2024 the Company amortized $278,256 of debt discount under interest expense.

 

Merchant Cash Advances – Entertainment Segment

 

In March 2024, the Company obtained a short-term merchant advance, which totaled $1,000,000, from a single lender to fund operations. These advances included origination and issuance fees totaling $85,000 for net proceeds of $915,000. The advance is, for the most part, is secured by expected future sales transactions of the Company with expected payments on a weekly basis. The Company will repay an aggregate of $1,425,000 to the lender. The loan bears interest at 5.05% per annum. During the three months ended March 31, 2024, the Company made no repayments. As of March 31, 2024 the outstanding balance was $1,425,000 which is expected to be repaid in 2024.

 

During the three months ended March 31, 2024 the Company amortized $63,750 of debt discount and issuance costs under interest expense.

 

NOTE 4. FAIR VALUE MEASUREMENT

 

In accordance with ASC Topic 820 — Fair Value Measurements and Disclosures (“ASC 820”), the Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a business.

 

ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

 

●	Level 1 — Quoted prices in active markets for identical assets and liabilities
●	Level 2 — Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities)
●	Level 3 — Significant unobservable inputs (including the Company’s own assumptions in determining the fair value)

 

20

 

 

The following table represents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023:

  

		March 31, 2024
		Level 1				Level 2				Level 3				Total
Liabilities:
Warrant derivative liabilities		$	—			$	—			$	1,718,629			$	1,718,629
Contingent consideration promissory notes and contingent consideration earn-out agreement			—				—				94,235				94,235
		$	—			$	—			$	1,812,864			$	1,812,864

 

		December 31, 2023
		Level 1				Level 2				Level 3				Total
Liabilities:
Warrant derivative liabilities		$	—			$	—			$	1,369,738			$	1,369,738
Contingent consideration promissory notes and contingent consideration earn-out agreement			—				—				188,470				188,470
		$	—			$	—			$	1,558,208			$	1,558,208

 

The following table represents the change in Level 3 tier value measurements for the three months ended March 31, 2024:

  

		Contingent Consideration Promissory Notes and Earn-Out Agreement				Warrant Derivative Liabilities
Balance, December 31, 2023		$	188,470			$	1,369,738
Issuance of warrant derivative liabilities			—				—
Change in fair value of warrant derivative liabilities			—				348,891
Principal payments on contingent consideration promissory notes – Revenue Cycle Management Acquisitions			(94,235	)			—
Change in fair value of contingent consideration promissory notes - Revenue Cycle Management Acquisitions			—				—
Balance, March 31, 2024		$	94,235			$	1,718,629

 

21

 

 

NOTE 5. ACCRUED EXPENSES

 

Accrued expenses consisted of the following at March 31, 2024 and December 31, 2023:

  

		March 31, 2024				December 31, 2023
Accrued warranty expense		$	20,529			$	17,699
Accrued litigation costs			2,040,292				2,040,292
Accrued sales commissions			40,000				87,421
Accrued payroll and related fringes			161,763				367,826
Accrued sales returns and allowances			93,170				117,713
Accrued taxes			66,114				150,981
Accrued interest - related party			187,346				95,031
Customer deposits			45,380				219,462
Other			482,550				172,905
		$	3,137,144			$	3,269,330

 

Accrued warranty expense was comprised of the following for the three months ended March 31, 2024:

  

Beginning balance		$	17,699
Provision for warranty expense			14,201
Charges applied to warranty reserve			(11,371	)
Ending balance		$	20,529

 

NOTE 6. INCOME TAXES

 

The effective tax rate for the three months ended March 31, 2024 and 2023 varied from the expected statutory rate due to the Company continuing to provide a 100% valuation allowance on net deferred tax assets. The Company determined that it was appropriate to continue the full valuation allowance on net deferred tax assets as of March 31, 2024, primarily because of the Company’s history of operating losses.

 

The Company has incurred operating losses in recent years, and it continues to be in a three-year cumulative loss position at March 31, 2024. Accordingly, the Company determined there was not sufficient positive evidence regarding its potential for future profits to outweigh the negative evidence of our three-year cumulative loss position under the guidance provided in ASC 740. Therefore, it is determined to continue to provide a 100% valuation allowance on its net deferred tax assets. The Company expects to continue to maintain a full valuation allowance until it determines that it can sustain a level of profitability that demonstrates its ability to realize these assets. To the extent the Company determines that the realization of some or all of these benefits is more likely than not based upon expected future taxable income, a portion or all of the valuation allowance will be reversed. The Company has available to it approximately $140.9 million (based on its December 31, 2023 tax return) in net operating loss carryforwards to offset future taxable income as of March 31, 2024.

 

NOTE 7. PREPAID EXPENSES

 

Prepaid expenses were the following at March 31, 2024 and December 31, 2023: 

  

		March 31, 2024				December 31, 2023
Prepaid inventory		$	5,570,087			$	5,318,939
Prepaid advertising			485,429				612,292
Other			519,497				435,137
Total prepaid expenses		$	6,575,013			$	6,366,368

 

22

 

 

NOTE 8. PROPERTY, PLANT AND EQUIPMENT

 

Property, plant and equipment consisted of the following at March 31, 2024 and December 31, 2023:

  

		Estimated Useful Life		March 31, 2024				December 31, 2023
Building		25 years		$	4,537,037			$	4,537,037
Land		Infinite			739,734				739,734
Office furniture, fixtures, equipment, and aircraft		3-20 years			826,929				2,065,092
Warehouse and production equipment		3-7 years			239,055				29,055
Demonstration and tradeshow equipment		3-7 years			87,987				87,987
Building improvements		5-7 years			1,328,654				1,328,654
Total cost					7,759,396				8,787,559
Less: accumulated depreciation and amortization					(1,551,601	)			(1,503,857	)
Net property, plant and equipment				$	6,207,795			$	7,283,702

 

Depreciation expense for the three months ended March 31, 2024 and 2023 was $162,712 and $171,631, respectively, and is included in general and administrative expenses.

 

During the three months ended March 31, 2024 the Company engaged a broker and sold its aircraft for $1,100,000 less closing costs of $1,500. The carrying amount of the aircraft on the date of sale was $1,141,661. As a result of the sale the Company recorded a loss of $41,161 in the Consolidated Statement of Operations.

 

NOTE 9. OPERATING LEASE

 

The Company entered into an operating lease with a third party in October 2023 for copiers used for office and warehouse purposes. The terms of the lease include 48 monthly payments of $1,786 with a maturity date of October 2027. The Company has the option to purchase such equipment at maturity for its estimated fair market value at that point in time. The remaining lease term for the Company’s copier operating lease as of March 31, 2024 was forty-three months.

 

On May 13, 2020, the Company entered into an operating lease for new warehouse and office space, which served as its new principal executive office and primary business location. The original lease agreement was amended on August 28, 2020 to correct the footage under lease and monthly payment amounts resulting from such correction. The lease terms, as amended include no base rent for the first nine months and monthly payments ranging from $12,398 to $14,741 thereafter, with a termination date of December 2026. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to its new location. The Company took possession of the leased facilities on June 15, 2020. The remaining lease term for the Company’s office and warehouse operating lease as of March 31, 2024 was thirty-three months.

 

On June 30, 2021, the Company completed the acquisition of its first medical billing company, through Nobility Healthcare. Upon completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $2,648 to $2,774 thereafter, with a termination date in July 2024. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The remaining lease term for the Company’s office operating lease as of March 31, 2024 was four months.

 

On August 31, 2021, the Company completed the acquisition of its second acquired medical billing company, through Nobility Healthcare. Upon completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space. The lease was renewed in April 2023 with favorable terms and payments ranging from $7,436 to $8,877 thereafter, with a termination date in March 2030. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The remaining term for the Company’s office operating lease was seventy-two months as of March 31, 2024.

 

On September 1, 2021, the Company completed the acquisition of Goody Tickets, LLC and TicketSmarter, LLC through TicketSmarter. Upon completion of this acquisition, the Company became responsible for the operating lease for TicketSmarter’s office space. The lease terms include monthly payments ranging from $7,211 to $7,364 thereafter, with a termination date of December 2022. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The Company took possession of the leased facilities on September 1, 2021. The Company currently rents this space on a month-to-month basis with intentions to relocate upon the identification of suitable space.

 

23

 

 

On January 1, 2022, the Company completed the acquisition of a private medical billing company, through its revenue cycle management segment. Upon completion of this acquisition, the Company became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $4,233 to $4,626, with a termination date of June 2025. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The Company took possession of the leased facilities on January 1, 2022. The Company terminated this lease in January 2024 and reversed the right of use asset and lease liability by $73,894.

 

Lease expense related to the office space and copier operating leases were recorded on a straight-line basis over their respective lease terms. Total lease expense under the operating leases was approximately $108,879 during the three months ended March 31, 2023.

 

The weighted-average remaining lease term related to the Company’s lease liabilities as of March 31, 2023 was 4.5 years.

 

The discount rate implicit within the Company’s operating leases was not generally determinable and therefore the Company determined the discount rate based on its incremental borrowing rate on the information available at commencement date. As of commencement date, the operating lease liabilities reflect a weighted average discount rate of 8%.

 

The following sets forth the operating lease right of use assets and liabilities as of March 31, 2024:

  

Assets:
Operating lease right of use assets		$	925,128
Liabilities:
Operating lease obligations-current portion		$	225,960
Operating lease obligations-less current portion			749,718
Total operating lease obligations		$	975,678

 

The components of lease expense were as follows for the three months ended March 31, 2024:

 

Selling, general and administrative expenses

$

108,879

 

Following are the minimum lease payments for each year and in total:

  

Year ending December 31:
2023 (April 1, to December 31, 2024)		$	225,247
2024			288,720
2025			293,300
2026			117,492
Thereafter			235,020
Total undiscounted minimum future lease payments			1,159,779
Imputed interest			(184,101	)
Total operating lease liability		$	975,678

 

 

24

 

 

NOTE 10. GOODWILL AND OTHER INTANGIBLE ASSETS

 

Intangible assets consisted of the following at March 31, 2024 and December 31, 2023:

 

Patents and trademarks pending will be amortized beginning at the time they are issued by the appropriate authorities. If issuance of the final patent or trademark is denied, then the amount deferred will be immediately charged to expense.

 

Amortization expense for the three months ended March 31, 2024 and 2023 was $388,278 and $371,478, respectively. Estimated amortization for intangible assets with definite lives for the next five years ending December 31 and thereafter is as follows:

 

		March 31, 2024												December 31, 2023
		Gross value				Accumulated amortization				Net carrying value				Gross value				Accumulated amortization				Net carrying value
Amortized intangible assets:
Licenses (video solutions segment)		$	225,545			$	92,525			$	133,020			$	225,545			$	89,887			$	135,658
Patents and trademarks (video solutions segment)			483,521				306,702				176,819				483,521				266,403				217,118
Sponsorship agreement network (entertainment segment)			5,600,000				2,893,333				2,706,667				5,600,000				2,613,333				2,986,667
SEO content (entertainment segment)			600,000				387,500				212,500				600,000				350,000				250,000
Personal seat licenses (entertainment segment)			87,679				7,542				80,137				180,081				14,004				166,077
Software			23,653				—				23,653
Website enhancements (entertainment segment)			25,630				1,878				23,752				13,500				—				13,500
Client agreements (revenue cycle management segments)			999,034				251,744				747,290				999,034				226,768				772,266
			8,045,062				3,941,224				4,103,838				8,101,681				3,560,395				4,541,286
Indefinite life intangible assets:
Goodwill (entertainment and revenue cycle management segments)			11,593,473				—				11,593,473				11,367,514				—				11,367,514
Trade name (entertainment segment)			900,000				—				900,000				600,000				—				600,000
Patents and trademarks pending (video solutions segment)			27,721				—				27,721				1,622				—				1,622
Total		$	20,566,256			$	3,941,224			$	16,625,032			$	20,070,817			$	3,560,395			$	16,510,422

 

Year ending December 31:
2024 (April 1, to December 31, 2024)		$	1,117,290
2025			1,413,938
2026			909,400
2027			113,600
2028 and thereafter			549,610
		$	4,103,838

 

25

 

 

NOTE 11. OTHER ASSETS

 

Other assets were the following at March 31, 2024 and December 31, 2023:

 

		March 31, 2024				December 31, 2023
Lease receivable		$	5,880,809			$	6,095,050
Restricted Cash			97,600				97,600
Other			354,776				404,382
Total other assets		$	6,333,185			$	6,597,032

 

NOTE 12. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

From time to time, we are notified that we may be a party to a lawsuit or that a claim is being made against us. It is our policy to not disclose the specifics of any claim or threatened lawsuit until the summons and complaint are actually served on us. After carefully assessing the claim, and assuming we determine that we are not at fault or we disagree with the damages or relief demanded, we vigorously defend any lawsuit filed against us. We record a liability when losses are deemed probable and reasonably estimable. When losses are deemed reasonably possible but not probable, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claim, if material for disclosure. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time.

 

On May 31, 2022, the Company filed a lawsuit against Culp McAuley, Inc. (“defendant”) in the United States District Court for the District of Kansas. The lawsuit arises from the defendant’s multiple breaches of its obligations to the Company. The Company seeks monetary damages and injunctive relief based on certain conduct by the defendant. On July 18, 2022, the defendant filed its Answer to the Company’s Verified Complaint and included Counterclaims alleging breach of contract and seeking monetary damages. On August 8, 2022, the Company filed its Reply and Affirmative Defenses to the Counterclaims by, among other things, denying the allegations and any and all liability.

 

As of March 31, 2024, we are able to estimate a range of reasonably possible loss related to the Culp McCauley case, our estimate of the aggregate reasonably possible loss (in excess of any accrued amounts) was approximately $1.8 million. Our estimate with respect to the aggregate reasonably possible loss is based upon currently available information and is subject to significant judgment and a variety of assumptions and known and unknown uncertainties, which may change quickly and significantly from time to time, particularly if and as we engage with applicable governmental agencies or plaintiffs in connection with a proceeding. Also, the matters underlying the reasonably possible loss will change from time to time. As a result, actual results may vary significantly from the current estimate.

 

While the ultimate resolution is unknown, based on the information currently available, we do not expect that these lawsuits will individually, or in the aggregate, have a material adverse effect to our results of operations, financial condition or cash flows. However, the outcome of any litigation is inherently uncertain and there can be no assurance that any expense, liability or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage and will not have a material adverse effect on our operating results, financial condition or cash flows.

 

26

 

 

Notice of Failure to Satisfy a Continued Listing Rule

 

On March 14, 2024, the Nasdaq Listing Qualifications staff notified Digital Ally, Inc. (the “Company”), that due to resignation of Mr. Michael J. Caulfield from the Company’s board of directors (the “Board”) effective on January 31, 2024, the Company no longer complies with the audit committee and compensation committee requirements as set forth in Listing Rule 5605 of The Nasdaq Stock Market LLC (“Nasdaq”), including the requirements that there are at least three independent directors on the Company’s audit committee and at least two independent directors on the Company’s compensation committee.

 

The notification has no immediate effect on the Company’s listing on the Nasdaq Capital Market. In accordance with Nasdaq Listing Rules, the Company is provided a cure period until the earlier of the Company’s next annual shareholders’ meeting (or July 29, 2024 if the next shareholders’ meeting will be held before July 29, 2024) or January 31, 2025 (the “Cure Period”). If the Company does not regain compliance by within the Cure Period, Nasdaq will provide written notice that the Company’s common stock, par value $0.001 per share, will be subject to delisting from the Nasdaq Capital Market, at which time, the Company may appeal the delisting determination to a Hearings Panel.

 

The management of the Company has resolved to take commercially reasonable steps to fill the vacancy on the Board with a new director who qualifies as independent under the Nasdaq Listing Rules as soon as is practical and anticipates regaining compliance during the Cure Period. However, there can be no assurance that the Company will be able to satisfy Nasdaq Listing Rule 5605 or will otherwise be in compliance with other Nasdaq listing criteria.

 

NOTE 13. STOCK-BASED COMPENSATION

 

The Company recorded pre-tax compensation expense related to the grant of stock options and restricted stock issued of $40,695 and $114,848 for the three months ended March 31, 2024 and 2023, respectively.

 

As of March 31, 2024, the Company had adopted ten separate stock option and restricted stock plans: (i) the 2005 Stock Option and Restricted Stock Plan (the “2005 Plan”), (ii) the 2006 Stock Option and Restricted Stock Plan (the “2006 Plan”), (iii) the 2007 Stock Option and Restricted Stock Plan (the “2007 Plan”), (iv) the 2008 Stock Option and Restricted Stock Plan (the “2008 Plan”), (v) the 2011 Stock Option and Restricted Stock Plan (the “2011 Plan”), (vi) the 2013 Stock Option and Restricted Stock Plan (the “2013 Plan”), (vii) the 2015 Stock Option and Restricted Stock Plan (the “2015 Plan”), (viii) the 2018 Stock Option and Restricted Stock Plan (the “2018 Plan”), (ix) the 2020 Stock Option and Restricted Stock Plan (the “2020 Plan”), and (x) the 2022 Stock Option and Restricted Stock Plan (the “2022 Plan”). The 2005 Plan, 2006 Plan, 2007 Plan, 2008 Plan, 2011 Plan, 2013 Plan, 2015 Plan, 2018 Plan, 2020 Plan and 2022 Plan are referred to as the “Plans.”

 

These Plans permit the grant of stock options or restricted stock to its employees, non-employee directors and others for up to a total of 333,750 shares of common stock. The 2005 Plan terminated during 2015 with 1,078 shares not awarded or underlying options, which shares are now unavailable for issuance. Stock options granted under the 2005 Plan that remain unexercised and outstanding as of March 31, 2024 total 284. The 2006 Plan terminated during 2016 with 2,739 shares not awarded or underlying options, which shares are now unavailable for issuance. Stock options granted under the 2006 Plan that remain unexercised and outstanding as of March 31, 2024 total 531. The 2007 Plan terminated during 2017 with 4,733 shares not awarded or underlying options, which shares are now unavailable for issuance. There are no stock options granted under the 2007 Plan that remain unexercised and outstanding as of March 31, 2024. The 2008 Plan terminated during 2018 with 2,025 shares not awarded or underlying options, which shares are now unavailable for issuance. There are no stock options granted under the 2008 Plan that remain unexercised and outstanding as of March 31, 2024.

 

Stock option grants. The Company believes that such awards better align the interests of our employees with those of its stockholders. Option awards have been granted with an exercise price equal to the market price of its stock at the date of grant with such option awards generally vesting based on the completion of continuous service and having ten-year contractual terms. These option awards typically provide for accelerated vesting if there is a change in control (as defined in the Plans). The Company has registered all shares of common stock that are issuable under its Plans with the SEC. A total of 137,042 shares remained available for awards under the various Plans as of March 31, 2024.

 

27

 

 

The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model.

 

A summary of all stock option activity under the Plans for the three months ended March 31, 2024 is as follows: 

 

Options		Number of Shares				Weighted Average Exercise Price
Outstanding at December 31, 2023			53,600			$	45.55
Granted			—				—
Exercised			—				—
Forfeited			—				—
Outstanding at March 31, 2024			53,600			$	45.55
Exercisable at March 31, 2024			53,600			$	45.55

 

The Plans allow for the cashless exercise of stock options. This provision allows the option holder to surrender/cancel options with an intrinsic value equivalent to the purchase/exercise price of other options exercised. There were no shares surrendered pursuant to cashless exercises during the three months ended March 31, 2024 and 2023.

 

The aggregate intrinsic value of options outstanding was $-0- and $-0-, at March 31, 2024 and December 31, 2023, respectively. The aggregate intrinsic value of options exercisable was $-0- and $-0-, at March 31, 2024 and December 31, 2023, respectively.

 

As of March 31, 2024, the unrecognized portion of stock compensation expense on all existing stock options was $-0-.

 

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of March 31, 2024: 

 

Outstanding options

Exercisable options

Exercise price range

Number of options

Weighted average remaining contractual life

Number of options

Weighted average remaining contractual life

$

0.01 to $49.99

37,000

6.4 years

37,000

6.4 years

$

50.00 to $69.99

15,100

4.2 years

15,100

4.2 years

$

70.00 to $89.99

1,500

2.1 years

1,500

2.1 years

53,600

5.6 years

53,600

5.6 years

 

Restricted stock grants. The Board of Directors has granted restricted stock awards under the Plans. Restricted stock awards are valued on the date of grant and have no purchase price for the recipient. Restricted stock awards typically vest over one to five years corresponding to anniversaries of the grant date. Under the Plans, unvested shares of restricted stock awards may be forfeited upon the termination of service to or employment with the Company, depending upon the circumstances of termination. Except for restrictions placed on the transferability of restricted stock, holders of unvested restricted stock have full stockholder’s rights, including voting rights and the right to receive cash dividends.

 

28

 

 

A summary of all restricted stock activity under the Plans for the three months ended March 31, 2024 is as follows:

 

		Number of Restricted shares				Weighted average grant date fair value
Nonvested balance, December 31, 2023			53,875			$	11.27
Granted			80,197				2.12
Vested			(30,750	)			10.06
Forfeited			(1,125	)			22.20
Nonvested balance, March 31, 2024			102,197			$	4.34

 

The Company estimated the fair market value of these restricted stock grants based on the closing market price on the date of grant. As of March 31, 2024, there were $245,233 of total unrecognized compensation costs related to all remaining non-vested restricted stock grants, which will be amortized over the next forty-eight months in accordance with their respective vesting scale.

 

The nonvested balance of restricted stock vests as follows:

 

Years ended		Number of shares
2024 (April 1, 2024 through December 31, 2024)			1,500
2025			73,349
2026			18,349
2027			5,000
2028			4,000

 

NOTE 14. COMMON STOCK PURCHASE WARRANTS

 

2023 Purchase Warrants

 

On April 5, 2023, the Company issued warrants to purchase a total of 1,125,000 shares of Common Stock. The warrant terms provide for net cash settlement outside the control of the Company under certain circumstances. As such, the Company is required to treat these warrants as derivative liabilities which are valued at their estimated fair value at their issuance date and at each reporting date with any subsequent changes reported in the consolidated statements of operations as the change in fair value of warrant derivative liabilities. Furthermore, the Company re-values the fair value of warrant derivative liability as of the date the warrant is exercised with the resulting warrant derivative liability transitioned to change in fair value of warrant derivative liabilities through the consolidated statement of operations.

 

The Company has utilized the following assumptions in its Black-Scholes option valuation model to calculate the estimated fair value of the warrant derivative liabilities as of their date of issuance and as of March 31, 2024:

 

		Issuance date assumptions				March 31, 2024 assumptions
Volatility - range			106.0	%		$	108.5	%
Risk-free rate			3.36	%			4.21	%
Dividend			0	%			0	%
Remaining contractual term			5.0 years				4.0 years
Exercise price			5.50 – 7.50				5.50 – 7.50
Common stock issuable under the warrants			1,125,000				1,125,000

 

29

 

 

The following table summarizes information about shares issuable under warrants outstanding during the three months ended March 31, 2024 and 2023:

  

		Warrants				Weighted average exercise price
Vested Balance, December 31, 2023			1,125,000			$	6.50
Granted			—				—
Exercised			—				—
Forfeited/cancelled			—				—
Vested Balance, March 31, 2024			1,125,000			$	6.50

 

The total intrinsic value of all outstanding warrants aggregated $-0- as of March 31, 2024 and 2023, and the weighted average remaining term was 48.2 months as of March 31, 2024, respectively.

 

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase shares of common stock as of March 31, 2024:

 

				Outstanding and exercisable warrants
Exercise price				Number of warrants				Weighted average remaining contractual life
$	5.50				375,000			4.0 years
$	6.50				375,000			4.0 years
$	7.50				375,000			4.0 years
					1,125,000			4.0 years

 

NOTE 15. STOCKHOLDERS’ EQUITY

 

2023 Issuance of Restricted Common Stock

 

On January 10, 2023, the board of directors approved the grant of 22,500 shares of common stock to officers of the Company. Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates. Additionally, the board of directors approved the grant of 12,500 restricted common shares to certain new employees of the Company. Such shares will generally vest over a period of one to two years on their respective anniversary dates in January through January 2025, provided that each grantee remains an employee of the company on such dates.

 

2024 Issuance of Restricted Common Stock

 

In January 2024, the board of directors approved the grant of 55,000 shares of common stock to officers of the Company. Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates. Additionally, the board of directors approved the grant of 25,197 restricted common shares to certain new employees of the Company. Such shares will generally vest over a period of one to two years on their respective anniversary dates in January through January 2026, provided that each grantee remains an employee of the company on such dates.

 

Cancellation of Restricted Stock

 

During the three months ended March 31, 2024, the Company cancelled 1,125 shares due to termination of employee.

 

Reverse Stock Split

 

On February 6, 2023, we filed a Certificate of Amendment to the Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada to effect a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the shares of our common stock. The Reverse Stock Split was effective as of time of filing. No fractional shares were issued in connection with the Reverse Stock Split. Any fractional shares of our Common Stock that would have otherwise resulted from the Reverse Stock Split were rounded up to the nearest whole number. In connection with the Reverse Stock Split, our board approved appropriate and proportional adjustments to all outstanding securities or other rights convertible or exercisable into shares of our Common Stock, including, without limitation, all preferred stock, warrants, options, and other equity compensation rights. All historical share and per-share amounts reflected throughout our consolidated financial statements and other financial information in this Report have been adjusted to reflect the Reverse Stock Split as if the split occurred as of the earliest period presented. The par value per share of our common stock was not affected by the Reverse Stock Split.

 

30

 

 

Noncontrolling Interests

 

The Company owns a 51% equity interest in its consolidated subsidiary, Nobility Healthcare. As a result, the noncontrolling shareholders or minority interest is allocated 49% of the income/loss of Nobility Healthcare which is reflected in the statement of (income) loss as “net (income) loss attributable to noncontrolling interests of consolidated subsidiary”. We reported net (income) loss attributable to noncontrolling interests of consolidated subsidiary of $12,248 and ($126,239) for the three months ended March 31, 2024 and 2023, respectively.

 

NOTE 16. NET LOSS PER SHARE

 

The calculation of the weighted average number of shares outstanding and loss per share outstanding for the three months ended March 31, 2024 and 2023 are as follows:

 

		Three months ended March 31,
		2024				2023
Numerator for basic and diluted loss per share – Net loss attributable to common stockholders		$	(3,931,020	)		$	(6,105,818	)
Denominator for basic loss per share – weighted average shares outstanding			2,861,229				2,751,662
Dilutive effect of shares issuable upon conversion of convertible debt and the exercise of stock options and warrants outstanding			—				—
Denominator for diluted loss per share – adjusted weighted average shares outstanding			2,861,229				2,751,662
Net loss per share:
Basic		$	(1.37	)		$	(2.22	)
Diluted		$	(1.37	)		$	(2.22	)

 

Basic income (loss) per share is based upon the weighted average number of common shares outstanding during the period. For the three months ended March 31, 2024 and 2023, all shares issuable upon conversion of convertible debt and the exercise of outstanding stock options and warrants were antidilutive and, therefore, not included in the computation of diluted income (loss) per share.

 

31

 

 

NOTE 17. COUNTRY STAMPEDE ACQUISITION

 

On March 1, 2024, Kustom 440, entered into an Asset Purchase Agreement (the “Acquisition Agreement”) with JC Entertainment, LLC, a Kansas limited liability company (“JC Entertainment”). Pursuant to the Acquisition Agreement, Kustom 440 acquired certain assets associated with a music entertainment event (“Country Stampede”), including all intellectual property arising out of and relating to Country Stampede (“Country Stampede Intellectual Property”) and certain contracts in which JC Entertainment is a party to host and operate the 2024 Country Stampede (the “Assumed Contracts”, and together with the Country Stampede Intellectual Property, the “Purchased Assets”).

 

As consideration for acquiring the Purchased Assets, Kustom 440 paid JC Entertainment the aggregate purchase price amount $542,959, with the sum of $400,000 paid at the time of closing (“Closing”), and the remainder to be paid on or before thirty days from the time of Closing. Kustom 440 shall receive a credit for all non-refunded festival ticket sales for the 2024 Country Stampede to be calculated immediately prior to Closing, and JC Entertainment shall be entitled to keep all ticket sale proceeds made and/or received prior to Closing. Kustom 440 shall be obligated, to the extent a refund is sought after Closing, to provide such refund, if appropriate, to the customer requesting a refund, and shall indemnify and hold harmless JC Entertainment from any and all claims, liabilities, costs, suits, or the like relating to such refund request.

 

The Company accounts for business combinations using the acquisition method and that the Company has early adopted the amendments of Regulation S-X dated May 21, 2020 and has concluded that this acquisition was not significant. Accordingly, the presentation of the assets acquired, historical financial statements under Rule 3-05 and related pro forma information under Article 11 of Regulation S-X, respectively, are not required to be presented. Under the acquisition method, the purchase price of the Country Stampede Acquisition has been allocated to the acquired tangible and identifiable intangible assets and assumed liabilities based on their estimated fair values at the time of the Country Stampede Acquisition. This allocation involves a number of assumptions, estimates, and judgments that could materially affect the timing or amounts recognized in our financial statements. The Country Stampede Acquisition was structured as an asset purchase; however the parties agreed to coordinate the election to invoke IRS Section 338(h)(10) relative to this transaction for tax purposes. Therefore, the excess purchase price over the fair value of net tangible assets acquired was recorded as goodwill, which will be amortized over 15 years for income tax filing purposes. Likewise, the other acquired assets were stepped up to fair value and is deductible for income tax purposes. The results of operations of acquired businesses are included in the consolidated financial statements from the acquisition date.

 

32

 

 

The purchase price of the Country Stampede Acquisition was allocated to tangible assets, goodwill, identifiable intangible assets, and assumed liabilities based on their preliminary estimated fair values at the time of the acquisition. The Company retained the services of an independent valuation firm to determine the fair value of these identifiable intangible assets. The Company will continue to evaluate the fair value of the identified intangible assets. The preliminary estimated fair value of assets acquired, and liabilities assumed in the Country Stampede Acquisition were as follows:

 

		As allocated (Preliminary)
Description		March 1, 2024
Assets acquired (provisional):
Tangible assets acquired		$	305,000
Identifiable intangible assets acquired (Trademarks and trade names)			300,000
Goodwill			225,959
Liabilities assumed			(288,000	)
Net assets acquired and liabilities assumed		$	542,959
Consideration:
Cash paid at Country Stampede Acquisition date		$	400,000
Cash paid subsequent to closing			142,959
Total Country Stampede Acquisition purchase price		$	542,959

 

During the measurement period (which is the period required to obtain all necessary information that existed at the acquisition date, or to conclude that such information is unavailable, not to exceed one year), additional assets or liabilities may be recognized, or there could be changes to the amounts of assets or liabilities previously recognized on a preliminary basis, if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of these assets or liabilities as of that date.

 

33

 

 

NOTE 18. SEGMENT DATA

 

The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information of those segments to be presented in financial statements. Operating segments are identified as components of an enterprise for which separate discrete financial information is available for evaluation by the chief operating decision maker (the Company’s Chief Executive Officer or “CODM”) in making decisions on how to allocate resources and assess performance. The Company’s three operating segments are Video Solutions, Revenue Cycle Management, and Entertainment, each of which has specific personnel responsible for that business and reports to the CODM. Corporate expenses capture the Company’s corporate administrative activities, is also to be reported in the segment information. The Company’s captive insurance subsidiary provides services to the Company’s other business segments and not to outside customers. Therefore, its operations are eliminated in consolidation and is not considered a separate business segment for financial reporting purposes.

 

The Video Solutions Segment encompasses our law, commercial, and Shield™ divisions. This segment includes both service and product revenues through our subscription models offering cloud and warranty solutions, and hardware sales for video and health safety solutions. The Revenue Cycle Management Segment provides working capital and back-office services to a variety of healthcare organizations throughout the country, as a monthly service fee. The Entertainment Segment acts as an intermediary between ticket buyers and sellers within our secondary ticketing platform, ticketsmarter.com, and we also acquire tickets from primary sellers to then sell through various platforms.

 

The Company’s corporate administration activities are reported in the corporate line item. These activities primarily include expense related to certain corporate officers and support staff, certain accounting staff, expense related to the Company’s Board of Directors, stock option expense for options granted to corporate administration employees, certain consulting expenses, investor relations activities, and a portion of the Company’s legal, auditing and professional fee expenses. Corporate identifiable assets primarily consist of cash, invested cash (if any), refundable income taxes (if any), and deferred income taxes.

 

Summarized financial information for the Company’s reportable business segments is provided for the indicated periods and as of March 31, 2024, and March 31, 2023:

 

		Three Months Ended March 31,
		2024				2023
Net Revenues:
Video Solutions		$	1,718,293			$	1,899,364
Revenue Cycle Management			1,434,598				1,781,590
Entertainment			2,376,460				4,016,236
Total Net Revenues		$	5,529,351			$	7,697,190
Gross Profit:
Video Solutions		$	565,694			$	534,195
Revenue Cycle Management			463,731				775,934
Entertainment			494,274				234,663
Total Gross Profit		$	1,523,699			$	1,544,792
Operating Income (loss):
Video Solutions		$	(891,588	)		$	(1,963,186	)
Revenue Cycle Management			(24,031	)			103,765
Entertainment			(642,219	)			(1,233,006	)
Corporate			(2,081,196	)			(3,080,379	)
Total Operating Loss		$	(3,639,034	)		$	(6,172,806	)
Depreciation and Amortization:
Video Solutions		$	198,028			$	198,122
Revenue Cycle Management			26,715				25,507
Entertainment			326,248				319,481
Total Depreciation and Amortization		$	550,991			$	543,110

 

34

 

 

		March 31, 2024				December 31, 2023
Assets (net of eliminations):
Video Solutions		$	24,172,478			$	26,396,559
Revenue Cycle Management			1,989,068				2,260,376
Entertainment			6,482,510				6,324,211
Corporate			12,520,139				12,047,663
Total Identifiable Assets		$	45,164,195			$	47,028,809

 

The segments recorded noncash items effecting the gross profit and operating income (loss) through the established inventory reserves based on estimates of excess and/or obsolete current and non-current inventory. The Company recorded a reserve for excess and obsolete inventory in the video solutions segment of $4,315,132 and a reserve for the entertainment segment of $171,257 as of March 31, 2024.

 

The segment net revenues reported above represent sales to external customers. Segment gross profit represents net revenues less cost of revenues. Segment operating income, which is used in management’s evaluation of segment performance, represents net revenues, less cost of revenues, less all operating expenses. Identifiable assets are those assets used by each segment in its operations. Corporate assets primarily consist of cash, property, plant and equipment, accounts receivable, inventories, and other assets.

 

NOTE 19. RELATED PARTY TRANSACTIONS

 

Transactions with Managing Member of Nobility Healthcare

 

The Company accrued reimbursable expenses payable to Nobility, LLC totaling $576,690 and $265,241 for the three months ended March 31, 2024 and 2023 and management fees in accordance with the operating agreement of $12,379 and $32,181 for the three months ended March 31, 2024 and 2023.

 

Transactions with Related Party of TicketSmarter

 

On September 22, 2023, a trust, the beneficiaries of which are TicketSmarter’s Chief Executive Officer and his spouse, made a loan in the amount of $2,325,000 to TicketSmarter to support TicketSmarter’s operations. On October 2, 2023 an additional $375,000 was advanced to Ticketsmarter. The transaction was recorded as a related party note payable (the “TicketSmarter Related Party Note”). The TicketSmarter Related Party Note bears interest of 13.25% per annum with repayment beginning January 2, 2024. As of March 31 2024, the entire TicketSmarter Related Party note is $2,700,000, is classified as current, with an accrued interest balance of $187,346. The use of proceeds of the TicketSmarter Related Party Note was to resolve numerous outstanding payables at a discounted rate, the discount received is recognized as a gain on extinguishment of liabilities on the statement of operations. Additionally, these negotiations relieved TicketSmarter of numerous future obligations following fiscal year 2023.

 

NOTE 20. SUBSEQUENT EVENTS

 

Series A Preferred Stock and Series B Preferred Stock Elimination

 

On April 5, 2024, Digital Ally, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada an Elimination of Certificate of Designations of the Preferences, Rights and Limitations of the Series A Convertible Redeemable Preferred Stock (the “Series A Elimination Certificate”) and Elimination of Certificate of Designations of the Preferences, Rights and Limitations of the Series B Convertible Redeemable Preferred Stock (the “Series B Elimination Certificate”) in order to eliminate and cancel all designations, rights, preferences and limitations of the shares of the Company’s Series A Convertible Redeemable Preferred Stock, par value $0.001 per share (the “Series A Preferred Stock”) and Series B Convertible Redeemable Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”). In December 2022, all 1,400,000 shares of Series A Preferred Stock that had originally been issued pursuant to the Certificate of Designations of the Preferences, Rights and Limitations of the Series A Preferred Stock of the Company (the “Series A Certificate of Designations”) and all 100,000 shares of Series B Preferred Stock that had originally been issued pursuant to the Certificate of Designations of the Preferences, Rights and Limitations of the Series B Preferred Stock of the Company (the “Series B Certificate of Designations”) were exchanged for shares of the Company’s common stock and warrants to purchase shares of the Company’s common stock. Such shares of Series A Preferred Stock and Series B Preferred Stock have resumed the status of authorized but unissued shares of preferred stock of the Company.

 

Prior to the filing of the Series A Elimination Certificate, none of the 1,400,000 authorized shares of Series A Preferred Stock or 100,000 authorized shares of Series B Preferred Stock were issued and outstanding, and no shares of Series A Preferred Stock or Series B Preferred Stock were to be issued subject to the Series A Certificate of Designations or Series B Certificate of Designations. The Series A Elimination Certificate and Series B Elimination Certificate became effective upon their filing with the Secretary of State of the State of Nevada.

 

Merchant Cash Advances – Video Solutions Segment  

 

In April 2024, the Company received additional advances of $444,000 from the lender and agreed to new terms where total proceeds received since inception totaled $2,144,000. The Company will repay an aggregate of $2,880,000 to the lender. The advances remain secured by expected future sales of the Company with payments on a weekly basis and the full amount is expected to be repaid in 2024.

 

*************************************

 

35

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation.

 

This quarterly report on Form 10-Q (the “Report”) of Digital Ally, Inc. (the “Company”, “we”, “us”, or “our”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The words “aim,” “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “feel,” “forecast,” “intend,” “may,” “outlook,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will,” “would,” and similar expressions intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are based largely on our expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond our control. Therefore, actual results could differ materially from the forward-looking statements contained in this document, and readers are cautioned not to place undue reliance on such forward-looking statements.

 

We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. A wide variety of factors could cause or contribute to such differences and could adversely impact revenues, profitability, cash flows and capital needs. There can be no assurance that the forward-looking statements contained in this document will, in fact, transpire or prove to be accurate.

 

Factors that could cause or contribute to our actual results differing materially from those discussed herein or for our stock price to be adversely affected include, but are not limited to: (1) our losses in recent years, including fiscal years 2024 and 2023; (2) economic and other risks for our business from the effects of the COVID-19 pandemic, including the impacts on our law-enforcement and commercial customers, suppliers and employees and on our ability to raise capital as required; (3) our ability to increase revenues, increase our margins and return to consistent profitability in the current economic and competitive environment; (4) our operation in developing markets and uncertainty as to market acceptance of our technology and new products; (5) the availability of funding from federal, state and local governments to facilitate the budgets of law enforcement agencies, including the timing, amount and restrictions on such funding; (6) our ability to maintain or expand our share of the market for our products in the domestic and international markets in which we compete, including increasing our international revenues; (7) our ability to produce our products in a cost-effective manner; (8) competition from larger, more established companies with far greater economic and human resources; (9) our ability to attract and retain quality employees; (10) risks related to dealing with governmental entities as customers; (11) our expenditure of significant resources in anticipation of sales due to our lengthy sales cycle and the potential to receive no revenue in return; (12) characterization of our market by new products and rapid technological change; (13) our dependence on sales of our EVO-HD, DVM-800, DVM-250 and FirstVU products; (14) that stockholders may lose all or part of their investment if we are unable to compete in our markets and return to profitability; (15) defects in our products that could impair our ability to sell our products or could result in litigation and other significant costs; (16) our dependence on a few manufacturers and suppliers for components of our products and our dependence on domestic and foreign manufacturers for certain of our products; (17) our ability to protect technology through patents and to protect our proprietary technology and information, such as trade secrets, through other similar means; (18) our ability to generate more recurring cloud and service revenues; (19) risks related to our license arrangements; (20) the fluctuation of our operation results from quarter to quarter; (21) sufficient voting power by coalitions of a few of our larger stockholders, including directors and officers, to make corporate governance decisions that could have a significant effect on us and the other stockholders; (22) the issuance or sale of substantial amounts of our Common Stock, or the perception that such sales may occur in the future, which may have a depressive effect on the market price of our securities; (23) potential dilution from the issuance of Common Stock underlying outstanding options and warrants; (24) our additional securities available for issuance, which, if issued, could adversely affect the rights of the holders of our Common Stock; (25) the volatility of our stock price due to a number of factors, including, but not limited to, a relatively limited public float; (26) our ability to integrate and realize the anticipated benefits from acquisitions; (27) our ability to maintain the listing of our Common Stock on the Nasdaq Capital Market

 

Current Trends and Recent Developments for the Company

 

Segment Overview

 

Video Solutions Operating Segment – Within our video solutions operating segment we supply technology-based products utilizing our portable digital video and audio recording capabilities for the law enforcement and security industries and for the commercial fleet and mass transit markets. We have the ability to integrate electronic, radio, computer, mechanical, and multi-media technologies to create positive solutions to our customers’ requests. Our products include: the EVO-HD, DVM-800 and DVM-800 Lite, which are in-car digital video systems for law enforcement and commercial markets; the FirstVU body-worn camera line, consisting of the FirstVu Pro, FirstVu, and the FirstVU HD; our patented and revolutionary VuLink product integrates our body-worn cameras with our in-car systems by providing hands-free automatic activation for both law enforcement and commercial markets; the FLT-250, DVM-250, and DVM-250 Plus, which are our commercial line of digital video mirrors that serve as “event recorders” for the commercial fleet and mass transit markets; and FleetVu and VuLink, which are our cloud-based evidence management systems. We further diversified and broadened our product offerings in 2020, by introducing two new lines of branded products: (1) the ThermoVu™ which is a line of self-contained temperature monitoring stations that provides alerts and controls facility access when an individual’s temperature exceeds a pre-set threshold and (2) our Shield™ disinfectants and cleansers which are for use against viruses and bacteria.

 

Our video solutions segment revenue encompasses video recording products and services for our law enforcement and commercial customers and the sale of Shield disinfectant and personal protective products. This segment generates revenues through our subscription models offering cloud and warranty solutions, and hardware sales for video and personal protective safety products and solutions. Revenues for product sales are recognized upon delivery of the product, and revenues from our cloud and warranty subscription plans are deferred over the term of the subscription, typically 3 or 5 years.

 

Revenue Cycle Management Operating Segment – We entered the revenue cycle management business late in the second quarter of 2021 with the formation of our wholly owned subsidiary, Digital Ally Healthcare, Inc. and its majority-owned subsidiary Nobility Healthcare. Nobility Healthcare completed its first acquisition in June 2021, when it acquired a private medical billing company, and has since completed three additional acquisitions of private medical billing companies, in which we will assist in providing working capital and back-office services to healthcare organizations throughout the country. Our assistance consists of insurance and benefit verification, medical treatment documentation and coding, and collections. Through our expertise and experience in this field, we maximize our customers’ service revenues collected, leading to substantial improvements in their operating margins and cash flows.

 

36

 

 

Our revenue cycle management segment consists of our medical billing subsidiaries. Revenues of this segment are recognized after we perform the obligations of our revenue cycle management services. Our revenue cycle management services are services, performed and charged monthly, generally based on a contractual percentage of total customer collections, for which we recognize our net service fees.

 

Entertainment Operating Segment - We also entered into live entertainment and events ticketing services through the formation of our wholly owned subsidiary, TicketSmarter and its completed acquisitions of Goody Tickets, LLC and TicketSmarter, LLC, on September 1, 2021. TicketSmarter provides ticket sales, partnerships, and mainly, ticket resale services through its online ticketing marketplace for live events, TicketSmarter.com. TicketSmarter offers tickets for over 125,000 live events through its platform, for a wide range of events, including concerts, sporting events, theatres, and performing arts, throughout the country. We also offer production and promotion of live music events in third-party venues throughout the country. These services begin with the logistical matters of an event, including artist booking and research, ticketing, staging, on-site operations, vendor sourcing, and day of production.

 

Our entertainment operating segment consists of entertainment services provided through TicketSmarter and its online platform, TicketSmarter.com. Revenues of this segment include ticketing service charges generally determined as a percentage of the face value of the underlying ticket and ticket sales from our ticket inventory which are recognized when the underlying tickets are sold. Entertainment direct expenses include the cost of tickets purchased for resale by the Company and held as inventory, credit card fees, ticketing platform expenses, website maintenance fees, along with other administrative costs.

 

Results of Operations

 

Summarized financial information for the Company’s reportable business segments is provided for the three months ended March 31, 2024, and 2023:

 

		Three Months Ended March 31,
		2024				2023
Net Revenues:
Video Solutions		$	1,718,293			$	1,899,364
Revenue Cycle Management			1,434,598				1,781,590
Entertainment			2,376,460				4,016,236
Total Net Revenues		$	5,529,351			$	7,697,190
Gross Profit:
Video Solutions		$	565,694			$	534,195
Revenue Cycle Management			463,731				775,934
Entertainment			494,274				234,663
Total Gross Profit		$	1,523,699			$	1,544,792
Operating Income (loss):
Video Solutions		$	(891,588	)		$	(1,963,186	)
Revenue Cycle Management			(24,031	)			103,765
Entertainment			(642,219	)			(1,233,006	)
Corporate			(2,081,196	)			(3,080,379	)
Total Operating Loss		$	(3,639,034	)		$	(6,172,806	)
Depreciation and Amortization:
Video Solutions		$	198,028			$	198,122
Revenue Cycle Management			26,715				25,507
Entertainment			326,248				319,481
Total Depreciation and Amortization		$	550,991			$	543,110

 

		March 31, 2024				December 31, 2023
Assets (net of eliminations):
Video Solutions		$	24,172,478			$	26,396,559
Revenue Cycle Management			1,989,068				2,260,376
Entertainment			6,482,510				6,324,211
Corporate			12,520,139				12,047,663
Total Identifiable Assets		$	45,164,195			$	47,028,809

 

37

 

 

Segment net revenues reported above represent only sales to external customers. Segment gross profit represents net revenues less cost of revenues. Segment operating income (loss), which is used in management’s evaluation of segment performance, represents net revenues, less cost of revenues, less all operating expenses. Identifiable assets are those assets used by each segment in its operations. Corporate assets primarily consist of cash, property, plant and equipment, accounts receivable, inventories, and other assets.

 

Consolidated Results of Operations

 

We experienced operating losses for the first quarter of 2024 and all quarters during 2023. The following is a summary of our recent operating results on a quarterly basis:

 

		For the Three Months Ended:
		March 31, 2024				December 31, 2023				September 30, 2023				June 30, 2023				March 31, 2023
Total revenue		$	5,529,351			$	6,228,351			$	6,337,699			$	8,062,097			$	7,697,190
Gross profit			1,523,699				549,031				1,226,149				2,519,505				1,544,792
Gross profit margin %			27.6	%			8.8	%			19.3	%			31.3	%			20.1	%
Total selling, general and administrative expenses			5,162,733				6,528,031				6,374,192				7,460,209				7,717,598
Operating income (loss)			(3,639,034	)			(5,979,000	)			(5,148,043	)			(4,940,704	)			(6,172,806	)
Operating income (loss) %			(65.8	)%			(96.0	)%			(81.2	)%			(61.3	)%			(80.2	)%
Net income (loss)		$	(3,943,268	)		$	(7,484,778	)		$	(3,679,043	)		$	(8,320,549	)		$	(5,979,579	)

 

Our business is subject to substantial fluctuations on a quarterly basis as reflected in the significant variations in revenues and operating results in the above table. These variations result from various factors, including but not limited to: (1) the timing of large individual orders; (2) the traction gained by products, such as the recently released FirstVu Pro, FirstVu II, FLT-250, EVO HD, the ThermoVu™ and the Shield™ lines; (3) production, quality and other supply chain issues affecting our cost of goods sold; (4) unusual increases in operating expenses, such as the timing of trade shows and stock-based and bonus compensation; (5) the timing of patent infringement litigation settlements (6) ongoing patent and other litigation and related expenses respecting outstanding lawsuits; and (7) the completion of corporate acquisitions including the recent purchases in the revenue cycle management and entertainment operating segments. We reported a net loss of $3,943,268 on revenues of $5,529,351 for first quarter of 2024.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet debt, nor did we have any transactions, arrangements, obligations (including contingent obligations) or other relationships with any unconsolidated entities or other persons that may have a material current or future effect on financial conditions, changes in the financial conditions, results of operations, liquidity, capital expenditures, capital resources, or significant components of revenue or expenses other than the following:

 

We are a party to operating leases and license agreements that represent commitments for future payments (described in Note 9, “Operating Leases,” to our condensed consolidated financial statements) and we have issued purchase orders in the ordinary course of business that represent commitments to future payments for goods and services.

 

38

 

 

For the Three Months Ended March 31, 2024 and 2023

 

Results of Operations

 

Summarized immediately below and discussed in more detail in the subsequent subsections is an analysis of our operating results for the three months ended March 31, 2024 and 2023, represented as a percentage of total revenues for each such quarter:

 

		Three Months Ended March 31,
		2024				2023
Revenue			100	%			100	%
Cost of revenue			72	%			80	%
Gross profit			28	%			20	%
Selling, general and administrative expenses:
Research and development expense			9	%			12	%
Selling, advertising and promotional expense			14	%			24	%
General and administrative expense			71	%			64	%
Total selling, general and administrative expenses			94	%			100	%
Operating loss			(66	)%			(80	)%
Change in fair value of derivative liabilities			(6	)%			—	%
Gain on extinguishment of debt			13	%			2	%
Interest expense			(12	)%			—	%
Other income and interest income (expense), net			—	%			—	%
Income (loss) before income tax benefit			(71	)%			(78	)%
Income tax (provision)			—	%			—	%
Net income/(loss)			(71	)%			(78	)%
Net income (loss) attributable to noncontrolling interests of consolidated subsidiary			—	%			(2	)%
Net income (loss) attributable to common stockholders			(71	)%			(80	)%
Net income/(loss) per share information:
Basic		$	(1.37	)		$	(2.22	)
Diluted		$	(1.37	)		$	(2.22	)

 

39

 

 

Revenues

 

Revenues by Type and by Operating Segment

 

Our operating segments generate two types of revenues:

 

Product revenues primarily includes video operating segment hardware sales of in-car and body-worn cameras, along with sales of our ThermoVu^TM units, disinfectants, and personal protective equipment. Additionally, product revenues also include the sale of tickets by our entertainment operating segment that have been purchased or received through our sponsorships and partnerships and held in inventory by our entertainment segment until their sale.

 

Service and other revenues consist of cloud and warranty services revenues from our subscription plan and storage offerings of our video solutions segment. Our entertainment operating segments’ secondary ticketing marketplace revenues are included in service revenue. We recognize service revenue from sales generated through its secondary ticketing marketplace as we collect net services fees on secondary ticketing marketplace transactions. Lastly, our revenue cycle management segment revenues are included in the service revenues for services provided to medical providers throughout the country.

 

Our video operating segment sells our products and services to customers in the following manner:

 

	●	Sales to domestic customers are made directly to the end customer (typically a law enforcement agency or a commercial customer) through our sales force, comprised of our employees. Revenue is recorded when the product is shipped to the end customer.
	●	Sales to international customers are made through independent distributors who purchase products from us at a wholesale price and sell to the end user (typically law enforcement agencies or a commercial customer) at a retail price. The distributor retains the margin as compensation for its role in the transaction. The distributor generally maintains product inventory, customer receivables and all related risks and rewards of ownership. Revenue is recorded when the product is shipped to the distributor consistent with the terms of the distribution agreement.
	●	Repair parts and services for domestic and international customers are generally handled by our inside customer service employees. Revenue is recognized upon shipment of the repair parts and acceptance of the service or materials by the end customer.

 

Our revenue cycle management operating segment sells its services to customers in the following manner:

 

●

Our revenue cycle management operating segment generates service revenues through relationships with medium to large healthcare organizations, in which the underlying service revenue is recognized upon execution of services. Service revenues are generally determined as a percentage of the dollar amount of medical billings collected by the customer.

 

Our entertainment operating segment sells our products and services to customers in the following manner:

 

●

Our entertainment operating segment generates product revenues from the sale of tickets directly to consumers for a particular event that the entertainment operating segment has previously purchased and held in inventory for ultimate resale to the end consumer. Service sales through TicketSmarter, are driven largely in part to the usage of the TicketSmarter.com marketplace by buyers and sellers, in which the Company collects service fees for each transaction completed through this platform.

 

We may discount our prices on specific orders based upon the size of the order, the specific customer and the competitive landscape.

 

40

 

 

Product revenues by operating segment are as follows:

 

		Three Months Ended March 31,
		2024				2023
Product Revenues:
Video Solutions		$	721,188			$	1,193,021
Revenue Cycle Management			—				—
Entertainment			844,658				1,260,789
Total Product Revenues		$	1,565,846			$	2,453,810

 

Product revenues for the three months ended March 31, 2024 and 2023 were $1,565,846 and $2,453,810 respectively, an decrease of $887,964 (36%), due to the following factors:

 

●

Revenues generated by the entertainment operating segment began with the Company’s September 2021 acquisition of TicketSmarter. The entertainment operating segment generated $844,658 in product revenues for the three months ended March 31, 2024, compared to $1,260,789 for the three months ended March 31, 2023. This product revenue relates to the resale of tickets purchased for live events, including sporting events, concerts, and theatre, then sold through various platforms to customers.

 

	●	The Company’s video segment operating segment generated revenues totaling $721,188 during the three months ended March 31, 2024 compared to $1,193,021 for the three months ended March 31, 2023. In general, our video solutions operating segment has experienced pressure on its product revenues as our in-car and body-worn systems are facing increased competition because our competitors have released new products with advanced features. Additionally, our law enforcement revenues declined compared to the same period in 2023 due to price-cutting and competitive actions by our competitors, adverse marketplace effects related to our patent litigation proceedings and our recent financial condition.
	●	Our video solutions operating segment management has continued to focus on migrating commercial customers, from a hardware sale to a service fee model. Therefore, we expect a reduction in commercial hardware sales (principally DVM-250’s, FLT-250’s, and a portion of our body-worn camera line) as we convert these customers to a service model under which we provide the hardware as part of a recurring monthly service fee. In that respect, we introduced a monthly subscription agreement plan for our body worn cameras and related equipment during the second quarter of 2020 that allowed law enforcement agencies to pay a monthly service fee to obtain body worn cameras without incurring a significant upfront capital outlay. This program has gained some traction, resulting in decreased product revenues and increasing our service revenues. We expect this program to continue to hold traction, resulting in recurring revenues over a span of three to five years.

 

Service and other revenues by operating segment are as follows:

 

		Three Months Ended March 31,
		2024				2023
Service and Other Revenues:
Video Solutions		$	997,105			$	706,343
Revenue Cycle Management			1,434,599				1,781,590
Entertainment			1,531,801				2,755,447
Total Service and Other Revenues		$	3,963,505			$	5,243,380

 

Service and other revenues for the three months ended March 31, 2024 and 2023 were $3,963,505 and $5,243,380, respectively, a decrease of $1,279,875 (24%), due to the following factors:

 

●

Cloud revenues generated by the video solutions operating segment were $616,488 and $422,823 for the three months ended March 31, 2024 and 2023, respectively, an increase of $193,665 (46%). We have experienced increased interest in our cloud solutions for law enforcement primarily due to the deployment of our cloud-based EVO-HD in-car system and our next generation body-worn camera products, which contributed to our increased cloud revenues in the three months ended March 31, 2024. We expect this trend to continue throughout 2024 as the migration from local storage to cloud storage continues in our customer base.

 

41

 

 

	●	Video solutions operating segment revenues from extended warranty services and other services were $380,618 and $283,520 for the three months ended March 31, 2024 and 2023, respectively, an increase of $97,098 (34%). This correlates with the increase in sales of DVM-800 hardware systems resulting in an increase in their associated extended warranty.
	●	Our entertainment operating segment generated service revenues totaling $1,531,801 and $2,755,447 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $1,223,646 (44%). TicketSmarter collects fees on transactions administered through the TicketSmarter.com platform for the buying and selling of tickets for live events throughout the country. We expect our entertainment operating segment to continue to present a strong revenue outlook moving forward.
	●	Our revenue cycle management operating segment generated service revenues totaling $1,434,599 and $1,781,590 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $346,991 (20%). Our revenue cycle management operating segment provides revenue cycle management solutions and back-office services to healthcare organizations throughout the country. We expect our revenue cycle management segment to continue to present a strong revenue outlook moving forward.

 

Total revenues for the three months ended March 31, 2024 and 2023 were $5,529,351 and $7,697,190, respectively, a decrease of $2,167,839 (28%), due to the reasons noted above.

 

Cost of Product Revenue

 

Overall cost of product revenue sold for the three months ended March 31, 2024, and 2023 was $1,567,393 and $2,301,100, respectively, a decrease of $733,707 (32%). Overall cost of goods sold for products as a percentage of product revenues for the three months ended March 31, 2024, and 2023 were 100% and 94%, respectively. Cost of products sold by operating segment is as follows:

 

		Three Months Ended March 31,
		2024				2023
Cost of Product Revenues:
Video Solutions		$	797,494			$	1,037,594
Revenue Cycle Management			—				—
Entertainment			769,899				1,263,506
Total Cost of Product Revenues		$	1,567,393			$	2,301,100

 

The decrease in cost of goods sold for our video solutions segment products is directly correlated with the decrease in product sales for the three months ended March 31, 2024 compared to the three months ended March 31, 2023. In addition, the Video Solutions Segment recorded valuation allowances for its older product lines and a portion of its Shield™ products during the first quarter of 2023. Cost of product sold as a percentage of product revenues for the video solutions segment increased to 111% for the three months ended March 31, 2024 as compared to 87% for the three months ended March 31, 2023.

 

The decrease in entertainment operating segment cost of product sold directly correlates to the decrease in product revenues for the three months ended March 31, 2024 compared to March 31, 2023, resulting in cost of product revenue of $769,899 for the three months ended March 31, 2024, compared to $1,263,506 for the three months ended March 31, 2023. Cost of product sold as a percentage of product revenues for the entertainment segment was 91% for the three months ended March 31, 2024 as compared to 100% for the three months ended March 31, 2023.

 

42

 

 

We recorded $4,486,389 and $4,542,461 in reserves for obsolete and excess inventories at March 31, 2024 and December 31, 2023, respectively. Total raw materials, component parts, and work-in-progress were $2,964,525 and $3,065,049 at March 31, 2024 and December 31, 2023, respectively, a decrease of $100,524 (3%). Finished goods balances were $4,670,553 and $5,322,693 at March 31, 2024 and December 31, 2023, respectively, a decrease of $652,140 (12%) which was attributable to a decrease in finished goods from our entertainment segment. The small decrease in the inventory reserve is primarily due to the reduction in finished goods and movement of excess inventory, offset by the decrease in reserve at the entertainment segment. We believe the reserves are appropriate given our inventory levels as of March 31, 2024.

 

Cost of Service Revenue

 

Overall cost of service revenue sold for the three months ended March 31, 2024, and 2023 was $2,438,259 and $3,851,298, respectively, a decrease of $1,413,039 (37%). Overall cost of goods sold for services as a percentage of service revenues for the three months ended March 31, 2024, and 2023 was 62% and 73%, respectively. Cost of service revenues by operating shipment is as follows:

 

		Three Months Ended March 31,
		2024				2023
Cost of Service Revenues:
Video Solutions		$	355,105			$	327,575
Revenue Cycle Management			970,867				1,005,656
Entertainment			1,112,287				2,518,067
Total Cost of Service Revenues		$	2,438,259			$	3,851,298

 

The increase in cost of service revenues for our video solutions segment is commensurate with the increase in service revenues in the three months ended March 31, 2024 compared to the three months ended March 31, 2023. Cost of service revenues as a percentage of service revenues for the video solutions segment decreased to 36% for the three months ended March 31, 2024 as compared to 46% for the three months ended March 31, 2023.

 

Cost of service revenues as a percentage of service revenues for the revenue cycle management operating segment was 68% for the three months ended March 31, 2024 as compared to 56% for the three months ended March 31, 2023.

 

The decrease in entertainment operating segment cost of service revenues is commensurate with the decrease in service revenues in the three months ended March 31, 2024, compared to the three months ended March 31, 2023. Cost of service revenues as a percentage of service revenues for the entertainment segment was 73% for the three months ended March 31, 2024 as compared to 91% for the three months ended March 31, 2023.

 

Gross Profit

 

Overall gross profit for the three months ended March 31, 2024 and 2023 was $1,523,699 and $1,544,792, respectively, a decrease of $21,093 (1%). Gross profit by operating segment was as follows:

 

		Three Months Ended March 31,
		2024				2023
Gross Profit:
Video Solutions		$	565,694			$	534,195
Revenue Cycle Management			463,731				775,934
Entertainment			494,274				234,663
Total Gross Profit		$	1,523,699			$	1,544,792

 

The overall decrease is attributable to the decrease in revenues for the three months ended March 31, 2024 and a decrease in the overall cost of sales as a percentage of overall revenues to 72% for the three months ended March 31, 2024 from 80% for the three months ended March 31, 2023. Our goal is to improve our margins over the longer term based on the expected margins generated by our new recent revenue cycle management and entertainment operating segments together with our video solutions operating segment and its expected margins from our EVO-HD, DVM-800, VuLink, FirstVu Pro, FirstVu II, Shield^TM disinfectants and our cloud evidence storage and management offering, provided that they gain traction in the marketplace. In addition, if revenues from the video solutions segment increase, we will seek to further improve our margins from this segment through expansion and increased efficiency utilizing fixed manufacturing overhead components. We plan to continue our initiative to more efficient management of our supply chain through outsourcing production, quantity purchases and more effective purchasing practices.

 

43

 

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses were $5,162,732 and $7,717,598 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $2,554,865 (33%). The decrease was primarily attributable to the reduction in sponsorships and advertising being by the Company. Our selling, general and administrative expenses as a percentage of sales increased to 93% for the three months ended March 31, 2024 compared to 100% in the same period in 2023. The significant components of selling, general and administrative expenses are as follows:

 

		Three months ended March 31,
		2024				2023
Research and development expense		$	487,466			$	934,939
Selling, advertising and promotional expense			761,118				1,847,489
General and administrative expense			3,914,149				4,935,170
Total		$	5,162,733			$	7,717,598

 

Research and development expense. We continue to focus on bringing new products to market, including updates and improvements to current products. Our research and development expenses totaled $487,466 and $934,939 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $447,473 (48%). Most of our engineers are dedicated to research and development activities for new products, primarily the new generation of body-worn cameras, EVO-HD and EVO Fleet that can be located in multiple places in a vehicle. We expect our research and development activities will continue to trend higher in future quarters as we continue to expand our product offerings based on our new body-worn camera and EVO-HD product platform and as we outsource more development projects. We consider our research and development capabilities and new product focus to be a competitive advantage and intend to continue to invest in this area on a prudent basis and consistent with our financial resources.

 

Selling, advertising and promotional expenses. Selling, advertising and promotional expense totaled $761,118 and $1,847,489 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $1,086,371 (59%). Promotional and advertising expenses represent the primary component of these costs and totaled $377,231 during the three months ended March 31, 2024, compared to $1,460,823 during the three months ended March 31, 2023, a decrease of $1,083,592 (74%). The decrease is primarily attributable to the reduction in sponsorships being entered into by the Company.

 

General and administrative expense. General and administrative expenses totaled $3,914,149 and $4,935,170 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $1,021,021 (21%). The decrease in general and administrative expenses in the three months ended March 31, 2024 compared to the same period in 2023 is primarily attributable to a decrease in administrative salaries, as payroll begins to adjust from the new acquisitions completed by the Company and reductions in headcount. General and administrative expenses also decreased due to a decline in rent expenses for the three months ended March 31, 2024 compared to the same period in 2023.

 

44

 

 

Operating Loss

 

For the reasons stated above, our operating loss was $3,639,034 and $6,172,806 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $2,533,772 (41%). Operating loss as a percentage of revenues decreased to 66% in the three months ended March 31, 2024 from 80% in the same period in 2023.

 

Interest Income

 

Interest income decreased to $14,938 for the three months ended March 31, 2024, from $15,477 in the same period of 2023, which primarily represents interest charges on our subscription receivables.

 

Interest Expense

 

We incurred interest expenses of $648,567 and $5,664 during the three months ended March 31, 2024 and 2023, respectively. The increase is attributable to interest charges and the amortization of debt issuance and discounts associated with several debt issuances.

 

Change in Fair Value of Contingent Consideration Promissory Notes

 

The Company recognized a gain on the change in fair value of contingent consideration promissory notes of $-0- compared to a loss of $158,021 during the three months ended March 31, 2024 and 2023, respectively. This is in connection with the four acquisitions made by our revenue cycle management segment.

 

Change in Fair Value of Derivative Liabilities

 

During the second quarter of 2023, the Company issued detachable warrants to purchase a total of 1,125,000 shares of Common Stock in association with the two secured convertible notes previously described. The underlying warrant agreement terms provide for net cash settlement outside the control of the Company in the event of tender offers under certain circumstances. As such, the Company is required to treat these warrants as derivative liabilities which are valued at their estimated fair value at their issuance date and at each reporting date with any subsequent changes reported in the consolidated statement of operations as the change in fair value of warrant derivative liabilities. The change in fair value of the warrant derivative liabilities during three months ended March 31, 2024 totaled $348,891, compared to $-0- for the three months March 31, 2023, which was recognized as a loss on the Consolidated Statements of Operations.

 

Gain on Extinguishment of Liabilities

 

Gain on extinguishment of liabilities increased to $682,345 for the period ended March 31, 2024, from $-0- during the period ended March 31, 2023, which reflects income related to the video segment’s ability to negotiate down payables and contract liabilities during the period.

 

Loss on sale of fixed asset

 

The Company recorded a loss on sale of fixed assets of $41,661 and $-0- for the three months ended March 31, 2024 and 2023.

 

Other income

 

Other income increased to $27,602 for the three months ended March 31, 2024, from $25,393 during the three months ended March 31, 2023, which largely reflects income related to a warehouse lease within the corporate headquarters.

 

Loss before Income Tax Benefit

 

As a result of the above results of operations, we reported a loss before income tax benefit of $3,943,268 and $5,979,579 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $2,036,311 (34%).

 

45

 

 

Income Tax Benefit

 

We did not record an income tax expense related to our income for the three months ended March 31, 2024 due to our overall net operating loss carryforwards available. We have further determined to continue providing a full valuation reserve on our net deferred tax assets as of March 31, 2024. We had approximately $145.0 million of net operating loss carryforwards and $1.8 million of research and development tax credit carryforwards as of March 31, 2024 available to offset future net taxable income.

 

Net Loss

 

As a result of the above results of operations, we reported a net loss of $3,943,268 and $5,979,579 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $2,036,311 (34%).

 

Net Income/(Loss) Attributable to Noncontrolling Interests of Consolidated Subsidiary

 

The Company owns a 51% equity interest in its consolidated subsidiary, Nobility Healthcare. As a result, the noncontrolling shareholders or minority interest is allocated 49% of the income/(loss) of Nobility Healthcare which is reflected in the statement of income (loss) as “net income (loss) attributable to noncontrolling interests of consolidated subsidiary”. We reported net income/(loss) attributable to noncontrolling interests of consolidated subsidiary of ($12,248) and $126,239 for the three months ended March 31, 2024 and 2023, respectively.

 

Net Loss Attributable to Common Stockholders

 

As a result of the above, we reported a net loss attributable to common stockholders of $3,931,020 and $6,105,818 for the three months March 31, 2024 and 2023, respectively, a decrease of $2,174,798 (36%).

 

Basic and Diluted Loss per Share

 

The basic and diluted loss per share was $1.37 and $2.22 for the three months ended March 31, 2024 and 2023, respectively. Basic loss per share is based upon the weighted average number of common shares outstanding during the period. For the three months ended March 31, 2024 and 2023, all shares issuable upon conversion of convertible debt and the exercise of outstanding stock options and warrants were antidilutive, and, therefore, not included in the computation of diluted loss per share.

 

Liquidity and Capital Resources

 

Overall:

 

Management’s Liquidity Plan. We have experienced net losses and cash outflows from operating activities since inception. Based upon our current operating forecast, we anticipate that we will need to restore positive operating cash flows and/or raise additional capital in the short-term to fund operations, meet our customary payment obligations and otherwise execute our business plan over the next 12 months. We are continuously in discussions to raise additional capital, which may include a variety of equity and debt instruments; however, there can be no assurance that our capital raising initiatives will be successful. Our recurring losses and level of cash used in operations, along with uncertainties concerning our ability to raise additional capital, raise substantial doubt about our ability to continue as a going concern.

 

Our Common Stock is currently listed on The Nasdaq Capital Market. In order to maintain our listing, we must satisfy minimum financial and other continued listing requirements and standards, including those regarding director independence and independent committee requirements, minimum stockholders’ equity, minimum share price, and certain corporate governance requirements. There can be no assurances that we will be able to comply with the applicable listing standards. See “Nasdaq Listing” below.

 

46

 

 

Cash, cash equivalents, and restricted cash: As of March 31, 2024, we had cash, cash equivalents, and restricted cash with an aggregate balance of $1,025,461, an increase from a balance of $778,149 at December 31, 2023. Summarized immediately below and discussed in more detail in the subsequent subsections are the main elements of the $247,312 net increase in cash during the three months ended March 31, 2024:

 

	●	Operating activities:	$918,545 of net cash used in operating activities. Net cash used in operating activities was $918,545 and $1,216,876 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $298,331. The decrease is attributable to the decrease in net loss and a decrease in the usage of cash for operating assets during the three months ended March 31, 2024 compared to the same period in 2023.
	●	Investing activities:	$160,830 of net cash provided by investing activities. Cash provided by investing activities was $160,830 for the three months ended March 31, 2024 compared to cash used in investing activities of $70,645 for the three months ended March 31, 2023. During the three months ended March 31, 2024, we made capital expenditures for: (i) acquired Country Stampede; (ii) sold an aircraft; and (iii) sold personal seat licenses.
	●	Financing activities:	$1,005,027 of net cash provided by financing activities. Cash provided by financing activities was $1,005,027 and $615,045 for the three months ended March 31, 2024 and 2023, respectively. During the first three months of 2024, we most notably made principal payments on contingent consideration promissory notes and merchant advances, received additional funds from the merchant advance and entered into an additional advance agreement. During the first three months of 2023 we received proceeds from a Commercial Extension of Credit agreement and the Company made principal payments on contingent consideration promissory notes and the credit agreement.

 

Commitments:

 

We had $1,025,461 of cash and cash equivalents, including restricted cash of $97,600, and net negative working capital $9,624,118 as of March 31, 2024. Accounts receivable and other receivables balances represented $4,421,492 of our net working capital at March 31, 2024. We intend to collect our outstanding receivables on a timely basis and reduce the overall level during 2024, which would help to provide positive cash flow to support our operations during 2024. Inventory represents $3,148,689 of our net working capital at March 31, 2024. We are actively managing the level of inventory and our goal is to reduce such level during the balance of 2024 by our sales activities, the increase of which should provide additional cash flow to help support our operations during 2024.

 

Capital Expenditures:

 

We had the following material commitments for capital expenditures at March 31, 2024:

 

Lease commitments. The following sets forth the operating lease right of use assets and liabilities as of March 31, 2024:

 

The following sets forth the operating lease right of use assets and liabilities as of March 31, 2024:

 

Assets:
Operating lease right of use assets		$	925,128
Liabilities:
Operating lease obligations-current portion		$	225,960
Operating lease obligations-less current portion			749,718
Total operating lease obligations		$	975,678

 

47

 

 

The components of lease expense were as follows for the three months ended March 31, 2024:

 

Selling, general and administrative expenses

$

108,879

 

Following are the minimum lease payments for each year and in total:

 

Year ending December 31:
2023 (April 1, to December 31, 2024)		$	225,247
2024			288,720
2025			293,300
2026			117,492
Thereafter			235,020
Total undiscounted minimum future lease payments			1,159,779
Imputed interest			(184,101	)
Total operating lease liability		$	975,678

 

Debt obligations is comprised of the following:

 

		March 31, 2024				December 31, 2023
Economic injury disaster loan (EIDL)		$	146,971			$	147,781
Contingent consideration promissory note – Nobility Healthcare Division Acquisition			64,826				129,651
Contingent consideration promissory note – Nobility Healthcare Division Acquisition			29,409				58,819
Revolving Loan Agreement			4,880,000				4,880,000
Commercial Extension of Credit- Entertainment Segment			69,643				87,928
Merchant Advances – Video Solutions Segment			1,348,000				1,350,000
Merchant Advances – Entertainment Segment			1,425,000				—
Unamortized debt issuance costs			(684,989	)			(540,429	)
Debt obligations			7,278,860				6,113,750
Less: current maturities of debt obligations			2,403,029				1,260,513
Debt obligations, long-term		$	4,875,831			$	4,853,237

 

Debt obligations mature as follows as of March 31, 2024:

 

		March 31, 2024
2024		$	2,402,188
2025			4,735,589
2026			3,542
2027			3,677
2028 and thereafter			133,864
Total		$	7,278,860

 

48

 

 

Critical Accounting Estimates

 

Our significant accounting policies are summarized in Note 1, “Nature of Business and Summary of Significant Accounting Policies,” to our consolidated financial statements. While the selection and application of any accounting policy may involve some level of subjective judgments and estimates, we believe the following accounting policies and estimates are the most critical to our financial statements, potentially involve the most subjective judgments in their selection and application, and are the most susceptible to uncertainties and changing conditions:

 

	●	Revenue Recognition / Allowance for Doubtful Accounts;
	●	Allowance for Excess and Obsolete Inventory;
	●	Goodwill, other intangible assets, fair value of assets and liabilities acquired in business combinations;
	●	Warranty Reserves;
	●	Fair value of warrant derivative liabilities;
	●	Stock-based Compensation Expense; and
	●	Accounting for Income Taxes.

 

Revenue Recognition / Allowances for Doubtful Accounts. Revenue is recognized for the shipment of products or delivery of service when all five of the following conditions are met:

 

	(i)	Identify the contract with the customer;
	(ii)	Identify the performance obligations in the contract;
	(iii)	Determine the transaction price;
	(iv)	Allocate the transaction price to the performance obligations in the contract; and
	(v)	Recognize revenue when a performance obligation is satisfied.

 

We consider the terms and conditions of the contract and our customary business practices in identifying our contracts under ASC 606. We determine we have a contract when the customer order is approved, we can identify each party’s rights regarding the services to be transferred, we can identify the payment terms for the services, we have determined the customer has the ability and intent to pay and the contract has commercial substance. At contract inception we evaluate whether the contract includes more than one performance obligation. We apply judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, credit and financial information pertaining to the customer.

 

Performance obligations promised in a contract are identified based on the services and the products that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the services and the products is separately identifiable from other promises in the contract. Our performance obligations consist of (i) products, (ii) professional services, and (iii) extended warranties.

 

The transaction price is determined based on the consideration to which we expect to be entitled in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in our judgment it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of our contracts contain a significant financing component.

 

49

 

 

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on the relative standalone selling price (“SSP”).

 

Revenue for our video solutions segment is recognized at the time the related performance obligation is satisfied by transferring the control of the promised service to a customer. Revenue is recognized when control of the service is transferred to the customer, in an amount that reflects the consideration that we expect to receive in exchange for our services. We generate all our revenue from contracts with customers.

 

Revenue for our revenue cycle management segment is recorded on a net basis, as its primary source of revenue is its end-to-end service fees. These service fees are reported as revenue monthly upon completion of our performance obligation to provide the agreed upon services.

 

Revenue for our entertainment segment is recorded on a gross or net basis based on management’s assessment of whether we are acting as a principal or agent in the transaction. The determination is based upon the evaluation of control over the event ticket, including the right to sell the ticket, prior to its transfer to the ticket buyer.

 

We sell our tickets held in inventory, which consists of one performance obligation, being to transfer control of an event ticket to the buyer upon confirmation of the order. We act as the principal in these transactions as we own the ticket at the time of sale, therefore we control the ticket prior to transferring to the customer. In these transactions, revenue is recorded on a gross basis based on the value of the ticket and is recognized when an order is confirmed. Payment is typically due upon delivery of the ticket.

 

We also act as an intermediary between buyers and sellers through the online secondary marketplace. Revenues derived from this marketplace primarily consist of service fees from entertainment operations, and consists of one primary performance obligation, which is facilitating the transaction between the buyer and seller, being satisfied at the time the order has been confirmed. As we do not control the ticket prior to the transfer, we act as an agent in these transactions. Revenue is recognized on a net basis, net of the amount due to the seller when an order is confirmed, the seller is then obligated to deliver the tickets to the buyer per the seller’s listing. Payment is due at the time of sale.

 

We review all significant, unusual, or nonstandard shipments of product or delivery of services as a routine part of our accounting and financial reporting process to determine compliance with these requirements. Extended warranties are offered on selected products, and when a customer purchases an extended warranty, the associated proceeds are treated as contract liability and recognized over the term of the extended warranty.

 

For our video solutions segment, our principal customers are state, local, and federal law enforcement agencies, which historically have been low risks for uncollectible accounts. However, we have commercial customers and international distributors that present a greater risk for uncollectible accounts than such law enforcement customers and we consider a specific reserve for bad debts based on their individual circumstances. Our historical bad debts have been negligible, with less than $258,000 charged off as uncollectible on cumulative revenues of $248.0 million since we commenced deliveries during 2006.

 

For our entertainment segment, our customers are mainly online visitors that pay at the time of the transaction, and we collect the service fees charged with the transaction. Thus, leading to minimal risk for uncollectible accounts, to which we then consider a specific reserve for bad debts based on their individual circumstances. As we continue to learn more about the collectability related to this recent acquisition, we will track historical bad debts and continue to assess appropriate reserves.

 

For our revenue cycle management segment, our customers are mainly medium to large healthcare organizations that are charged monthly upon the execution of our services. Being these customers are healthcare organizations with minimal risk for uncollectible accounts, we consider a specific reserve for bad debts based on their individual circumstances. As we continue to learn more about the collectability related to this recently added segment, we will track historical bad debts and continue to assess appropriate reserves.

 

50

 

 

Allowance for Excess and Obsolete Inventory. We record valuation reserves on our inventory for estimated excess or obsolete inventory items. The amount of the reserve is equal to the difference between the cost of the inventory and the estimated market value based upon assumptions about future demand and market conditions. On a quarterly basis, management performs an analysis of the underlying inventory to identify reserves needed for excess and obsolescence. Management uses its best judgment to estimate appropriate reserves based on this analysis. In addition, we adjust the carrying value of inventory if the current market value of that inventory is below its cost.

 

Inventories consisted of the following at March 31, 2024 and December 31, 2023:

 

		March 31, 2024				December 31, 2023
Raw material and component parts– video solutions segment		$	2,938,434			$	3,044,653
Work-in-process– video solutions segment			26,091				20,396
Finished goods – video solutions segment			4,180,699				4,623,489
Finished goods – entertainment segment			489,854				699,204
Subtotal			7,635,078				8,387,742
Reserve for excess and obsolete inventory– video solutions segment			(4,315,132	)			(4,355,666	)
Reserve for excess and obsolete inventory – entertainment segment			(171,257	)			(186,795	)
Total inventories		$	3,148,689			$	3,845,281

 

We balance the need to maintain strategic inventory levels to ensure competitive delivery performance to our customers against the risk of inventory obsolescence due to changing technology and customer requirements. As reflected above, our inventory reserves represented 59% of the gross inventory balance at March 31, 2024, compared to 54% of the gross inventory balance at December 31, 2023. We had $4,486,389 and $4,542,461 in reserves for obsolete and excess inventories at March 31, 2024 and December 31, 2023, respectively. Total raw materials, component parts, and work-in-process were $2,964,525 and $3,065,049 at March 31, 2024 and December 31, 2023, respectively, a decrease of $100,524 (3%). Finished goods balances were $4,670,553 and $5,322,693 at March 31, 2024 and December 31, 2023, respectively, a decrease of $652,140 (12%). The small decrease in the inventory reserve is primarily due to the reduction in finished goods and movement of excess inventory. Additionally, the Company determined a reasonable reserve for inventory held at the ticket operating segment, in which some inventory items sell below cost or go unsold, thus having to be fully written-off following the event date. We believe the reserves are appropriate given our inventory levels as of March 31, 2024.

 

If actual future demand or market conditions are less favorable than those projected by management or significant engineering changes to our products that are not anticipated and appropriately managed, additional inventory write-downs may be required in excess of the inventory reserves already established.

 

Goodwill and other intangible assets. When we acquire a business, we determine the fair value of the assets acquired and liabilities assumed on the date of acquisition, which may include a significant amount of intangible assets such as customer relationships, software and content, as well as goodwill. When determining the fair values of the acquired intangible assets, we consider, among other factors, analyses of historical financial performance and an estimate of the future performance of the acquired business. The fair values of the acquired intangible assets are primarily calculated using an income approach that relies on discounted cash flows. This method starts with a forecast of the expected future net cash flows for the asset and then adjusts the forecast to present value by applying a discount rate that reflects the risk factors associated with the cash flow streams. We consider this approach to be the most appropriate valuation technique because the inherent value of an acquired intangible asset is its ability to generate future income. In a typical acquisition, we engage a third-party valuation expert to assist us with the fair value analyses for acquired intangible assets.

 

51

 

 

Determining the fair values of acquired intangible assets requires us to exercise significant judgment. We select reasonable estimates and assumptions based on evaluating a number of factors, including, but not limited to, marketplace participants, consumer awareness and brand history. Additionally, there are significant judgments inherent in discounted cash flows such as estimating the amount and timing of projected future cash flows, the selection of discount rates, hypothetical royalty rates and contributory asset capital charges. Specifically, the selected discount rates are intended to reflect the risk inherent in the projected future cash flows generated by the underlying acquired intangible assets.

 

Determining an acquired intangible asset’s useful life also requires significant judgment and is based on evaluating a number of factors, including, but not limited to, the expected use of the asset, historical client retention rates, consumer awareness and trade name history, as well as any contractual provisions that could limit or extend an asset’s useful life.

 

The Company’s goodwill is evaluated in accordance with FASB ASC Topic 350, which requires goodwill to be assessed for impairment at least annually and whenever events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable. In addition, an impairment evaluation of our amortizable intangible assets may also be performed if events or circumstances indicate potential impairment. Among the factors that could trigger an impairment review are current operating results that do not align with our annual plan or historical performance; changes in our strategic plans or the use of our assets; restructuring changes or other changes in our business segments; competitive pressures and changes in the general economy or in the markets in which we operate; and a significant decline in our stock price and our market capitalization relative to our net book value.

 

When performing our annual assessment of the recoverability of goodwill, we initially perform a qualitative analysis evaluating whether any events or circumstances occurred or exist that provide evidence that it is more likely than not that the fair value of any of our reporting units is less than the related carrying amount. If we do not believe that it is more likely than not that the fair value of any of our reporting units is less than the related carrying amount, then no quantitative impairment test is performed. However, if the results of our qualitative assessment indicate that it is more likely than not that the fair value of a reporting unit is less than its respective carrying amount, then we perform a two-step quantitative impairment test.

 

Evaluating the recoverability of goodwill requires judgments and assumptions regarding future trends and events. As a result, both the precision and reliability of our estimates are subject to uncertainty. Among the factors that we consider in our qualitative assessment are general economic conditions and the competitive environment; actual and projected reporting unit financial performance; forward-looking business measurements; and external market assessments. To determine the fair values of our reporting units for a quantitative analysis, we typically utilize detailed financial projections, which include significant variables, such as projected rates of revenue growth, profitability and cash flows, as well as assumptions regarding discount rates, the Company’s weighted average cost of capital and other data.

 

Our most recent annual impairment test of goodwill was a qualitative analysis conducted as of December 31, 2023 that indicated no impairment. Subsequent to completing our 2023 annual impairment test, no events or changes in circumstances were noted that required an interim goodwill impairment test. Note 1 — Nature of Business and Summary of Significant Accounting Policies and Note 10 — Goodwill and Other Intangible Assets in the Notes to Consolidated Financial Statements provide additional information regarding the Company’s goodwill and other intangible assets.

 

Warranty Reserves. We generally provide up to a two-year parts and labor standard warranty on our products to our customers. Provisions for estimated expenses related to product warranties are made at the time products are sold. These estimates are established using historical information on the nature, frequency, and average cost of claims. We actively study trends of claims and take action to improve product quality and minimize claims. Our warranty reserves were increased to $20,529 as of March 31, 2024 compared to $17,699 as of December 31, 2023 due to newer products gaining a long history of claims to consider, which was slightly offset as we begin to slow our warranty exposures through the roll-off of DVM-750 and DVM-800 units from warranty coverage. Standard warranty exposure on the DVM-800 and DVM-250plus are the responsibility of the contract manufacturers which reduced our overall warranty exposure as these are very popular products in our line. There is a risk that we will have higher warranty claim frequency rates and average cost of claims than our history has indicated on our legacy mirror products on our new products for which we have limited experience. Actual experience could differ from the amounts estimated requiring adjustments to these liabilities in future periods.

 

52

 

 

Warrant derivative liabilities. On April 5, 2023, the Company issued warrants to purchase a total of 1,125,000 shares of Common Stock. The warrant terms provide for net cash settlement outside the control of the Company under certain circumstances in the event of tender offers. As such, the Company is required to treat these warrants as derivative liabilities which are valued at their estimated fair value at their issuance date and at each reporting date with any subsequent changes reported in the consolidated statements of operations as the change in fair value of warrant derivative liabilities. Furthermore, the Company revalues the fair value of warrant derivative liability as of the date the warrant is exercised with the resulting warrant derivative liability transitioned to equity.

 

The Company has utilized the following assumptions in its Black-Scholes option valuation model to calculate the estimated fair value of the warrant derivative liabilities as of their date of issuance and as of March 31, 2024:

 

		Issuance date assumptions				March 31, 2024 assumptions
Volatility - range			106.0	%		$	108.5	%
Risk-free rate			3.36	%			4.21	%
Dividend			0	%			0	%
Remaining contractual term			5.0 years				4.0 years
Exercise price			5.50 – 7.50				5.50 – 7.50
Common stock issuable under the warrants			1,125,000				1,125,000

 

Stock-based Compensation Expense. We grant stock options to our employees and directors and such benefits provided are share-based payment awards which require us to make significant estimates related to determining the value of our share-based compensation. Our expected stock-price volatility assumption is based on historical volatilities of the underlying stock that are obtained from public data sources and there were no stock options granted during the three months ended March 31, 2024.

 

If factors change and we develop different assumptions in future periods, the compensation expense that we record in the future may differ significantly from what we have recorded in the current period. There is a high degree of subjectivity involved when using option pricing models to estimate share-based compensation. Changes in the subjective input assumptions can materially affect our estimates of fair values of our share-based compensation. Certain share-based payment awards, such as employee stock options, may expire worthless or otherwise result in zero intrinsic value compared to the fair values originally estimated on the grant date and reported in our financial statements. Alternatively, values may be realized from these instruments that are significantly in excess of the fair values originally estimated on the grant date and reported in our financial statements. Although the fair value of employee share-based awards is determined using an established option pricing model, that value may not be indicative of the fair value observed in a willing buyer/willing seller market transaction. In addition, we account for forfeitures as they occur.

 

Accounting for Income Taxes. Accounting for income taxes requires significant estimates and judgments on the part of management. Such estimates and judgments include, but are not limited to, the effective tax rate anticipated to apply to tax differences that are expected to reverse in the future, the sufficiency of taxable income in future periods to realize the benefits of net deferred tax assets and net operating losses currently recorded and the likelihood that tax positions taken in tax returns will be sustained on audit.

 

As required by authoritative guidance, we record deferred tax assets or liabilities based on differences between financial reporting and tax bases of assets and liabilities using currently enacted rates that will be in effect when the differences are expected to reverse. Authoritative guidance also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that all or some portion of the deferred tax asset will not be realized. As of March 31, 2024, we have fully reserved all of our deferred tax assets. Based on a review of our deferred tax assets and recent operating performance, we determined that our valuation allowance should be increased by $7,410,000 to a balance of $41,610,000 to fully reserve our deferred tax assets at December 31, 2023. We determined that it was appropriate to continue to provide a full valuation reserve on our net deferred tax assets as of March 31, 2024, because of the overall net operating loss carryforwards available. We expect to continue to maintain a full valuation allowance until we determine that we can sustain a level of profitability that demonstrates our ability to realize these assets. To the extent we determine that the realization of some or all of these benefits is more likely than not based upon expected future taxable income, a portion or all of the valuation allowance will be reversed. Such a reversal would be recorded as an income tax benefit and, for some portion related to deductions for stock option exercises, an increase in shareholders’ equity.

 

As required by authoritative guidance, we have performed a comprehensive review of our portfolio of uncertain tax positions in accordance with recognition standards established by the FASB, an uncertain tax position represents our expected treatment of a tax position taken in a filed tax return or planned to be taken in a future tax return, that has not been reflected in measuring income tax expense for financial reporting purposes. We have no recorded liability as of March 31, 2024 representing uncertain tax positions.

 

We have generated substantial deferred income tax assets related to our operations primarily from the charge to compensation expense taken for stock options, certain tax credit carryforwards and net operating loss carryforwards. For us to realize the income tax benefit of these assets, we must generate sufficient taxable income in future periods when such deductions are allowed for income tax purposes. In some cases where deferred taxes were the result of compensation expense recognized on stock options, our ability to realize the income tax benefit of these assets is also dependent on our share price increasing to a point where these options have intrinsic value at least equal to the grant date fair value and are exercised. In assessing whether a valuation allowance is needed in connection with our deferred income tax assets, we have evaluated our ability to generate sufficient taxable income in future periods to utilize the benefit of the deferred income tax assets. We continue to evaluate our ability to use recorded deferred income tax asset balances. If we fail to generate taxable income for financial reporting in future years, no additional tax benefit would be recognized for those losses, since we will not have accumulated enough positive evidence to support our ability to utilize net operating loss carryforwards in the future. Therefore, we may be required to increase our valuation allowance in future periods should our assumptions regarding the generation of future taxable income not be realized.

 

Inflation and Seasonality

 

Inflation has not materially affected us during the past fiscal year. We do not believe that our Video Solutions and Revenue Cycle Management segments business are seasonal in nature, however; the Entertainment Segment is expected to generate higher revenues during the second half of the calendar year than in the first half.

 

53

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not Applicable.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

The Company maintains disclosure controls and procedures, as such terms are defined in Rules 13a-15(e) under the Exchange Act. The Company, under the supervision and with the participation of its management, including its Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of such disclosure controls and procedures for this Report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were not effective as of March 31, 2024 to provide reasonable assurance that material information required to be disclosed by the Company in this Report was recorded, processed, summarized and communicated to the Company’s management as appropriate and within the time periods specified in SEC rules and forms.

 

As part of our plan to remediate our controls which were not effective, we are performing a full review of our internal control procedures. We have implemented, and plan to continue to implement, new controls and new processes. We have hired and plan to continue to hire additional qualified personnel and establish more robust processes to support our internal control over financial reporting, including clearly defined roles and responsibilities. The Company anticipates time being required to complete the implementation and to assess and ensure the sustainability of these controls. The effectiveness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

 

Changes in Internal Control over Financial Reporting

 

There have not been any changes in the Company’s internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during the Company’s last fiscal quarter that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

The information regarding certain legal proceedings in which we are involved as set forth in Note 12 – Contingencies of the Notes to the Condensed Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report on Form 10-Q) is incorporated by reference into this Item 1.

 

54

 

 

In addition to such legal proceedings, we are faced with or involved in various other claims and legal proceedings arising in the normal course of our businesses. At this time, we do not believe any material losses under such other claims and proceedings to be probable. While the ultimate outcome of such claims or legal proceedings cannot be predicted with certainty, it is in the opinion of management, after consultation with legal counsel, that the final outcome in such proceedings, in the aggregate, would not have a material adverse effect on our consolidated financial condition, results of operations or cash flows.

 

Item 1A. Risk Factors.

 

As a smaller reporting company, we are not required to provide the information required by this Item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

There were no unregistered sales of equity securities during the first quarter of 2024 that were not disclosed by the Company on a Current Report on Form 8-K.

 

Item 3. Defaults upon Senior Securities.

 

Not applicable.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

Not applicable.

 

Item 6. Exhibits.

 

(a) Exhibits.

 

	3.1	Certificate of Amendment to Articles of Incorporation of Digital Ally, Inc (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on February 7, 2023).
	10.1	Form of Promissory Note (incorporated by reference to Exhibit 10.1 to Company’s Current Report on Form 8-K with the SEC on March 5, 2024).
	10.2	Form of Note Purchase Agreement (incorporated by reference to Exhibit 10.2 to Company’s Current Report on Form 8-K with the SEC on March 5, 2024).
	10.3	Form of Security Agreement (incorporated by reference to Exhibit 10.3 to Company’s Current Report on Form 8-K with the SEC on March 5, 2024).
	10.4	Form of Asset Purchase Agreement (incorporated by reference to Exhibit 10.4 to Company’s Current Report on Form 8-K with the SEC on March 5, 2024).
	31.1	Certificate of Stanton E. Ross pursuant to Rule 13a-14(a) under the Securities and Exchange Act of 1934, as amended.
	31.2	Certificate of Thomas J. Heckman pursuant to Rule 13a-14(a) under the Securities and Exchange Act of 1934, as amended.
	32.1	Certificate of Stanton E. Ross pursuant to Rule 13a-14(b) under the Securities and Exchange Act of 1934, as amended.
	32.2	Certificate of Thomas J. Heckman pursuant to Rule 13a-14(b) under the Securities and Exchange Act of 1934, as amended.
	101.INS	Inline XBRL Instance Document
	101.SCH	Inline XBRL Schema Document
	101.CAL	Inline XBRL Calculation Linkbase Document
	101.DEF	Inline XBRL Definition Linkbase Document
	101.LAB	Inline XBRL Label Linkbase Document
	101.PRE	Inline XBRL Presentation Linkbase Document
	104	Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit)

 

In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.

 

55

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: May 17, 2024

 

	DIGITAL ALLY, INC.
	By:	/s/ Stanton E. Ross
	Name:	Stanton E. Ross
	Title:	Chief Executive Officer
	By:	/s/ Thomas J. Heckman
	Name:	Thomas J. Heckman
	Title:	Chief Financial Officer, Secretary and Treasurer (Principal Financial and Accounting Officer)

 

56

 

EXHIBIT 31.1

 

DIGITAL ALLY, INC.

 

CERTIFICATIONS

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Stanton E. Ross, Chief Executive Officer of Digital Ally, Inc., certify that:

 

	1.	I have reviewed this report on Form 10-Q for the three months ended March 31, 2024 of Digital Ally, Inc.
	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.
	4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
		(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
		(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
		(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
		(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
	5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
		(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
		(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: May 17, 2024

 

/s/ Stanton E. Ross
Stanton E. Ross
Chief Executive Officer
(Principal Executive Officer)

 

 

EXHIBIT 31.2

 

DIGITAL ALLY, INC.

 

CERTIFICATIONS

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Thomas J. Heckman, Chief Financial Officer of Digital Ally, Inc., certify that:

 

	1.	I have reviewed this report on Form 10-Q for the three months ended March 31, 2024 of Digital Ally, Inc.
	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.
	4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
		(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
		(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
		(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
		(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
	5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
		(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
		(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: May 17, 2024

 

/s/ Thomas J. Heckman
THOMAS J. HECKMAN
Chief Financial Officer
(Principal Financial Officer)

 

 

EXHIBIT 32.1

 

DIGITAL ALLY, INC.

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Digital Ally, Inc. (the “Company”) on Form 10-Q for the three months ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stanton E. Ross, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Stanton E. Ross
Stanton E. Ross
Chief Executive Officer
(Principal Executive Officer)
May 17, 2024

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Digital Ally, Inc. and will be retained by Digital Ally, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

EXHIBIT 32.2

 

DIGITAL ALLY, INC.

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Digital Ally, Inc. (the “Company”) on Form 10-Q for the three months ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas J. Heckman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Thomas J. Heckman
THOMAS J. HECKMAN
Chief Financial Officer
(Principal Financial Officer)
May 17, 2024

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Digital Ally, Inc. and will be retained by Digital Ally, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

Cover - shares	3 Months Ended
	Mar. 31, 2024	May 17, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	001-33899
Entity Registrant Name	Digital Ally, Inc.
Entity Central Index Key	0001342958
Entity Tax Identification Number	20-0064269
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	14001 Marshall Drive
Entity Address, City or Town	Lenexa
Entity Address, State or Province	KS
Entity Address, Postal Zip Code	66215
City Area Code	(913)
Local Phone Number	814-7774
Title of 12(b) Security	Common stock, $0.001 par value per share
Trading Symbol	DGLY
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		2,879,826

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 927,861	$ 680,549
Accounts receivable – trade, net of $234,727 allowance – March 31, 2024 and $200,668 – December 31, 2023	1,207,752	1,584,662
Other receivables, net of $25,000 allowance – March 31, 2024 and $5,000 – December 31, 2023	3,213,740	3,107,634
Inventories, net	3,148,689	3,845,281
Prepaid expenses	6,575,013	6,366,368
Total current assets	15,073,055	15,584,494
Property, plant, and equipment, net	6,207,795	7,283,702
Goodwill and other intangible assets, net	16,625,032	16,510,422
Operating lease right of use assets, net	925,128	1,053,159
Other assets	6,333,185	6,597,032
Total assets	45,164,195	47,028,809
Current liabilities:
Accounts payable	11,212,697	10,732,089
Accrued expenses	3,137,144	3,269,330
Current portion of operating lease obligations	225,960	279,538
Contract liabilities – current portion	3,299,714	2,937,168
Notes payable – related party – current portion	2,700,000	2,700,000
Debt obligations – current portion	2,403,029	1,260,513
Warrant derivative liabilities	1,718,629	1,369,738
Income taxes payable		61
Total current liabilities	24,697,173	22,548,437
Long-term liabilities:
Debt obligations – long term	4,875,831	4,853,237
Operating lease obligation – long term	749,718	827,836
Contract liabilities – long term	7,285,206	7,340,459
Lease Deposit	10,445	10,445
Total liabilities	37,618,373	35,580,414
Commitments and contingencies
Stockholders’ Equity:
Common stock, $0.001 par value per share; 200,000,000 shares authorized; shares issued: 2,879,826 shares issued – March 31, 2024 and 2,800,754 shares issued – December 31, 2023	2,880	2,801
Additional paid in capital	128,481,699	128,441,083
Noncontrolling interest in consolidated subsidiary	661,044	673,292
Accumulated deficit	(121,599,801)	(117,668,781)
Total stockholders’ equity	7,545,822	11,448,395
Total liabilities and stockholders’ equity	$ 45,164,195	$ 47,028,809

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Allowance for doubtful accounts receivable	$ 234,727	$ 200,668
Allowance for other receivable, current	$ 25,000	$ 5,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	2,879,826	2,800,754

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Total revenue	$ 5,529,351	$ 7,697,190
Cost of revenue:
Total cost of revenue	4,005,652	6,152,398
Gross profit	1,523,699	1,544,792
Selling, general and administrative expenses:
Research and development expense	487,466	934,939
Selling, advertising and promotional expense	761,118	1,847,489
General and administrative expense	3,914,149	4,935,170
Total selling, general and administrative expenses	5,162,733	7,717,598
Operating loss	(3,639,034)	(6,172,806)
Other income (expense):
Interest income	19,356	15,477
Interest expense	(648,567)	(5,664)
Other income	27,602	25,393
Change in fair value of warrant derivative liabilities	(348,891)
Change in fair value of contingent consideration promissory notes and earn-out agreements		158,021
Gain on extinguishment of liabilities	682,345
Gain on sale of intangibles	5,582
Loss on sale of property, plant and equipment	(41,661)
Total other income	(304,234)	193,227
Income (loss) before income tax benefit	(3,943,268)	(5,979,579)
Income tax benefit
Net loss	(3,943,268)	(5,979,579)
Net (income) loss attributable to noncontrolling interests of consolidated subsidiary	12,248	(126,239)
Net loss attributable to common stockholders	$ (3,931,020)	$ (6,105,818)
Net loss per share information:
Basic	$ (1.37)	$ (2.22)
Diluted	$ (1.37)	$ (2.22)
Weighted average shares outstanding:
Basic	2,861,229	2,751,662
Diluted	2,861,229	2,751,662
Product [Member]
Revenue:
Total revenue	$ 1,565,846	$ 2,453,810
Cost of revenue:
Total cost of revenue	1,567,393	2,301,100
Service, Other [Member]
Revenue:
Total revenue	3,963,505	5,243,380
Cost of revenue:
Total cost of revenue	$ 2,438,259	$ 3,851,298

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Noncontrolling Interest [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022	$ 2,721	$ 127,869,342	$ 448,694	$ (91,980,234)	$ 36,340,523
Balance, shares at Dec. 31, 2022	2,720,170
Stock-based compensation		114,848			114,848
Restricted common stock grant	$ 35	$ (35)
Restricted common stock grant, shares	35,000
Issuance due to rounding from reverse stock split
Issuance due to rounding from reverse stock split, shares	54
Net Income (loss)			126,239	$ (6,105,818)	$ (5,979,579)
Balance at Mar. 31, 2023	$ 2,756	127,984,155	574,933	(98,086,052)	30,475,792
Balance, shares at Mar. 31, 2023	2,755,224
Balance at Dec. 31, 2023	$ 2,801	128,441,083	673,292	(117,668,781)	11,448,395
Balance, shares at Dec. 31, 2023	2,800,754
Stock-based compensation		40,695			40,695
Restricted common stock grant	$ 80	(80)
Restricted common stock grant, shares	80,197
Net Income (loss)			(12,248)	(3,931,020)	(3,943,268)
Restricted common stock forfeitures	$ (1)	1
Restricted common stock grant, shares	(1,125)				1,125
Balance at Mar. 31, 2024	$ 2,880	$ 128,481,699	$ 661,044	$ (121,599,801)	$ 7,545,822
Balance, shares at Mar. 31, 2024	2,879,826

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities:
Net loss	$ (3,943,268)	$ (5,979,579)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation and amortization	550,991	543,110
Loss on sale of property, plant and equipment	41,661
Gain on sale of intangible	(5,582)
Stock-based compensation	40,695	114,848
Amortization of debt issuance costs	360,330
Gain on extinguishment of liabilities	(682,345)
Change in fair value of warrant derivative liabilities	348,891
Provision for inventory obsolescence	(56,072)	80,434
Provision for doubtful accounts receivable	34,059	29,025
Provision for doubtful lease receivable	20,000	5,000
Change in fair value of contingent consideration promissory note		(158,021)
(Increase) decrease in:
Accounts receivable – trade	142,606	(211,201)
Other receivable	(126,106)	1,479,476
Inventories	793,664	837,893
Prepaid expenses	(154,645)	684,403
Operating lease right of use assets	54,137	110,115
Other assets	263,847	(2,445,206)
Increase (decrease) in:
Accounts payable	1,569,346	3,009,912
Accrued expenses	(132,185)	(184,976)
Operating lease obligations	(57,801)	(110,115)
Income taxes payable	(61)
Lease deposit		10,445
Contract liabilities	19,293	967,561
Net cash used in operating activities	(918,545)	(1,216,876)
Cash Flows from Investing Activities:
Purchases of furniture, fixtures and equipment	(18,467)	(23,657)
Additions to intangible assets	(61,882)	(46,988)
Cash paid for acquisition of Country Stampede	(400,000)
Proceeds from sale of intangible assets	90,535
Proceeds from sale of property, plant and equipment	550,644
Net cash provided by (used in) investing activities	160,830	(70,645)
Cash Flows from Financing Activities:
Proceeds – Merchant Advances – Video Solutions Segment	700,000
Proceeds – Merchant Advances – Entertainment Segment	915,000
Proceeds – Commercial Extension of Credit – Entertainment Segment	275,000	1,000,000
Payments on Commercial Extension of Credit – Entertainment Segment	(87,928)	(264,166)
Payments on Merchant Advances – Video Solutions Segment	(702,000)
Principal payment on EIDL loan	(810)
Principal payment on contingent consideration promissory notes	(94,235)	(120,789)
Net cash provided by financing activities	1,005,027	615,045
Net increase (decrease) in cash, cash equivalents, and restricted cash	247,312	(672,476)
Cash, cash equivalents, and restricted cash, beginning of period	778,149	3,532,199
Cash, cash equivalents, and restricted cash, end of period	1,025,461	2,859,723
Supplemental disclosures of cash flow information:
Cash payments for interest	158,517	6,348
Supplemental disclosures of non-cash investing and financing activities:
Restricted common stock grant	80	35
Restricted common stock forfeitures	1
Adjustments of accounts payable with the sale proceeds of property, plant and equipment	549,356
Assets acquired in business acquisitions	605,000
Goodwill acquired in business acquisitions	225,959
Liabilities assumed in business acquisitions	288,000
Amounts payable for Country Stampede acquisition	142,959
Commercial Extension of Credit repaid through accrued revenue – Entertainment Segment	205,357	26,977
ROU and lease liability recorded on extension (termination) of lease	$ (73,894)	$ 517,039

NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1. NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   Nature of Operations:   Digital Ally, Inc. was originally incorporated in Nevada on December 13, 2000 as Vegas Petra, Inc. and had no operations until 2004. On November 30, 2004, Vegas Petra, Inc. entered into a Plan of Merger with Digital Ally, Inc., at which time the merged entity was renamed Digital Ally, Inc. (such merged entity, the “Predecessor Registrant”).   On August 23, 2022 (the “Effective Time”), the Predecessor Registrant merged with and into its wholly owned subsidiary, DGLY Subsidiary Inc., a Nevada corporation (the “Registrant”), pursuant to an agreement and plan of merger, dated as of August 23, 2022 (the “Merger Agreement”), between the Predecessor Registrant and the Registrant, with the Registrant as the surviving corporation in the merger (such transaction, the “Merger”). At the Effective Time, Articles of Merger were filed with the Secretary of State of the State of Nevada, pursuant to which the Registrant was renamed “Digital Ally, Inc.” and, by operation of law, succeeded to the assets, continued the business and assumed the rights and obligations of the Predecessor Registrant immediately prior to the Merger. Under the Nevada Revised Statutes, shareholder approval was not required in connection with the Merger Agreement or the transactions contemplated thereby.   At the Effective Time, pursuant to the Merger Agreement, (i) each outstanding share of Predecessor Registrant’s common stock, par value $0.001 per share (the “Predecessor Common Stock”) automatically converted into one share of common stock, par value $0.001 per share, of the Registrant (“Registrant Common Stock”), (ii) each outstanding option, right or warrant to acquire shares of Predecessor Common Stock converted into an option, right or warrant, as applicable, to acquire an equal number of shares of Registrant Common Stock under the same terms and conditions as the original options, rights or warrants, and (iii) the directors and executive officers of the Predecessor Registrant were appointed as directors and executive officers, as applicable, of the Registrant, each to serve in the same capacity and for the same term as such person served with the Predecessor Registrant immediately before the Merger.   The business of the Registrant, Digital Ally, Inc. (with its wholly-owned subsidiaries, Digital Ally International, Inc., Shield Products, LLC, Digital Ally Healthcare, LLC (“Digital Ally Healthcare”), TicketSmarter, Inc. (“TicketSmarter”), Worldwide Reinsurance, Ltd., Digital Connect, Inc., BirdVu Jets, Inc., Kustom 440, Inc. (“Kustom 440”), Kustom Entertainment, Inc., and its majority-owned subsidiary Nobility Healthcare, LLC, collectively, “Digital Ally,” “Digital,” and the “Company”), is divided into three reportable operating segments: 1) the Video Solutions Segment, 2) the Revenue Cycle Management Segment and 3) the Ticketing Segment. The Video Solutions Segment is our legacy business that produces digital video imaging, storage products, disinfectant and related safety products for use in law enforcement, security and commercial applications. This segment includes both service and product revenues through our subscription models offering cloud and warranty solutions, and hardware sales for video and health safety solutions. The Revenue Cycle Management Segment provides working capital and back-office services to a variety of healthcare organizations throughout the country, as a monthly service fee. The Entertainment Segment acts as an intermediary between ticket buyers and sellers within our secondary ticketing platform, ticketsmarter.com, and we also acquire tickets from primary sellers to then sell through various platforms. The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information of those segments to be presented in financial statements. Such required segment information is included in Note 18.   Reverse Stock Split   On February 6, 2023, the Company filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada to effect a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the shares of its common stock. The Reverse Stock Split was effective as of time of filing. No fractional shares were issued in connection with the Reverse Stock Split. Any fractional shares of our Common Stock that would have otherwise resulted from the Reverse Stock Split were rounded up to the nearest whole number. In connection with the Reverse Stock Split, the board of directors of the Company approved appropriate and proportional adjustments to all outstanding securities or other rights convertible or exercisable into shares of the Company’s common stock, including, without limitation, all preferred stock, warrants, options, and other equity compensation rights. All historical share and per-share amounts reflected throughout the Company’s consolidated financial statements and other financial information in this Report have been adjusted to reflect the Reverse Stock Split as if the split occurred as of the earliest period presented. The par value per share of the Company’s common stock was not affected by the Reverse Stock Split.     Business Combination   In June 2023, the Company, entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Clover Leaf Capital Corp., a Delaware corporation (Nasdaq: CLOE) (“Clover Leaf”), CL Merger Sub, Inc., a Nevada corporation and a wholly owned subsidiary of Clover Leaf (“Merger Sub”), Yntegra Capital Investments LLC, a Delaware limited liability company, in the capacity as the representative from and after the Effective Time (as defined in the Merger Agreement) for the stockholders of Clover Leaf in accordance with the terms and conditions of the Merger Agreement, and Kustom Entertainment, Inc., a Nevada corporation, a wholly owned subsidiary of the Company, with a focus and mission to own and produce events, festivals, and entertainment alongside its evolving primary and secondary ticketing technologies (“Kustom”). Pursuant to the Merger Agreement, subject to the terms and conditions set forth therein upon the consummation of the transactions contemplated by the Merger Agreement (the “Closing”), Merger Sub will merge with and into Kustom, with Kustom continuing as the surviving corporation in the Merger and a wholly owned subsidiary of Clover Leaf. Upon the Closing which is subject to the approval of Clover Leaf’s shareholders and the satisfaction or waiver of certain other customary closing conditions, the common stock of the combined company is expected to be listed on the Nasdaq under a mutually agreed new ticker symbol that reflects the name “Kustom Entertainment”.   Basis of Presentation:   The unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.   The balance sheet at December 31, 2023 has been derived from the audited financial statements at that date, but does not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements.   For further information, refer to the audited financial statements and footnotes included in the Company’s annual report on Form 10-K for the year ended December 31, 2023.   Liquidity and Going Concern   During the second quarter of 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. This update provided U.S. GAAP guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. Under this standard, the Company is required to evaluate whether there is substantial doubt about its ability to continue as a going concern each reporting period, including interim periods. In evaluating the Company’s ability to continue as a going concern, management considered the conditions and events that could raise substantial doubt about the Company’s ability to continue as a going concern within 12 months after the Company’s financial statements were issued (May 15, 2023). Management considered the Company’s current financial condition and liquidity sources, including current funds available, forecasted future cash flows and the Company’s obligations due before May 15, 2024.   The Company has experienced net losses and cash outflows from operating activities since inception. For the three months ended March 31, 2024, the Company had a net loss attributable to common stockholders of $3,931,020, net cash used in operating activities of $918,545, $160,830 provided by investing activities and $1,005,027 provided by financing activities. The Company will have to restore positive operating cash flows and profitability over the next year and/or raise additional capital to fund its operational plans, meet its customary payment obligations and otherwise execute its business plan. There can be no assurance that it will be successful in restoring positive cash flows and profitability, or that it can raise additional financing when needed, and obtain it on terms acceptable or favorable to the Company.   The Company has implemented an enhanced quality control program to detect and correct product issues before they result in significant rework expenditures affecting its gross margins and has seen progress in that regard. The Company has also implemented a marketing and advertisement reduction plan for its entertainment segment, which will focus on reducing and alleviating current obligations from its media marketing agreements and place a hold on entering into any new agreements. The Company believes that its quality control, cost-cutting initiatives, and new product introduction will eventually restore positive operating cash flows and profitability, although it can offer no assurances in this regard.   Management has evaluated the significance of the conditions described above in relation to the Company’s ability to meet its obligations and concluded that, without additional funding, the Company will not have sufficient funds to meet its obligations within one year from the date the unaudited condensed consolidated financial statements were issued.   Basis of Consolidation:   The accompanying financial statements include the consolidated accounts of Digital Ally, its wholly-owned subsidiaries, Digital Ally International, Inc., Shield Products, LLC, Digital Ally Healthcare, LLC, TicketSmarter, Inc., Worldwide Reinsurance, Ltd., Digital Connect, Inc., BirdVu Jets, Inc., Kustom 440, Inc., and its majority-owned subsidiary Nobility Healthcare, LLC. All intercompany balances and transactions have been eliminated during consolidation.     The Company formed Digital Ally International, Inc. during August 2009 to facilitate the export sales of its products. The Company formed Shield Products, LLC in May 2020 to facilitate the sales of its Shield™ line of disinfectant/cleanser products and ThermoVu™ line of temperature monitoring equipment. The Company formed Nobility Healthcare, LLC (“Nobility Healthcare”) in June 2021 to facilitate the operations of its revenue cycle management solutions and back-office services for healthcare organizations. The Company formed TicketSmarter, Inc. upon its acquisition of Goody Tickets, LLC and TicketSmarter, LLC, to facilitate its global ticketing operations. The Company formed Worldwide Reinsurance Ltd., which is a captive insurance company domiciled in Bermuda. It will provide primarily liability insurance coverage to the Company for which insurance may not be currently available or economically feasible in today’s insurance marketplace. The Company formed Kustom 440, Inc. in 2022 to create unique entertainment experiences directly for consumers, and Kustom Entertainment, Inc. in 2023 to serve as the participant in the Business Combination.   Fair Value of Financial Instruments:   The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and subordinated notes payable approximate fair value because of the short-term nature of these items.   Revenue Recognition:   The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.   The Company has two different revenue streams, product and service, represented through its three segments. The Company reports all revenues on a gross basis, other than service revenues from the Company’s entertainment and revenue cycle management segments, Revenues generated by all segments are reported net of sales taxes.   Video Solutions   The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situation where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e. when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement products. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.     Service and other revenue is comprised of revenues from extended warranties, repair services, cloud revenue and software revenue. Revenue is recognized upon shipment of the product and acceptance of the service or materials by the end customer for repair services. Revenue for extended warranty, cloud service or other software-based products is over the term of the contract warranty or service period. A time-elapsed method is used to measure progress because the Company transfers control evenly over the contractual period. Accordingly, the fixed consideration related to these revenues is generally recognized on a straight-line basis over the contract term, as long as the other revenue recognition criteria have been met.   The Company’s multiple performance obligations may include future in-car or body-worn camera devices to be delivered at defined points within a multi-year contract, and in those arrangements, the Company allocates total arrangement consideration over the life of the multi-year contract to future deliverables using management’s best estimate of selling price.   Revenue Cycle Management   The Company reports revenue cycle management revenues on a net basis, as its primary source of revenue is its end-to-end service fees which is generally determined as a percentage of the invoice amounts collected. These service fees are reported as revenue monthly upon completion of the Company’s performance obligation to provide the agreed upon service.   Entertainment   The Company reports ticketing revenue on a gross or net basis based on management’s assessment of whether the Company is acting as a principal or agent in the transaction. The determination is based upon the evaluation of control over the event ticket, including the right to sell the ticket, prior to its transfer to the ticket buyer.   The Company sells tickets held in inventory, which consists of one performance obligation, being to transfer control of an event ticket to the buyer upon confirmation of the order. The Company acts as the principal in these transactions as the ticket is owned by the Company at the time of sale, therefore controlling the ticket prior to transferring to the customer. In these transactions, revenue is recorded on a gross basis based on the value of the ticket and is recognized when an order is confirmed. Payment is typically due upon delivery of the ticket.   The Company also acts as an intermediary between buyers and sellers through online secondary marketplace. Revenues derived from this marketplace primarily consist of service fees from ticketing operations, and consists of one primary performance obligation, which is facilitating the transaction between the buyer and seller, being satisfied at the time the order has been confirmed. As the Company does not control the ticket prior to the transfer, the Company acts as an agent in these transactions. Revenue is recognized on a net basis, net of the amount due to the seller when an order is confirmed, the seller is then obligated to deliver the tickets to the buyer per the seller’s listing. Payment is due at the time of sale.   Other   Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract and are reported separately as current liabilities and non-current liabilities in the Consolidated Balance Sheets. Such amounts consist of extended warranty contracts, prepaid cloud services and prepaid installation services and are generally recognized as the respective performance obligations are satisfied. During the three months ended March 31, 2024, the Company recognized revenue of $241,371 related to its contract liabilities. Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract and are reported separately as current liabilities and non-current liabilities in the Consolidated Balance Sheets. Such amounts consist of extended warranty contracts, prepaid cloud services and prepaid installation services and are generally recognized as the respective performance obligations are satisfied. Total contract liabilities consist of the following:        March 31, 2024       December 31, 2023     Additions/Reclass     Recognized Revenue     March 31, 2024   Contract liabilities, current   $ 2,937,168     $ 535,598     $ 173,052     $ 3,299,714   Contract liabilities, non-current     7,340,459       13,066       68,319       7,285,206                                         $ 10,277,627     $ 548,664     $ 241,371     $ 10,584,920         March 31, 2023       December 31, 2022     Additions/Reclass     Recognized Revenue     March 31, 2023   Contract liabilities, current   $ 2,154,874     $ 562,809     $ 92,813     $ 2,624,870   Contract liabilities, non-current     5,818,082       868,211       370,646       6,315,647                                         $ 7,972,956     $ 1,431,020     $ 463,459     $ 8,940,517       Sales returns and allowances aggregated $93,170 and $117,713 as of March 31, 2024 and December 31, 2023, respectively. Obligations for estimated sales returns and allowances are recognized at the time of sales on an accrual basis. The accrual is determined based upon historical return rates adjusted for known changes in key variables affecting these return rates.   Use of Estimates:   The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management utilizes various other estimates, including but not limited to determining the estimated lives of long-lived assets, determining the potential impairment of long-lived assets, the fair value of warrants, options, the recognition of revenue, allowance for doubtful accounts, the estimate of fair value of the lease liabilities and related right of use asset, inventory valuation reserve, fair value of assets and liabilities acquired in a business combination, incremental borrowing rate on leases, the valuation allowance for deferred tax assets and other legal claims and contingencies. The results of any changes in accounting estimates are reflected in the financial statements in the period in which the changes become evident. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the period that they are determined to be necessary.   Cash and cash equivalents:   Cash and cash equivalents include funds on hand, in bank and short-term investments with original maturities of ninety (90) days or less. The following table shows the Company’s cash and cash equivalents by significant investment category as of March 31, 2024 and December 31, 2023:        March 31, 2024       Adjusted Cost     Realized Gains     Realized Losses     Fair Value   Demand deposits   $ 769,982     $ —     $ —     $ 769,982   Short-term investments with original maturities of 90 days or less (Level 1):                                 Money market funds     157,879       —       —       157,879                                         $ 927,861     $ —     $ —     $ 927,861         December 31, 2023       Adjusted Cost     Realized Gains     Realized Losses     Fair Value   Demand deposits   $ 545,207     $ —     $ —     $ 545,207   Short-term investments with original maturities of 90 days or less (Level 1):                                 Money market funds     135,342       —       —       135,342                                         $ 680,549     $ —     $ —     $ 680,549     The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At March 31, 2024 and December 31, 2023, the uninsured balance amounted to $296,799 and $29,700, respectively.     Restricted Cash:   Restricted cash of $97,600 and $97,600 was included in other assets as of March 31, 2024 and December 31, 2023, respectively. Restricted cash consists of bank deposits that collateralize our debt obligations.   The following table provides a reconciliation of cash and cash equivalents in the consolidated balance sheets to cash, cash equivalents and restricted cash in the consolidated statements of cash flows:        March 31, 2024     December 31, 2023   Cash and cash equivalents   $ 927,861     $ 680,549   Long-term restricted cash included in other assets     97,600       97,600   Total cash, cash equivalents and restricted cash in the statements of cash flows   $ 1,025,461     $ 778,149     Accounts Receivable:   Accounts receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a weekly basis. The Company determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, and current economic conditions.   Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received. A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for more than thirty (30) days beyond terms. No interest is charged on overdue trade receivables.   Goodwill and Other Intangibles:   Goodwill - In connection with acquisitions, the Company applies the provisions of ASC 805, Business Combinations, using the acquisition method of accounting. The excess purchase price over the fair value of net tangible assets and identifiable intangible assets acquired is recorded as goodwill. In accordance with ASC 350, Intangibles - Goodwill and Other, the Company assesses goodwill for impairment annually as of December 31, and more frequently if events and circumstances indicate that goodwill might be impaired.   Goodwill impairment testing is performed at the reporting unit level. Goodwill is assigned to reporting units at the date the goodwill is initially recorded. Once goodwill has been assigned to reporting units, it no longer retains its association with a particular acquisition, and all of the activities within a reporting unit, whether acquired or internally generated, are available to support the value of the goodwill.   Traditionally, goodwill impairment testing is a two-step process. Step one involves comparing the fair value of the reporting units to its carrying amount. If the carrying amount of a reporting unit is greater than zero and its fair value is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount is greater than the fair value, the second step must be completed to measure the amount of impairment, if any. Step two involves calculating an implied fair value of goodwill. The Company has adopted ASU 2017-04 which simplifies subsequent goodwill measurement by eliminating step two from the goodwill impairment test. As a result, the Company compares the fair value of a reporting unit with its respective carrying value and recognized an impairment charge for the amount by which the carrying amount exceeded the reporting unit’s fair value.     The Company determines the fair value of its reporting units using the market approach. Under the market approach, we estimate the fair value based on multiples of comparable public companies and precedent transactions. Significant estimates in the market approach include: identifying similar companies with comparable business factors such as size, growth, profitability, risk and return on investment, and assessing comparable revenue and operating income multiples in estimating the fair value of the reporting unit.   Long-lived and Other Intangible Assets - The Company periodically assesses potential impairments of its long-lived assets in accordance with the provisions of ASC 360, Accounting for the Impairment or Disposal of Long-lived Assets. An impairment review is performed whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. The Company groups its assets at the lowest level for which identifiable cash flows are largely independent of the cash flows of the other assets and liabilities. The Company has determined that the lowest level for which identifiable cash flows are available is the operating segment level.   Factors considered by the Company include, but are not limited to, significant underperformance relative to historical or projected operating results; significant changes in the manner of use of the acquired assets or the strategy for the overall business; and significant negative industry or economic trends. When the carrying value of a long-lived asset may not be recoverable based upon the existence of one or more of the above indicators of impairment, the Company estimates the future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the sum of the expected future undiscounted cash flows and eventual disposition is less than the carrying amount of the asset, the Company recognizes an impairment loss. An impairment loss is reflected as the amount by which the carrying amount of the asset exceeds the fair value of the asset, based on the fair value if available, or discounted cash flows, if fair value is not available. The Company last assessed potential impairments of its long-lived assets as of December 31, 2023 and concluded that there was no impairment. Subsequent to completing our 2023 annual impairment test, no events or changes in circumstances were noted that required an interim goodwill impairment test.   Intangible assets include deferred patent costs, license agreements, trademarks and trade names. Legal expenses incurred in preparation of patent application have been deferred and will be amortized over the useful life of granted patents. Costs incurred in preparation of applications that are not granted will be charged to expense at that time. The Company has entered into several sublicense agreements under which it has been assigned the exclusive rights to certain licensed materials used in its products. These sublicense agreements generally require upfront payments to obtain the exclusive rights to such material. The Company capitalizes the upfront payments as intangible assets and amortizes such costs over their estimated useful life on a straight-line method.   Segment Reporting   The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information of those segments to be presented in financial statements. Operating segments are identified as components of an enterprise for which separate discrete financial information is available for evaluation by the chief operating decision maker (the Company’s Chief Executive Officer or “CODM”) in making decisions on how to allocate resources and assess performance. The Company’s three operating segments are Video Solutions, Revenue Cycle Management, and Entertainment, each of which has specific personnel responsible for that business and reports to the CODM. Corporate expenses capture the Company’s corporate administrative activities and are also to be reported in the segment information.   Contingent Consideration   In circumstances where an acquisition involves a contingent consideration arrangement that meets the definition of a liability under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity, the Company recognizes a liability equal to the fair value of the contingent payments the Company expects to make as of the acquisition date. The Company remeasures this liability each reporting period and records changes in the fair value through the consolidated statement of operations.     Non-Controlling Interests   Non-controlling interests in the Company’s Consolidated Financial Statements represent the interest in subsidiaries held by our venture partner. The venture partner holds a noncontrolling interest in the Company’s consolidated subsidiary Nobility Healthcare, LLC. Since the Company consolidates the financial statements of all wholly-owned and majority owned subsidiaries, the noncontrolling owners’ share of each subsidiary’s results of operations are deducted and reported as net income or loss attributable to noncontrolling interest in the Consolidated Statements of Operations.   New Accounting Standards   In November 2023, the FASB issued Accounting Standards Update No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The guidance is to be applied retrospectively to all prior periods presented in the financial statements. Upon transition, the segment expense categories and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in the period of adoption. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.   In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.

INVENTORIES	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
INVENTORIES	NOTE 2. INVENTORIES   Inventories consisted of the following at March 31, 2024 and December 31, 2023:        March 31, 2024     December 31, 2023   Raw material and component parts– video solutions segment   $ 2,938,434     $ 3,044,653   Work-in-process– video solutions segment     26,091       20,396   Finished goods – video solutions segment     4,180,699       4,623,489   Finished goods – entertainment segment     489,854       699,204   Subtotal     7,635,078       8,387,742   Reserve for excess and obsolete inventory– video solutions segment     (4,315,132 )     (4,355,666 ) Reserve for excess and obsolete inventory – entertainment segment     (171,257 )     (186,795 ) Total inventories   $ 3,148,689     $ 3,845,281       Finished goods inventory includes units held by potential customers and sales agents for test and evaluation purposes. The cost of such units totaled $51,099 and $42,797 as of March 31, 2024 and December 31, 2023, respectively.

DEBT OBLIGATIONS	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
DEBT OBLIGATIONS	NOTE 3. DEBT OBLIGATIONS   Debt obligations is comprised of the following:         March 31, 2024     December 31, 2023   Economic injury disaster loan (EIDL)   $ 146,971     $ 147,781   Contingent consideration promissory note – Nobility Healthcare Division Acquisition     64,826       129,651   Contingent consideration promissory note – Nobility Healthcare Division Acquisition     29,409       58,819   Revolving Loan Agreement     4,880,000       4,880,000   Commercial Extension of Credit- Entertainment Segment     69,643       87,928   Merchant Advances – Video Solutions Segment     1,348,000       1,350,000   Merchant Advances – Entertainment Segment     1,425,000       —   Unamortized debt issuance costs     (684,989 )     (540,429 ) Debt obligations     7,278,860       6,113,750   Less: current maturities of debt obligations     2,403,029       1,260,513   Debt obligations, long-term   $ 4,875,831     $ 4,853,237     Debt obligations mature as follows as of March 31, 2024:       March 31, 2024   2024   $ 2,402,188   2025     4,735,589   2026     3,542   2027     3,677   2028 and thereafter     133,864             Total   $ 7,278,860     2020 Small Business Administration Notes.   On May 12, 2020, the Company received $150,000 in loan funding from the SBA under the Economic Injury Disaster Loan (“EIDL”) program administered by the SBA, which program was expanded pursuant to the recently enacted CARES Act. The EIDL is evidenced by a secured promissory note, dated May 8, 2020, in the original principal amount of $150,000 with the SBA, the lender.   Under the terms of the note issued under the EIDL program, interest accrues on the outstanding principal at the rate of 3.75% per annum. The term of such note is thirty years, though it may be payable sooner upon an event of default under such note. Monthly principal and interest payments began in November 2022, after being deferred for thirty months after the date of disbursement and total $731 per month thereafter. Such note may be prepaid in part or in full, at any time, without penalty. The Company granted the SBA a continuing interest in and to any and all collateral, including but not limited to tangible and intangible personal property.     The Company made principal payments of $810 during the three months ended March 31, 2024 and recorded interest expense of $1,383.   Contingent Consideration Promissory Notes   On June 30, 2021, Nobility Healthcare, a subsidiary of the Company, issued a contingent consideration promissory note (the “June Contingent Note”) in connection with a stock purchase agreement between Nobility Healthcare and a private company (the “June Seller”) of $350,000. The June Contingent Note has a three-year term and bears interest at a rate of 3.00% per annum. Quarterly principal and interest payments are deferred for six months and is due in equal quarterly installments on the seventh business day of each quarter. The principal amount of the June Contingent Note is subject to an earn-out adjustment, being the difference between $975,000 (the “June Projected Revenue”) and the cash basis revenue (the “June Measurement Period Revenue”) collected by the June Seller in its normal course of business from the clients existing on June 30, 2021, during the period from October 1, 2021 through September 30, 2022 (the “June Measurement Period”) measured on a quarterly basis and annualized as of the relevant period. If the June Measurement Period Revenue is less than the June Projected Revenue, such amount will be subtracted from the principal balance of this June Contingent Note on a dollar-for-dollar basis. If the June Measurement Period Revenue is more than the June Projected Revenue, such amount will be added to the principal balance of this June Contingent Note on a dollar-for-dollar basis. In no event will the principal balance of this June Contingent Note become a negative number. The maximum downward earn-out adjustment to the principal balance will be a reduction to zero. There are no limits to the increases to the principal balance of the June Contingent Note as a result of the earn-out adjustments.   The June Contingent Note is considered to be additional purchase price; therefore, the estimated fair value of the contingent liability is recorded as a liability at the acquisition date and the fair value is considered part of the consideration paid for the acquisition with subsequent changes in fair value recorded as a gain or loss in the Consolidated Statements of Operations. Management recorded the contingent consideration promissory note at its estimated fair value of $350,000 at the acquisition date. Total principal payments, since inception, on this contingent consideration promissory note totaled $261,543. The estimated fair value of the June Contingent Note at March 31, 2024 is $29,409, representing a reduction in its estimated fair value of $29,409 as compared to its estimated fair value as of December 31, 2023. This reduction only relates to the principal payments made for the three months ended March 31, 2024. Therefore, the Company recorded no gain or loss in the Consolidated Statements of Operations for the three months ended March 31, 2024.   On August 31, 2021, Nobility Healthcare, issued another contingent consideration promissory note (the “August Contingent Payment Note”) in connection with a stock purchase agreement between Nobility Healthcare and a private company (the “August Sellers”) of $650,000. The August Contingent Payment Note has a three-year term and bears interest at a rate of 3.00% per annum. Quarterly principal and interest payments are deferred for six months and is due in equal quarterly installments on the seventh business day of each quarter. The principal amount of the August Contingent Payment Note is subject to an earn-out adjustment, being the difference between the $3,000,000 (the “August Projected Revenue”) and the cash basis revenue (the “August Measurement Period Revenue”) collected by the August Sellers in its normal course of business from the clients existing on September 1, 2021, during the period from December 1, 2021 through November 30, 2022 (the “August Measurement Period”) measured on a quarterly basis and annualized as of the relevant period. If the August Measurement Period Revenue is less than the August Projected Revenue, such amount will be subtracted from the principal balance of this August Contingent Payment Note on a dollar-for-dollar basis. If the August Measurement Period Revenue is more than the August Projected Revenue, such amount will be added to the principal balance of this August Contingent Payment Note on a dollar-for-dollar basis. In no event will the principal balance of this August Contingent Payment Note become a negative number. The maximum downward earn-out adjustment to the principal balance will be to zero. There are no limits to the increases to the principal balance of the August Contingent Payment Note as a result of the earn-out adjustments.   The August Contingent Payment Note is considered to be additional purchase price, therefore the estimated fair value of the contingent liability is recorded as a liability at the acquisition date and the fair value is considered part of the consideration paid for the acquisition. Management has recorded the contingent consideration promissory note at its estimated fair value of $650,000 at the acquisition date. Principal payments, since its inception, on this contingent consideration promissory note totaled $617,082. The estimated fair value of the August Contingent Note at March 31, 2024 is $64,826, representing a decrease in its estimated fair value of $64,826 as compared to is estimated fair value as of December 31, 2023. This reduction only relates to the principal payments made for the three months ended March 31, 2024. Therefore, the Company recorded no gain or loss in the Consolidated Statements of Operations for the three months ended March 31, 2024.     2023 Commercial Extension of Credit   On February 23, 2023, the Company’s Entertainment segment entered into an extension of credit in the form of a loan to use in marketing and operating its business in accordance with the Private Label Agreement previously entered into with the Lender. The Lender agreed to extend, subject to the conditions hereof, and Borrower agreed to take, a Loan for Principal Sum of $1,000,000.   Lender shall retain 25% of each remittance owed to Borrower under the terms of the Private Label Agreement. Such remittances shall include regular weekly remittances and any additional incentive payments to which the Borrower may be entitled. The 25% withholding of the Borrower’s applicable remittance shall be deemed a “Payment” under the terms of this Note, and Payments shall continue until the earlier of (i) repayment of the Principal Sum, accrued Interest, and a fee of $35,000 or (ii) expiration of the Private Label Agreement on December 31, 2023.   During the three months ended March 31, 2024, the Entertainment segment Company’s Entertainment segment repaid the outstanding principal of $87,928 and did not renew this agreement.   2024 Commercial Extension of Credit   On January 22, 2024, the Company’s Entertainment segment entered into an extension of credit in the form of a loan to use in marketing and operating its business in accordance with the Ticket Solution Agreement. The Lender, Ticket Evolution, Inc., agreed to extend, subject to the conditions hereof, and Borrower agreed to take, a Loan for Principal Sum of $75,000 with monthly advances of $100,000.   The advances made are recoupable from client service fees with no more than $25,000 being recouped in any one week. The total advances received for the three months ended March 31, 2024 were $275,000 and payments made totaled $205,357. The outstanding balance as of March 31, 2024 was $69,643.     Convertible Note   On April 5, 2023, the Company entered into and consummated the initial closing (the “First Closing”) of the transactions contemplated by a Securities Purchase Agreement, dated as of April 5, 2023 (the “Purchase Agreement”), between the Company and certain investors (the “Purchasers”).   At the First Closing, the Company issued and sold to the Purchasers Senior Secured Convertible Notes in the aggregate original principal amount of $3,000,000 (the “Notes”) and warrants (the “Warrants”). The Purchase Agreement provided for a ten percent (10%) original interest discount resulting in gross proceeds to the Company of $2,700,000. No interest accrues under the Notes. The Warrants are exercisable for an aggregate 1,125,000 shares comprised of 375,000 warrants at an exercise price of $5.50 per share of the Company’s common stock, par value $0.001 (the “Common Stock”), 375,000 warrants at an exercise price of $6.50 per share of Common Stock, and 375,000 warrants at an exercise price of $7.50 per share of Common Stock.   Subject to certain conditions, within 18 months from the effectiveness date and while the Notes remain outstanding, the Purchasers have the right to require the Company to consummate a second closing of up to an additional $3,000,000 of Notes (the “Second Notes”) and Warrants on the same terms and conditions as the First Closing, except that the Second Notes may be subordinate to a mortgage on the Company’s headquarters building (the “Bank Mortgage”).   The Notes are convertible into shares of Common Stock at the election of the Purchasers at any time at a fixed conversion price of $5.00 (the “Conversion Price”) per share of Common Stock. The Conversion Price is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like, and subject to price-based adjustment in the event of any issuances of Common Stock, or securities convertible, exercisable or exchangeable for, Common Stock at a price below the then-applicable Conversion Price (subject to certain exceptions). Subject to certain conditions, including certain equity conditions, the Company may redeem some or all of the then outstanding principal amount of the Note for cash in an amount equal to 110% of the outstanding principal amount of the Notes (the “Optional Redemption Amount”). In addition, the Purchasers may, at their option, demand repayment at the Optional Redemption Amount upon five (5) business days’ written notice following (i) the closing by the Company of the Bank Mortgage, or (ii) a sale by the Company of Common Stock or Common Stock equivalents.   The Notes rank senior to all outstanding and future indebtedness of the Company and its subsidiaries, and are secured by substantially all of the Company’s assets, as evidenced by (i) a security agreement entered into at the Closing, (ii) a trademark security agreement entered into at the Closing, (iii) a patent security agreement entered into at the Closing, (iv) a guaranty executed by all direct and indirect subsidiaries of the Company pursuant to which each of them has agreed to guaranty the obligations of the Company under the Notes, and (v) a mortgage on the Company’s headquarters building in favor of the Purchasers.   Also at the Closing, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Purchasers. Pursuant to the terms of the Registration Rights Agreement, the Company has agreed to prepare and file with the SEC within the 10th business day following the First Closing (the “Filing Date”) a registration statement covering the resale of the shares of Common Stock issuable upon conversion of the Notes and exercise of the Warrants, and to use its best efforts to cause such Registration Statement to be declared effective under the Securities Act of 1933, as amended (the “Securities Act”), as promptly as possible, but in any event no later than 45 days following the Filing Date (the “Effectiveness Date”). If the Registration Statement is not filed by the Filing Date or is not declared effective by the Effectiveness Date, or under certain other circumstances described in the Registration Rights Agreement, then the Company shall be obligated to pay, as partial liquidated damages, to each Purchaser an amount in cash equal to 2% of the original principal amount of the Notes each month until the applicable event giving rise to such payments is cured. If the Company fails to pay any partial liquidated damages in full within seven days after the date payable, the Company will pay interest thereon at a rate of 10% per annum.     The Company recognized the full warrant derivative value, with the remaining amount being allocated to the debt obligation. As the warrant derivative value exceeded the net proceeds from the issuance, the excess amount is recognized as a loss on the date of the issue date. Thus, the Company recorded a loss of $576,380 as an interest expense on the date of issuance relating to the Notes. The following is the assumptions used in calculating the estimated grant-date fair value of the detachable warrants to purchase common stock granted in connection with the Notes:        Terms at April 5, 2023 (issuance date)   Volatility - range     106.0 % Risk-free rate     3.36 % Dividend     0 % Remaining contractual term     5.0 years   Exercise price   $ 5.50 – 7.50   Common stock issuable under the warrants     1,125,000     On June 2, 2023, the Purchasers elected to convert $125,000 principal, at the fixed price of $5.00 per share of common stock, 25,000 shares valued at $119,750. The loss on conversion of convertible note into common shares, of $93,386, was recorded during the period.   On October 26, 2023, the Company entered into a Revolving Loan Agreement of which a portion of the net proceeds were used to repay the principal amount of the Convertible debt. The warrants associated with the convertible debt remain outstanding.   Revolving Loan Agreement   On October 26, 2023, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) by and between the Company, Digital Ally Healthcare, Inc., a Nevada corporation and wholly-owned subsidiary of the Company (“Digital Ally Healthcare” and, together with the Company, the “Borrower”), and Kompass Kapital Funding, LLC, a Kansas limited liability company (“Kompass”). In connection with the Loan Agreement, on October 26, 2023, the Company entered into a Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing (the “Mortgage”) by and between the Company, as grantor, and Kompass, as grantee, and issued a Revolving Note (the “Revolving Note”) to Kompass. The gross proceeds to the Company were $4,880,000 before repaying those certain Senior Secured Convertible Notes issued on April 5, 2023 in the aggregate amount of $3,162,500 and paying customary fees and expenses.   Pursuant to the Loan Agreement, Kompass agreed to make revolving loans (the “Revolving Loans”) available to the Borrower as the Borrower may from time to time request until, but not including, October 26, 2025, and in such amounts as the Borrower may from time to time request, provided, however, that the aggregate principal balance of the Revolving Loans outstanding at any time shall not exceed the lesser of $4,880,000 or an amount equal to eighty percent of the value of the mortgaged property, which consists of the real property owned by the Company having an address of 14001 Marshall Drive, Lenexa, KS 66215 (the “Mortgaged Property”). Under the Loan Agreement, the Revolving Loans made by Kompass may be repaid and, subject to customary terms and conditions, borrowed again up to, but not including October 26, 2025, unless the Revolving Loans are otherwise accelerated, terminated or extended as provided in the Loan Agreement. The Revolving Loans shall be used by the Borrower for the purpose of working capital and to retire existing debt. Under the Loan Agreement, the Borrower is required to provide written notice to Kompass prior to creating, assuming or incurring any debt or becoming liable, whether as endorser, guarantor, surety or otherwise, for any debt or obligation of any other party. While obligations remain outstanding under the Loan Agreement, the Borrower is required to maintain a minimum balance of $97,600 in a reserve account (the “Capital Reserve Account”). Under the Loan Agreement, the Borrower is prohibited from creating, assuming, incurring or suffering or permitting to exist any lien of any kind or character upon the collateral, which consists of the Mortgaged Property and the Company’s interest in the Capital Reserve Account. The Loan Agreement contains customary covenants, representations and warranties by the Borrower.     Pursuant to the Loan Agreement, the Company issued the Revolving Note to Kompass whereby the Company and Digital Ally Healthcare jointly and severally promise to pay to the order of Kompass the lesser of (i) $4,880,000.00, or (ii) the aggregate principal amount of all Revolving Loans outstanding under and pursuant to the Loan Agreement at the maturity or maturities and in the amount or amounts stated on the records of Kompass, together with interest (computed on the actual number of days elapsed on the basis of a 360 day year) at a floating per annum rate equal to the greater of (i) the Prime Rate plus four percent or (ii) eight percent, on the aggregate principal amount of all Revolving Loans outstanding from time to time as provided in the Loan Agreement.   The Company entered into the Mortgage to secure its obligations under the Loan Agreement. The property mortgaged under the Mortgage consists of the Mortgaged Property. The Mortgage contains customary covenants, representations and warranties by the Company. In addition, the Company recorded debt issuance costs of $188,255. During the three months ended March 31, 2024, the Company amortized $23,435 of debt discount under interest expense.   Merchant Cash Advances – Video Solutions Segment   In November 2023, the Company obtained a short-term merchant advance, which totaled $1,050,000, from a single lender to fund operations. These advances included origination fees totaling $50,000 for net proceeds of $1,000,000. The advance is, for the most part, secured by expected future sales transactions of the Company with expected payments on a weekly basis. The Company will repay an aggregate of $1,512,000 to the lender. The loan bears interest at 2.9% per week. During the three months ended March 31, 2024, the Company made repayments totaling $702,000 and received additional proceeds of $700,000. As of March 31, 2024 the outstanding balance was $1,348,000 which is expected to be repaid in 2024.   During the three months ended March 31, 2024 the Company amortized $278,256 of debt discount under interest expense.   Merchant Cash Advances – Entertainment Segment   In March 2024, the Company obtained a short-term merchant advance, which totaled $1,000,000, from a single lender to fund operations. These advances included origination and issuance fees totaling $85,000 for net proceeds of $915,000. The advance is, for the most part, is secured by expected future sales transactions of the Company with expected payments on a weekly basis. The Company will repay an aggregate of $1,425,000 to the lender. The loan bears interest at 5.05% per annum. During the three months ended March 31, 2024, the Company made no repayments. As of March 31, 2024 the outstanding balance was $1,425,000 which is expected to be repaid in 2024.   During the three months ended March 31, 2024 the Company amortized $63,750 of debt discount and issuance costs under interest expense.

FAIR VALUE MEASUREMENT	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENT	NOTE 4. FAIR VALUE MEASUREMENT   In accordance with ASC Topic 820 — Fair Value Measurements and Disclosures (“ASC 820”), the Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a business.   ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:   ● Level 1 — Quoted prices in active markets for identical assets and liabilities     ● Level 2 — Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities)     ● Level 3 — Significant unobservable inputs (including the Company’s own assumptions in determining the fair value)     The following table represents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023:        March 31, 2024       Level 1     Level 2     Level 3     Total   Liabilities:                                 Warrant derivative liabilities   $ —     $ —     $ 1,718,629     $ 1,718,629   Contingent consideration promissory notes and contingent consideration earn-out agreement     —       —       94,235       94,235       $ —     $ —     $ 1,812,864     $ 1,812,864         December 31, 2023       Level 1     Level 2     Level 3     Total   Liabilities:                                 Warrant derivative liabilities   $ —     $ —     $ 1,369,738     $ 1,369,738   Contingent consideration promissory notes and contingent consideration earn-out agreement     —       —       188,470       188,470       $ —     $ —     $ 1,558,208     $ 1,558,208     The following table represents the change in Level 3 tier value measurements for the three months ended March 31, 2024:        Contingent Consideration Promissory Notes and Earn-Out Agreement     Warrant Derivative Liabilities                 Balance, December 31, 2023   $ 188,470     $ 1,369,738                     Issuance of warrant derivative liabilities     —       —                     Change in fair value of warrant derivative liabilities     —       348,891                   Principal payments on contingent consideration promissory notes – Revenue Cycle Management Acquisitions     (94,235 )     —                     Change in fair value of contingent consideration promissory notes - Revenue Cycle Management Acquisitions     —       —                     Balance, March 31, 2024   $ 94,235     $ 1,718,629

ACCRUED EXPENSES	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
ACCRUED EXPENSES	NOTE 5. ACCRUED EXPENSES   Accrued expenses consisted of the following at March 31, 2024 and December 31, 2023:        March 31, 2024     December 31, 2023   Accrued warranty expense   $ 20,529     $ 17,699   Accrued litigation costs     2,040,292       2,040,292   Accrued sales commissions     40,000       87,421   Accrued payroll and related fringes     161,763       367,826   Accrued sales returns and allowances     93,170       117,713   Accrued taxes     66,114       150,981   Accrued interest - related party     187,346       95,031   Customer deposits     45,380       219,462   Other     482,550       172,905     $ 3,137,144     $ 3,269,330     Accrued warranty expense was comprised of the following for the three months ended March 31, 2024:    Beginning balance   $ 17,699   Provision for warranty expense     14,201   Charges applied to warranty reserve     (11,371 )           Ending balance   $ 20,529

INCOME TAXES	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 6. INCOME TAXES   The effective tax rate for the three months ended March 31, 2024 and 2023 varied from the expected statutory rate due to the Company continuing to provide a 100% valuation allowance on net deferred tax assets. The Company determined that it was appropriate to continue the full valuation allowance on net deferred tax assets as of March 31, 2024, primarily because of the Company’s history of operating losses.   The Company has incurred operating losses in recent years, and it continues to be in a three-year cumulative loss position at March 31, 2024. Accordingly, the Company determined there was not sufficient positive evidence regarding its potential for future profits to outweigh the negative evidence of our three-year cumulative loss position under the guidance provided in ASC 740. Therefore, it is determined to continue to provide a 100% valuation allowance on its net deferred tax assets. The Company expects to continue to maintain a full valuation allowance until it determines that it can sustain a level of profitability that demonstrates its ability to realize these assets. To the extent the Company determines that the realization of some or all of these benefits is more likely than not based upon expected future taxable income, a portion or all of the valuation allowance will be reversed. The Company has available to it approximately $140.9 million (based on its December 31, 2023 tax return) in net operating loss carryforwards to offset future taxable income as of March 31, 2024.

PREPAID EXPENSES	3 Months Ended
	Mar. 31, 2024
Prepaid Expenses
PREPAID EXPENSES	NOTE 7. PREPAID EXPENSES   Prepaid expenses were the following at March 31, 2024 and December 31, 2023:         March 31, 2024     December 31, 2023   Prepaid inventory   $ 5,570,087     $ 5,318,939   Prepaid advertising     485,429       612,292   Other     519,497       435,137   Total prepaid expenses   $ 6,575,013     $ 6,366,368

PROPERTY, PLANT AND EQUIPMENT	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT	NOTE 8. PROPERTY, PLANT AND EQUIPMENT   Property, plant and equipment consisted of the following at March 31, 2024 and December 31, 2023:        Estimated Useful Life   March 31, 2024     December 31, 2023   Building   25 years   $ 4,537,037     $ 4,537,037   Land   Infinite     739,734       739,734   Office furniture, fixtures, equipment, and aircraft   3-20 years     826,929       2,065,092   Warehouse and production equipment   3-7 years     239,055       29,055   Demonstration and tradeshow equipment   3-7 years     87,987       87,987   Building improvements   5-7 years     1,328,654       1,328,654   Total cost         7,759,396       8,787,559   Less: accumulated depreciation and amortization         (1,551,601 )     (1,503,857 )                       Net property, plant and equipment       $ 6,207,795     $ 7,283,702     Depreciation expense for the three months ended March 31, 2024 and 2023 was $162,712 and $171,631, respectively, and is included in general and administrative expenses.   During the three months ended March 31, 2024 the Company engaged a broker and sold its aircraft for $1,100,000 less closing costs of $1,500. The carrying amount of the aircraft on the date of sale was $1,141,661. As a result of the sale the Company recorded a loss of $41,161 in the Consolidated Statement of Operations.

OPERATING LEASE	3 Months Ended
	Mar. 31, 2024
Operating Lease
OPERATING LEASE	NOTE 9. OPERATING LEASE   The Company entered into an operating lease with a third party in October 2023 for copiers used for office and warehouse purposes. The terms of the lease include 48 monthly payments of $1,786 with a maturity date of October 2027. The Company has the option to purchase such equipment at maturity for its estimated fair market value at that point in time. The remaining lease term for the Company’s copier operating lease as of March 31, 2024 was forty-three months.   On May 13, 2020, the Company entered into an operating lease for new warehouse and office space, which served as its new principal executive office and primary business location. The original lease agreement was amended on August 28, 2020 to correct the footage under lease and monthly payment amounts resulting from such correction. The lease terms, as amended include no base rent for the first nine months and monthly payments ranging from $12,398 to $14,741 thereafter, with a termination date of December 2026. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to its new location. The Company took possession of the leased facilities on June 15, 2020. The remaining lease term for the Company’s office and warehouse operating lease as of March 31, 2024 was thirty-three months.   On June 30, 2021, the Company completed the acquisition of its first medical billing company, through Nobility Healthcare. Upon completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $2,648 to $2,774 thereafter, with a termination date in July 2024. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The remaining lease term for the Company’s office operating lease as of March 31, 2024 was four months.   On August 31, 2021, the Company completed the acquisition of its second acquired medical billing company, through Nobility Healthcare. Upon completion of this acquisition, Nobility Healthcare became responsible for the operating lease for the seller’s office space. The lease was renewed in April 2023 with favorable terms and payments ranging from $7,436 to $8,877 thereafter, with a termination date in March 2030. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The remaining term for the Company’s office operating lease was seventy-two months as of March 31, 2024.   On September 1, 2021, the Company completed the acquisition of Goody Tickets, LLC and TicketSmarter, LLC through TicketSmarter. Upon completion of this acquisition, the Company became responsible for the operating lease for TicketSmarter’s office space. The lease terms include monthly payments ranging from $7,211 to $7,364 thereafter, with a termination date of December 2022. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The Company took possession of the leased facilities on September 1, 2021. The Company currently rents this space on a month-to-month basis with intentions to relocate upon the identification of suitable space.     On January 1, 2022, the Company completed the acquisition of a private medical billing company, through its revenue cycle management segment. Upon completion of this acquisition, the Company became responsible for the operating lease for the seller’s office space. The lease terms include monthly payments ranging from $4,233 to $4,626, with a termination date of June 2025. The Company is responsible for property taxes, utilities, insurance and its proportionate share of common area costs related to this location. The Company took possession of the leased facilities on January 1, 2022. The Company terminated this lease in January 2024 and reversed the right of use asset and lease liability by $73,894.   Lease expense related to the office space and copier operating leases were recorded on a straight-line basis over their respective lease terms. Total lease expense under the operating leases was approximately $108,879 during the three months ended March 31, 2023.   The weighted-average remaining lease term related to the Company’s lease liabilities as of March 31, 2023 was 4.5 years.   The discount rate implicit within the Company’s operating leases was not generally determinable and therefore the Company determined the discount rate based on its incremental borrowing rate on the information available at commencement date. As of commencement date, the operating lease liabilities reflect a weighted average discount rate of 8%.   The following sets forth the operating lease right of use assets and liabilities as of March 31, 2024:    Assets:         Operating lease right of use assets   $ 925,128             Liabilities:         Operating lease obligations-current portion   $ 225,960   Operating lease obligations-less current portion     749,718   Total operating lease obligations   $ 975,678     The components of lease expense were as follows for the three months ended March 31, 2024:   Selling, general and administrative expenses   $ 108,879     Following are the minimum lease payments for each year and in total:    Year ending December 31:       2023 (April 1, to December 31, 2024)   $ 225,247   2024     288,720   2025     293,300   2026     117,492   Thereafter     235,020   Total undiscounted minimum future lease payments     1,159,779   Imputed interest     (184,101 ) Total operating lease liability   $ 975,678

GOODWILL AND OTHER INTANGIBLE ASSETS	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS	NOTE 10. GOODWILL AND OTHER INTANGIBLE ASSETS   Intangible assets consisted of the following at March 31, 2024 and December 31, 2023:   Patents and trademarks pending will be amortized beginning at the time they are issued by the appropriate authorities. If issuance of the final patent or trademark is denied, then the amount deferred will be immediately charged to expense.   Amortization expense for the three months ended March 31, 2024 and 2023 was $388,278 and $371,478, respectively. Estimated amortization for intangible assets with definite lives for the next five years ending December 31 and thereafter is as follows:       March 31, 2024     December 31, 2023       Gross value     Accumulated amortization     Net carrying value     Gross value     Accumulated amortization     Net carrying value   Amortized intangible assets:                                                 Licenses (video solutions segment)   $ 225,545     $ 92,525     $ 133,020     $ 225,545     $ 89,887     $ 135,658   Patents and trademarks (video solutions segment)     483,521       306,702       176,819       483,521       266,403       217,118   Sponsorship agreement network (entertainment segment)     5,600,000       2,893,333       2,706,667       5,600,000       2,613,333       2,986,667   SEO content (entertainment segment)     600,000       387,500       212,500       600,000       350,000       250,000   Personal seat licenses (entertainment segment)     87,679       7,542       80,137       180,081       14,004       166,077   Software     23,653       —       23,653                     Website enhancements (entertainment segment)     25,630       1,878       23,752       13,500       —       13,500   Client agreements (revenue cycle management segments)     999,034       251,744       747,290       999,034       226,768       772,266         8,045,062       3,941,224       4,103,838       8,101,681       3,560,395       4,541,286                                                     Indefinite life intangible assets:                                                 Goodwill (entertainment and revenue cycle management segments)     11,593,473       —       11,593,473       11,367,514       —       11,367,514   Trade name (entertainment segment)     900,000       —       900,000       600,000       —       600,000   Patents and trademarks pending (video solutions segment)     27,721       —       27,721       1,622       —       1,622                                                     Total   $ 20,566,256     $ 3,941,224     $ 16,625,032     $ 20,070,817     $ 3,560,395     $ 16,510,422     Year ending December 31:       2024 (April 1, to December 31, 2024)   $ 1,117,290   2025     1,413,938   2026     909,400   2027     113,600   2028 and thereafter     549,610     $ 4,103,838

OTHER ASSETS	3 Months Ended
	Mar. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
OTHER ASSETS	NOTE 11. OTHER ASSETS   Other assets were the following at March 31, 2024 and December 31, 2023:       March 31, 2024     December 31, 2023   Lease receivable   $ 5,880,809     $ 6,095,050   Restricted Cash     97,600       97,600   Other     354,776       404,382   Total other assets   $ 6,333,185     $ 6,597,032

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 12. COMMITMENTS AND CONTINGENCIES   Litigation   From time to time, we are notified that we may be a party to a lawsuit or that a claim is being made against us. It is our policy to not disclose the specifics of any claim or threatened lawsuit until the summons and complaint are actually served on us. After carefully assessing the claim, and assuming we determine that we are not at fault or we disagree with the damages or relief demanded, we vigorously defend any lawsuit filed against us. We record a liability when losses are deemed probable and reasonably estimable. When losses are deemed reasonably possible but not probable, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claim, if material for disclosure. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time.   On May 31, 2022, the Company filed a lawsuit against Culp McAuley, Inc. (“defendant”) in the United States District Court for the District of Kansas. The lawsuit arises from the defendant’s multiple breaches of its obligations to the Company. The Company seeks monetary damages and injunctive relief based on certain conduct by the defendant. On July 18, 2022, the defendant filed its Answer to the Company’s Verified Complaint and included Counterclaims alleging breach of contract and seeking monetary damages. On August 8, 2022, the Company filed its Reply and Affirmative Defenses to the Counterclaims by, among other things, denying the allegations and any and all liability.   As of March 31, 2024, we are able to estimate a range of reasonably possible loss related to the Culp McCauley case, our estimate of the aggregate reasonably possible loss (in excess of any accrued amounts) was approximately $1.8 million. Our estimate with respect to the aggregate reasonably possible loss is based upon currently available information and is subject to significant judgment and a variety of assumptions and known and unknown uncertainties, which may change quickly and significantly from time to time, particularly if and as we engage with applicable governmental agencies or plaintiffs in connection with a proceeding. Also, the matters underlying the reasonably possible loss will change from time to time. As a result, actual results may vary significantly from the current estimate.   While the ultimate resolution is unknown, based on the information currently available, we do not expect that these lawsuits will individually, or in the aggregate, have a material adverse effect to our results of operations, financial condition or cash flows. However, the outcome of any litigation is inherently uncertain and there can be no assurance that any expense, liability or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage and will not have a material adverse effect on our operating results, financial condition or cash flows.     Notice of Failure to Satisfy a Continued Listing Rule   On March 14, 2024, the Nasdaq Listing Qualifications staff notified Digital Ally, Inc. (the “Company”), that due to resignation of Mr. Michael J. Caulfield from the Company’s board of directors (the “Board”) effective on January 31, 2024, the Company no longer complies with the audit committee and compensation committee requirements as set forth in Listing Rule 5605 of The Nasdaq Stock Market LLC (“Nasdaq”), including the requirements that there are at least three independent directors on the Company’s audit committee and at least two independent directors on the Company’s compensation committee.   The notification has no immediate effect on the Company’s listing on the Nasdaq Capital Market. In accordance with Nasdaq Listing Rules, the Company is provided a cure period until the earlier of the Company’s next annual shareholders’ meeting (or July 29, 2024 if the next shareholders’ meeting will be held before July 29, 2024) or January 31, 2025 (the “Cure Period”). If the Company does not regain compliance by within the Cure Period, Nasdaq will provide written notice that the Company’s common stock, par value $0.001 per share, will be subject to delisting from the Nasdaq Capital Market, at which time, the Company may appeal the delisting determination to a Hearings Panel.   The management of the Company has resolved to take commercially reasonable steps to fill the vacancy on the Board with a new director who qualifies as independent under the Nasdaq Listing Rules as soon as is practical and anticipates regaining compliance during the Cure Period. However, there can be no assurance that the Company will be able to satisfy Nasdaq Listing Rule 5605 or will otherwise be in compliance with other Nasdaq listing criteria.

STOCK-BASED COMPENSATION	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	NOTE 13. STOCK-BASED COMPENSATION   The Company recorded pre-tax compensation expense related to the grant of stock options and restricted stock issued of $40,695 and $114,848 for the three months ended March 31, 2024 and 2023, respectively.   As of March 31, 2024, the Company had adopted ten separate stock option and restricted stock plans: (i) the 2005 Stock Option and Restricted Stock Plan (the “2005 Plan”), (ii) the 2006 Stock Option and Restricted Stock Plan (the “2006 Plan”), (iii) the 2007 Stock Option and Restricted Stock Plan (the “2007 Plan”), (iv) the 2008 Stock Option and Restricted Stock Plan (the “2008 Plan”), (v) the 2011 Stock Option and Restricted Stock Plan (the “2011 Plan”), (vi) the 2013 Stock Option and Restricted Stock Plan (the “2013 Plan”), (vii) the 2015 Stock Option and Restricted Stock Plan (the “2015 Plan”), (viii) the 2018 Stock Option and Restricted Stock Plan (the “2018 Plan”), (ix) the 2020 Stock Option and Restricted Stock Plan (the “2020 Plan”), and (x) the 2022 Stock Option and Restricted Stock Plan (the “2022 Plan”). The 2005 Plan, 2006 Plan, 2007 Plan, 2008 Plan, 2011 Plan, 2013 Plan, 2015 Plan, 2018 Plan, 2020 Plan and 2022 Plan are referred to as the “Plans.”   These Plans permit the grant of stock options or restricted stock to its employees, non-employee directors and others for up to a total of 333,750 shares of common stock. The 2005 Plan terminated during 2015 with 1,078 shares not awarded or underlying options, which shares are now unavailable for issuance. Stock options granted under the 2005 Plan that remain unexercised and outstanding as of March 31, 2024 total 284. The 2006 Plan terminated during 2016 with 2,739 shares not awarded or underlying options, which shares are now unavailable for issuance. Stock options granted under the 2006 Plan that remain unexercised and outstanding as of March 31, 2024 total 531. The 2007 Plan terminated during 2017 with 4,733 shares not awarded or underlying options, which shares are now unavailable for issuance. There are no stock options granted under the 2007 Plan that remain unexercised and outstanding as of March 31, 2024. The 2008 Plan terminated during 2018 with 2,025 shares not awarded or underlying options, which shares are now unavailable for issuance. There are no stock options granted under the 2008 Plan that remain unexercised and outstanding as of March 31, 2024.   Stock option grants. The Company believes that such awards better align the interests of our employees with those of its stockholders. Option awards have been granted with an exercise price equal to the market price of its stock at the date of grant with such option awards generally vesting based on the completion of continuous service and having ten-year contractual terms. These option awards typically provide for accelerated vesting if there is a change in control (as defined in the Plans). The Company has registered all shares of common stock that are issuable under its Plans with the SEC. A total of 137,042 shares remained available for awards under the various Plans as of March 31, 2024.     The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model.   A summary of all stock option activity under the Plans for the three months ended March 31, 2024 is as follows:    Options   Number of Shares     Weighted Average Exercise Price   Outstanding at December 31, 2023     53,600     $ 45.55   Granted     —       —   Exercised     —       —   Forfeited     —       —   Outstanding at March 31, 2024     53,600     $ 45.55   Exercisable at March 31, 2024     53,600     $ 45.55     The Plans allow for the cashless exercise of stock options. This provision allows the option holder to surrender/cancel options with an intrinsic value equivalent to the purchase/exercise price of other options exercised. There were no shares surrendered pursuant to cashless exercises during the three months ended March 31, 2024 and 2023.   The aggregate intrinsic value of options outstanding was $-0- and $-0-, at March 31, 2024 and December 31, 2023, respectively. The aggregate intrinsic value of options exercisable was $-0- and $-0-, at March 31, 2024 and December 31, 2023, respectively.   As of March 31, 2024, the unrecognized portion of stock compensation expense on all existing stock options was $-0-.   The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of March 31, 2024:          Outstanding options   Exercisable options Exercise price range     Number of options     Weighted average remaining contractual life   Number of options     Weighted average remaining contractual life                         $ 0.01 to $49.99       37,000     6.4 years     37,000     6.4 years $ 50.00 to $69.99       15,100     4.2 years     15,100     4.2 years $ 70.00 to $89.99       1,500     2.1 years     1,500     2.1 years                                         53,600     5.6 years     53,600     5.6 years   Restricted stock grants. The Board of Directors has granted restricted stock awards under the Plans. Restricted stock awards are valued on the date of grant and have no purchase price for the recipient. Restricted stock awards typically vest over one to five years corresponding to anniversaries of the grant date. Under the Plans, unvested shares of restricted stock awards may be forfeited upon the termination of service to or employment with the Company, depending upon the circumstances of termination. Except for restrictions placed on the transferability of restricted stock, holders of unvested restricted stock have full stockholder’s rights, including voting rights and the right to receive cash dividends.     A summary of all restricted stock activity under the Plans for the three months ended March 31, 2024 is as follows:       Number of Restricted shares     Weighted average grant date fair value   Nonvested balance, December 31, 2023     53,875     $ 11.27   Granted     80,197       2.12   Vested     (30,750 )     10.06   Forfeited     (1,125 )     22.20   Nonvested balance, March 31, 2024     102,197     $ 4.34     The Company estimated the fair market value of these restricted stock grants based on the closing market price on the date of grant. As of March 31, 2024, there were $245,233 of total unrecognized compensation costs related to all remaining non-vested restricted stock grants, which will be amortized over the next forty-eight months in accordance with their respective vesting scale.   The nonvested balance of restricted stock vests as follows:   Years ended   Number of shares           2024 (April 1, 2024 through December 31, 2024)     1,500   2025     73,349   2026     18,349   2027     5,000   2028     4,000

COMMON STOCK PURCHASE WARRANTS	3 Months Ended
	Mar. 31, 2024
Common Stock Purchase Warrants
COMMON STOCK PURCHASE WARRANTS	NOTE 14. COMMON STOCK PURCHASE WARRANTS   2023 Purchase Warrants   On April 5, 2023, the Company issued warrants to purchase a total of 1,125,000 shares of Common Stock. The warrant terms provide for net cash settlement outside the control of the Company under certain circumstances. As such, the Company is required to treat these warrants as derivative liabilities which are valued at their estimated fair value at their issuance date and at each reporting date with any subsequent changes reported in the consolidated statements of operations as the change in fair value of warrant derivative liabilities. Furthermore, the Company re-values the fair value of warrant derivative liability as of the date the warrant is exercised with the resulting warrant derivative liability transitioned to change in fair value of warrant derivative liabilities through the consolidated statement of operations.   The Company has utilized the following assumptions in its Black-Scholes option valuation model to calculate the estimated fair value of the warrant derivative liabilities as of their date of issuance and as of March 31, 2024:       Issuance date assumptions     March 31, 2024 assumptions   Volatility - range     106.0 %   $ 108.5 % Risk-free rate     3.36 %     4.21 % Dividend     0 %     0 % Remaining contractual term     5.0 years       4.0 years   Exercise price     5.50 – 7.50       5.50 – 7.50   Common stock issuable under the warrants     1,125,000       1,125,000       The following table summarizes information about shares issuable under warrants outstanding during the three months ended March 31, 2024 and 2023:        Warrants     Weighted average exercise price   Vested Balance, December 31, 2023     1,125,000     $ 6.50   Granted     —       —   Exercised     —       —   Forfeited/cancelled     —       —   Vested Balance, March 31, 2024     1,125,000     $ 6.50     The total intrinsic value of all outstanding warrants aggregated $-0- as of March 31, 2024 and 2023, and the weighted average remaining term was 48.2 months as of March 31, 2024, respectively.   The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase shares of common stock as of March 31, 2024:         Outstanding and exercisable warrants Exercise price     Number of warrants     Weighted average remaining contractual life $ 5.50       375,000     4.0 years $ 6.50       375,000     4.0 years $ 7.50       375,000     4.0 years                             1,125,000     4.0 years

STOCKHOLDERS’ EQUITY	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 15. STOCKHOLDERS’ EQUITY   2023 Issuance of Restricted Common Stock   On January 10, 2023, the board of directors approved the grant of 22,500 shares of common stock to officers of the Company. Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates. Additionally, the board of directors approved the grant of 12,500 restricted common shares to certain new employees of the Company. Such shares will generally vest over a period of one to two years on their respective anniversary dates in January through January 2025, provided that each grantee remains an employee of the company on such dates.   2024 Issuance of Restricted Common Stock   In January 2024, the board of directors approved the grant of 55,000 shares of common stock to officers of the Company. Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates. Additionally, the board of directors approved the grant of 25,197 restricted common shares to certain new employees of the Company. Such shares will generally vest over a period of one to two years on their respective anniversary dates in January through January 2026, provided that each grantee remains an employee of the company on such dates.   Cancellation of Restricted Stock   During the three months ended March 31, 2024, the Company cancelled 1,125 shares due to termination of employee.   Reverse Stock Split   On February 6, 2023, we filed a Certificate of Amendment to the Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada to effect a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the shares of our common stock. The Reverse Stock Split was effective as of time of filing. No fractional shares were issued in connection with the Reverse Stock Split. Any fractional shares of our Common Stock that would have otherwise resulted from the Reverse Stock Split were rounded up to the nearest whole number. In connection with the Reverse Stock Split, our board approved appropriate and proportional adjustments to all outstanding securities or other rights convertible or exercisable into shares of our Common Stock, including, without limitation, all preferred stock, warrants, options, and other equity compensation rights. All historical share and per-share amounts reflected throughout our consolidated financial statements and other financial information in this Report have been adjusted to reflect the Reverse Stock Split as if the split occurred as of the earliest period presented. The par value per share of our common stock was not affected by the Reverse Stock Split.     Noncontrolling Interests   The Company owns a 51% equity interest in its consolidated subsidiary, Nobility Healthcare. As a result, the noncontrolling shareholders or minority interest is allocated 49% of the income/loss of Nobility Healthcare which is reflected in the statement of (income) loss as “net (income) loss attributable to noncontrolling interests of consolidated subsidiary”. We reported net (income) loss attributable to noncontrolling interests of consolidated subsidiary of $12,248 and ($126,239) for the three months ended March 31, 2024 and 2023, respectively.

NET LOSS PER SHARE	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
NET LOSS PER SHARE	NOTE 16. NET LOSS PER SHARE   The calculation of the weighted average number of shares outstanding and loss per share outstanding for the three months ended March 31, 2024 and 2023 are as follows:       Three months ended March 31,       2024     2023   Numerator for basic and diluted loss per share – Net loss attributable to common stockholders   $ (3,931,020 )   $ (6,105,818 )                   Denominator for basic loss per share – weighted average shares outstanding     2,861,229       2,751,662   Dilutive effect of shares issuable upon conversion of convertible debt and the exercise of stock options and warrants outstanding     —       —                     Denominator for diluted loss per share – adjusted weighted average shares outstanding     2,861,229       2,751,662                     Net loss per share:                 Basic   $ (1.37 )   $ (2.22 ) Diluted   $ (1.37 )   $ (2.22 )   Basic income (loss) per share is based upon the weighted average number of common shares outstanding during the period. For the three months ended March 31, 2024 and 2023, all shares issuable upon conversion of convertible debt and the exercise of outstanding stock options and warrants were antidilutive and, therefore, not included in the computation of diluted income (loss) per share.

COUNTRY STAMPEDE ACQUISITION	3 Months Ended
	Mar. 31, 2024
Country Stampede Acquisition [Member]
Business Acquisition [Line Items]
COUNTRY STAMPEDE ACQUISITION	NOTE 17. COUNTRY STAMPEDE ACQUISITION   On March 1, 2024, Kustom 440, entered into an Asset Purchase Agreement (the “Acquisition Agreement”) with JC Entertainment, LLC, a Kansas limited liability company (“JC Entertainment”). Pursuant to the Acquisition Agreement, Kustom 440 acquired certain assets associated with a music entertainment event (“Country Stampede”), including all intellectual property arising out of and relating to Country Stampede (“Country Stampede Intellectual Property”) and certain contracts in which JC Entertainment is a party to host and operate the 2024 Country Stampede (the “Assumed Contracts”, and together with the Country Stampede Intellectual Property, the “Purchased Assets”).   As consideration for acquiring the Purchased Assets, Kustom 440 paid JC Entertainment the aggregate purchase price amount $542,959, with the sum of $400,000 paid at the time of closing (“Closing”), and the remainder to be paid on or before thirty days from the time of Closing. Kustom 440 shall receive a credit for all non-refunded festival ticket sales for the 2024 Country Stampede to be calculated immediately prior to Closing, and JC Entertainment shall be entitled to keep all ticket sale proceeds made and/or received prior to Closing. Kustom 440 shall be obligated, to the extent a refund is sought after Closing, to provide such refund, if appropriate, to the customer requesting a refund, and shall indemnify and hold harmless JC Entertainment from any and all claims, liabilities, costs, suits, or the like relating to such refund request.   The Company accounts for business combinations using the acquisition method and that the Company has early adopted the amendments of Regulation S-X dated May 21, 2020 and has concluded that this acquisition was not significant. Accordingly, the presentation of the assets acquired, historical financial statements under Rule 3-05 and related pro forma information under Article 11 of Regulation S-X, respectively, are not required to be presented. Under the acquisition method, the purchase price of the Country Stampede Acquisition has been allocated to the acquired tangible and identifiable intangible assets and assumed liabilities based on their estimated fair values at the time of the Country Stampede Acquisition. This allocation involves a number of assumptions, estimates, and judgments that could materially affect the timing or amounts recognized in our financial statements. The Country Stampede Acquisition was structured as an asset purchase; however the parties agreed to coordinate the election to invoke IRS Section 338(h)(10) relative to this transaction for tax purposes. Therefore, the excess purchase price over the fair value of net tangible assets acquired was recorded as goodwill, which will be amortized over 15 years for income tax filing purposes. Likewise, the other acquired assets were stepped up to fair value and is deductible for income tax purposes. The results of operations of acquired businesses are included in the consolidated financial statements from the acquisition date.     The purchase price of the Country Stampede Acquisition was allocated to tangible assets, goodwill, identifiable intangible assets, and assumed liabilities based on their preliminary estimated fair values at the time of the acquisition. The Company retained the services of an independent valuation firm to determine the fair value of these identifiable intangible assets. The Company will continue to evaluate the fair value of the identified intangible assets. The preliminary estimated fair value of assets acquired, and liabilities assumed in the Country Stampede Acquisition were as follows:       As allocated (Preliminary)   Description   March 1, 2024   Assets acquired (provisional):         Tangible assets acquired   $ 305,000   Identifiable intangible assets acquired (Trademarks and trade names)     300,000   Goodwill     225,959   Liabilities assumed     (288,000 ) Net assets acquired and liabilities assumed   $ 542,959   Consideration:         Cash paid at Country Stampede Acquisition date   $ 400,000   Cash paid subsequent to closing     142,959             Total Country Stampede Acquisition purchase price   $ 542,959     During the measurement period (which is the period required to obtain all necessary information that existed at the acquisition date, or to conclude that such information is unavailable, not to exceed one year), additional assets or liabilities may be recognized, or there could be changes to the amounts of assets or liabilities previously recognized on a preliminary basis, if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of these assets or liabilities as of that date.

SEGMENT DATA	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
SEGMENT DATA	NOTE 18. SEGMENT DATA   The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information of those segments to be presented in financial statements. Operating segments are identified as components of an enterprise for which separate discrete financial information is available for evaluation by the chief operating decision maker (the Company’s Chief Executive Officer or “CODM”) in making decisions on how to allocate resources and assess performance. The Company’s three operating segments are Video Solutions, Revenue Cycle Management, and Entertainment, each of which has specific personnel responsible for that business and reports to the CODM. Corporate expenses capture the Company’s corporate administrative activities, is also to be reported in the segment information. The Company’s captive insurance subsidiary provides services to the Company’s other business segments and not to outside customers. Therefore, its operations are eliminated in consolidation and is not considered a separate business segment for financial reporting purposes.   The Video Solutions Segment encompasses our law, commercial, and Shield™ divisions. This segment includes both service and product revenues through our subscription models offering cloud and warranty solutions, and hardware sales for video and health safety solutions. The Revenue Cycle Management Segment provides working capital and back-office services to a variety of healthcare organizations throughout the country, as a monthly service fee. The Entertainment Segment acts as an intermediary between ticket buyers and sellers within our secondary ticketing platform, ticketsmarter.com, and we also acquire tickets from primary sellers to then sell through various platforms.   The Company’s corporate administration activities are reported in the corporate line item. These activities primarily include expense related to certain corporate officers and support staff, certain accounting staff, expense related to the Company’s Board of Directors, stock option expense for options granted to corporate administration employees, certain consulting expenses, investor relations activities, and a portion of the Company’s legal, auditing and professional fee expenses. Corporate identifiable assets primarily consist of cash, invested cash (if any), refundable income taxes (if any), and deferred income taxes.   Summarized financial information for the Company’s reportable business segments is provided for the indicated periods and as of March 31, 2024, and March 31, 2023:       Three Months Ended March 31,       2024     2023   Net Revenues:                 Video Solutions   $ 1,718,293     $ 1,899,364   Revenue Cycle Management     1,434,598       1,781,590   Entertainment     2,376,460       4,016,236   Total Net Revenues   $ 5,529,351     $ 7,697,190                     Gross Profit:                 Video Solutions   $ 565,694     $ 534,195   Revenue Cycle Management     463,731       775,934   Entertainment     494,274       234,663   Total Gross Profit   $ 1,523,699     $ 1,544,792                     Operating Income (loss):                 Video Solutions   $ (891,588 )   $ (1,963,186 ) Revenue Cycle Management     (24,031 )     103,765   Entertainment     (642,219 )     (1,233,006 ) Corporate     (2,081,196 )     (3,080,379 ) Total Operating Loss   $ (3,639,034 )   $ (6,172,806 )                   Depreciation and Amortization:                 Video Solutions   $ 198,028     $ 198,122   Revenue Cycle Management     26,715       25,507   Entertainment     326,248       319,481   Total Depreciation and Amortization   $ 550,991     $ 543,110           March 31, 2024     December 31, 2023   Assets (net of eliminations):                 Video Solutions   $ 24,172,478     $ 26,396,559   Revenue Cycle Management     1,989,068       2,260,376   Entertainment     6,482,510       6,324,211   Corporate     12,520,139       12,047,663   Total Identifiable Assets   $ 45,164,195     $ 47,028,809     The segments recorded noncash items effecting the gross profit and operating income (loss) through the established inventory reserves based on estimates of excess and/or obsolete current and non-current inventory. The Company recorded a reserve for excess and obsolete inventory in the video solutions segment of $4,315,132 and a reserve for the entertainment segment of $171,257 as of March 31, 2024.   The segment net revenues reported above represent sales to external customers. Segment gross profit represents net revenues less cost of revenues. Segment operating income, which is used in management’s evaluation of segment performance, represents net revenues, less cost of revenues, less all operating expenses. Identifiable assets are those assets used by each segment in its operations. Corporate assets primarily consist of cash, property, plant and equipment, accounts receivable, inventories, and other assets.

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 19. RELATED PARTY TRANSACTIONS   Transactions with Managing Member of Nobility Healthcare   The Company accrued reimbursable expenses payable to Nobility, LLC totaling $576,690 and $265,241 for the three months ended March 31, 2024 and 2023 and management fees in accordance with the operating agreement of $12,379 and $32,181 for the three months ended March 31, 2024 and 2023.   Transactions with Related Party of TicketSmarter   On September 22, 2023, a trust, the beneficiaries of which are TicketSmarter’s Chief Executive Officer and his spouse, made a loan in the amount of $2,325,000 to TicketSmarter to support TicketSmarter’s operations. On October 2, 2023 an additional $375,000 was advanced to Ticketsmarter. The transaction was recorded as a related party note payable (the “TicketSmarter Related Party Note”). The TicketSmarter Related Party Note bears interest of 13.25% per annum with repayment beginning January 2, 2024. As of March 31 2024, the entire TicketSmarter Related Party note is $2,700,000, is classified as current, with an accrued interest balance of $187,346. The use of proceeds of the TicketSmarter Related Party Note was to resolve numerous outstanding payables at a discounted rate, the discount received is recognized as a gain on extinguishment of liabilities on the statement of operations. Additionally, these negotiations relieved TicketSmarter of numerous future obligations following fiscal year 2023.

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 20. SUBSEQUENT EVENTS   Series A Preferred Stock and Series B Preferred Stock Elimination   On April 5, 2024, Digital Ally, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada an Elimination of Certificate of Designations of the Preferences, Rights and Limitations of the Series A Convertible Redeemable Preferred Stock (the “Series A Elimination Certificate”) and Elimination of Certificate of Designations of the Preferences, Rights and Limitations of the Series B Convertible Redeemable Preferred Stock (the “Series B Elimination Certificate”) in order to eliminate and cancel all designations, rights, preferences and limitations of the shares of the Company’s Series A Convertible Redeemable Preferred Stock, par value $0.001 per share (the “Series A Preferred Stock”) and Series B Convertible Redeemable Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”). In December 2022, all 1,400,000 shares of Series A Preferred Stock that had originally been issued pursuant to the Certificate of Designations of the Preferences, Rights and Limitations of the Series A Preferred Stock of the Company (the “Series A Certificate of Designations”) and all 100,000 shares of Series B Preferred Stock that had originally been issued pursuant to the Certificate of Designations of the Preferences, Rights and Limitations of the Series B Preferred Stock of the Company (the “Series B Certificate of Designations”) were exchanged for shares of the Company’s common stock and warrants to purchase shares of the Company’s common stock. Such shares of Series A Preferred Stock and Series B Preferred Stock have resumed the status of authorized but unissued shares of preferred stock of the Company.   Prior to the filing of the Series A Elimination Certificate, none of the 1,400,000 authorized shares of Series A Preferred Stock or 100,000 authorized shares of Series B Preferred Stock were issued and outstanding, and no shares of Series A Preferred Stock or Series B Preferred Stock were to be issued subject to the Series A Certificate of Designations or Series B Certificate of Designations. The Series A Elimination Certificate and Series B Elimination Certificate became effective upon their filing with the Secretary of State of the State of Nevada.   Merchant Cash Advances – Video Solutions Segment     In April 2024, the Company received additional advances of $444,000 from the lender and agreed to new terms where total proceeds received since inception totaled $2,144,000. The Company will repay an aggregate of $2,880,000 to the lender. The advances remain secured by expected future sales of the Company with payments on a weekly basis and the full amount is expected to be repaid in 2024.

NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Combination	Business Combination   In June 2023, the Company, entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Clover Leaf Capital Corp., a Delaware corporation (Nasdaq: CLOE) (“Clover Leaf”), CL Merger Sub, Inc., a Nevada corporation and a wholly owned subsidiary of Clover Leaf (“Merger Sub”), Yntegra Capital Investments LLC, a Delaware limited liability company, in the capacity as the representative from and after the Effective Time (as defined in the Merger Agreement) for the stockholders of Clover Leaf in accordance with the terms and conditions of the Merger Agreement, and Kustom Entertainment, Inc., a Nevada corporation, a wholly owned subsidiary of the Company, with a focus and mission to own and produce events, festivals, and entertainment alongside its evolving primary and secondary ticketing technologies (“Kustom”). Pursuant to the Merger Agreement, subject to the terms and conditions set forth therein upon the consummation of the transactions contemplated by the Merger Agreement (the “Closing”), Merger Sub will merge with and into Kustom, with Kustom continuing as the surviving corporation in the Merger and a wholly owned subsidiary of Clover Leaf. Upon the Closing which is subject to the approval of Clover Leaf’s shareholders and the satisfaction or waiver of certain other customary closing conditions, the common stock of the combined company is expected to be listed on the Nasdaq under a mutually agreed new ticker symbol that reflects the name “Kustom Entertainment”.
Basis of Presentation	Basis of Presentation:   The unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.   The balance sheet at December 31, 2023 has been derived from the audited financial statements at that date, but does not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements.   For further information, refer to the audited financial statements and footnotes included in the Company’s annual report on Form 10-K for the year ended December 31, 2023.
Liquidity and Going Concern	Liquidity and Going Concern   During the second quarter of 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. This update provided U.S. GAAP guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. Under this standard, the Company is required to evaluate whether there is substantial doubt about its ability to continue as a going concern each reporting period, including interim periods. In evaluating the Company’s ability to continue as a going concern, management considered the conditions and events that could raise substantial doubt about the Company’s ability to continue as a going concern within 12 months after the Company’s financial statements were issued (May 15, 2023). Management considered the Company’s current financial condition and liquidity sources, including current funds available, forecasted future cash flows and the Company’s obligations due before May 15, 2024.   The Company has experienced net losses and cash outflows from operating activities since inception. For the three months ended March 31, 2024, the Company had a net loss attributable to common stockholders of $3,931,020, net cash used in operating activities of $918,545, $160,830 provided by investing activities and $1,005,027 provided by financing activities. The Company will have to restore positive operating cash flows and profitability over the next year and/or raise additional capital to fund its operational plans, meet its customary payment obligations and otherwise execute its business plan. There can be no assurance that it will be successful in restoring positive cash flows and profitability, or that it can raise additional financing when needed, and obtain it on terms acceptable or favorable to the Company.   The Company has implemented an enhanced quality control program to detect and correct product issues before they result in significant rework expenditures affecting its gross margins and has seen progress in that regard. The Company has also implemented a marketing and advertisement reduction plan for its entertainment segment, which will focus on reducing and alleviating current obligations from its media marketing agreements and place a hold on entering into any new agreements. The Company believes that its quality control, cost-cutting initiatives, and new product introduction will eventually restore positive operating cash flows and profitability, although it can offer no assurances in this regard.   Management has evaluated the significance of the conditions described above in relation to the Company’s ability to meet its obligations and concluded that, without additional funding, the Company will not have sufficient funds to meet its obligations within one year from the date the unaudited condensed consolidated financial statements were issued.
Basis of Consolidation	Basis of Consolidation:   The accompanying financial statements include the consolidated accounts of Digital Ally, its wholly-owned subsidiaries, Digital Ally International, Inc., Shield Products, LLC, Digital Ally Healthcare, LLC, TicketSmarter, Inc., Worldwide Reinsurance, Ltd., Digital Connect, Inc., BirdVu Jets, Inc., Kustom 440, Inc., and its majority-owned subsidiary Nobility Healthcare, LLC. All intercompany balances and transactions have been eliminated during consolidation.     The Company formed Digital Ally International, Inc. during August 2009 to facilitate the export sales of its products. The Company formed Shield Products, LLC in May 2020 to facilitate the sales of its Shield™ line of disinfectant/cleanser products and ThermoVu™ line of temperature monitoring equipment. The Company formed Nobility Healthcare, LLC (“Nobility Healthcare”) in June 2021 to facilitate the operations of its revenue cycle management solutions and back-office services for healthcare organizations. The Company formed TicketSmarter, Inc. upon its acquisition of Goody Tickets, LLC and TicketSmarter, LLC, to facilitate its global ticketing operations. The Company formed Worldwide Reinsurance Ltd., which is a captive insurance company domiciled in Bermuda. It will provide primarily liability insurance coverage to the Company for which insurance may not be currently available or economically feasible in today’s insurance marketplace. The Company formed Kustom 440, Inc. in 2022 to create unique entertainment experiences directly for consumers, and Kustom Entertainment, Inc. in 2023 to serve as the participant in the Business Combination.
Fair Value of Financial Instruments	Fair Value of Financial Instruments:   The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and subordinated notes payable approximate fair value because of the short-term nature of these items.
Revenue Recognition	Revenue Recognition:   The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.   The Company has two different revenue streams, product and service, represented through its three segments. The Company reports all revenues on a gross basis, other than service revenues from the Company’s entertainment and revenue cycle management segments, Revenues generated by all segments are reported net of sales taxes.   Video Solutions   The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situation where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e. when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement products. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.     Service and other revenue is comprised of revenues from extended warranties, repair services, cloud revenue and software revenue. Revenue is recognized upon shipment of the product and acceptance of the service or materials by the end customer for repair services. Revenue for extended warranty, cloud service or other software-based products is over the term of the contract warranty or service period. A time-elapsed method is used to measure progress because the Company transfers control evenly over the contractual period. Accordingly, the fixed consideration related to these revenues is generally recognized on a straight-line basis over the contract term, as long as the other revenue recognition criteria have been met.   The Company’s multiple performance obligations may include future in-car or body-worn camera devices to be delivered at defined points within a multi-year contract, and in those arrangements, the Company allocates total arrangement consideration over the life of the multi-year contract to future deliverables using management’s best estimate of selling price.   Revenue Cycle Management   The Company reports revenue cycle management revenues on a net basis, as its primary source of revenue is its end-to-end service fees which is generally determined as a percentage of the invoice amounts collected. These service fees are reported as revenue monthly upon completion of the Company’s performance obligation to provide the agreed upon service.   Entertainment   The Company reports ticketing revenue on a gross or net basis based on management’s assessment of whether the Company is acting as a principal or agent in the transaction. The determination is based upon the evaluation of control over the event ticket, including the right to sell the ticket, prior to its transfer to the ticket buyer.   The Company sells tickets held in inventory, which consists of one performance obligation, being to transfer control of an event ticket to the buyer upon confirmation of the order. The Company acts as the principal in these transactions as the ticket is owned by the Company at the time of sale, therefore controlling the ticket prior to transferring to the customer. In these transactions, revenue is recorded on a gross basis based on the value of the ticket and is recognized when an order is confirmed. Payment is typically due upon delivery of the ticket.   The Company also acts as an intermediary between buyers and sellers through online secondary marketplace. Revenues derived from this marketplace primarily consist of service fees from ticketing operations, and consists of one primary performance obligation, which is facilitating the transaction between the buyer and seller, being satisfied at the time the order has been confirmed. As the Company does not control the ticket prior to the transfer, the Company acts as an agent in these transactions. Revenue is recognized on a net basis, net of the amount due to the seller when an order is confirmed, the seller is then obligated to deliver the tickets to the buyer per the seller’s listing. Payment is due at the time of sale.   Other   Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract and are reported separately as current liabilities and non-current liabilities in the Consolidated Balance Sheets. Such amounts consist of extended warranty contracts, prepaid cloud services and prepaid installation services and are generally recognized as the respective performance obligations are satisfied. During the three months ended March 31, 2024, the Company recognized revenue of $241,371 related to its contract liabilities. Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract and are reported separately as current liabilities and non-current liabilities in the Consolidated Balance Sheets. Such amounts consist of extended warranty contracts, prepaid cloud services and prepaid installation services and are generally recognized as the respective performance obligations are satisfied. Total contract liabilities consist of the following:        March 31, 2024       December 31, 2023     Additions/Reclass     Recognized Revenue     March 31, 2024   Contract liabilities, current   $ 2,937,168     $ 535,598     $ 173,052     $ 3,299,714   Contract liabilities, non-current     7,340,459       13,066       68,319       7,285,206                                         $ 10,277,627     $ 548,664     $ 241,371     $ 10,584,920         March 31, 2023       December 31, 2022     Additions/Reclass     Recognized Revenue     March 31, 2023   Contract liabilities, current   $ 2,154,874     $ 562,809     $ 92,813     $ 2,624,870   Contract liabilities, non-current     5,818,082       868,211       370,646       6,315,647                                         $ 7,972,956     $ 1,431,020     $ 463,459     $ 8,940,517       Sales returns and allowances aggregated $93,170 and $117,713 as of March 31, 2024 and December 31, 2023, respectively. Obligations for estimated sales returns and allowances are recognized at the time of sales on an accrual basis. The accrual is determined based upon historical return rates adjusted for known changes in key variables affecting these return rates.
Use of Estimates	Use of Estimates:   The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management utilizes various other estimates, including but not limited to determining the estimated lives of long-lived assets, determining the potential impairment of long-lived assets, the fair value of warrants, options, the recognition of revenue, allowance for doubtful accounts, the estimate of fair value of the lease liabilities and related right of use asset, inventory valuation reserve, fair value of assets and liabilities acquired in a business combination, incremental borrowing rate on leases, the valuation allowance for deferred tax assets and other legal claims and contingencies. The results of any changes in accounting estimates are reflected in the financial statements in the period in which the changes become evident. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the period that they are determined to be necessary.
Cash and cash equivalents	Cash and cash equivalents:   Cash and cash equivalents include funds on hand, in bank and short-term investments with original maturities of ninety (90) days or less. The following table shows the Company’s cash and cash equivalents by significant investment category as of March 31, 2024 and December 31, 2023:        March 31, 2024       Adjusted Cost     Realized Gains     Realized Losses     Fair Value   Demand deposits   $ 769,982     $ —     $ —     $ 769,982   Short-term investments with original maturities of 90 days or less (Level 1):                                 Money market funds     157,879       —       —       157,879                                         $ 927,861     $ —     $ —     $ 927,861         December 31, 2023       Adjusted Cost     Realized Gains     Realized Losses     Fair Value   Demand deposits   $ 545,207     $ —     $ —     $ 545,207   Short-term investments with original maturities of 90 days or less (Level 1):                                 Money market funds     135,342       —       —       135,342                                         $ 680,549     $ —     $ —     $ 680,549     The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At March 31, 2024 and December 31, 2023, the uninsured balance amounted to $296,799 and $29,700, respectively.
Restricted Cash	Restricted Cash:   Restricted cash of $97,600 and $97,600 was included in other assets as of March 31, 2024 and December 31, 2023, respectively. Restricted cash consists of bank deposits that collateralize our debt obligations.   The following table provides a reconciliation of cash and cash equivalents in the consolidated balance sheets to cash, cash equivalents and restricted cash in the consolidated statements of cash flows:        March 31, 2024     December 31, 2023   Cash and cash equivalents   $ 927,861     $ 680,549   Long-term restricted cash included in other assets     97,600       97,600   Total cash, cash equivalents and restricted cash in the statements of cash flows   $ 1,025,461     $ 778,149
Accounts Receivable	Accounts Receivable:   Accounts receivable are carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a weekly basis. The Company determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, and current economic conditions.   Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received. A trade receivable is considered to be past due if any portion of the receivable balance is outstanding for more than thirty (30) days beyond terms. No interest is charged on overdue trade receivables.
Goodwill and Other Intangibles	Goodwill and Other Intangibles:   Goodwill - In connection with acquisitions, the Company applies the provisions of ASC 805, Business Combinations, using the acquisition method of accounting. The excess purchase price over the fair value of net tangible assets and identifiable intangible assets acquired is recorded as goodwill. In accordance with ASC 350, Intangibles - Goodwill and Other, the Company assesses goodwill for impairment annually as of December 31, and more frequently if events and circumstances indicate that goodwill might be impaired.   Goodwill impairment testing is performed at the reporting unit level. Goodwill is assigned to reporting units at the date the goodwill is initially recorded. Once goodwill has been assigned to reporting units, it no longer retains its association with a particular acquisition, and all of the activities within a reporting unit, whether acquired or internally generated, are available to support the value of the goodwill.   Traditionally, goodwill impairment testing is a two-step process. Step one involves comparing the fair value of the reporting units to its carrying amount. If the carrying amount of a reporting unit is greater than zero and its fair value is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount is greater than the fair value, the second step must be completed to measure the amount of impairment, if any. Step two involves calculating an implied fair value of goodwill. The Company has adopted ASU 2017-04 which simplifies subsequent goodwill measurement by eliminating step two from the goodwill impairment test. As a result, the Company compares the fair value of a reporting unit with its respective carrying value and recognized an impairment charge for the amount by which the carrying amount exceeded the reporting unit’s fair value.     The Company determines the fair value of its reporting units using the market approach. Under the market approach, we estimate the fair value based on multiples of comparable public companies and precedent transactions. Significant estimates in the market approach include: identifying similar companies with comparable business factors such as size, growth, profitability, risk and return on investment, and assessing comparable revenue and operating income multiples in estimating the fair value of the reporting unit.   Long-lived and Other Intangible Assets - The Company periodically assesses potential impairments of its long-lived assets in accordance with the provisions of ASC 360, Accounting for the Impairment or Disposal of Long-lived Assets. An impairment review is performed whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. The Company groups its assets at the lowest level for which identifiable cash flows are largely independent of the cash flows of the other assets and liabilities. The Company has determined that the lowest level for which identifiable cash flows are available is the operating segment level.   Factors considered by the Company include, but are not limited to, significant underperformance relative to historical or projected operating results; significant changes in the manner of use of the acquired assets or the strategy for the overall business; and significant negative industry or economic trends. When the carrying value of a long-lived asset may not be recoverable based upon the existence of one or more of the above indicators of impairment, the Company estimates the future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the sum of the expected future undiscounted cash flows and eventual disposition is less than the carrying amount of the asset, the Company recognizes an impairment loss. An impairment loss is reflected as the amount by which the carrying amount of the asset exceeds the fair value of the asset, based on the fair value if available, or discounted cash flows, if fair value is not available. The Company last assessed potential impairments of its long-lived assets as of December 31, 2023 and concluded that there was no impairment. Subsequent to completing our 2023 annual impairment test, no events or changes in circumstances were noted that required an interim goodwill impairment test.   Intangible assets include deferred patent costs, license agreements, trademarks and trade names. Legal expenses incurred in preparation of patent application have been deferred and will be amortized over the useful life of granted patents. Costs incurred in preparation of applications that are not granted will be charged to expense at that time. The Company has entered into several sublicense agreements under which it has been assigned the exclusive rights to certain licensed materials used in its products. These sublicense agreements generally require upfront payments to obtain the exclusive rights to such material. The Company capitalizes the upfront payments as intangible assets and amortizes such costs over their estimated useful life on a straight-line method.
Segment Reporting	Segment Reporting   The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information of those segments to be presented in financial statements. Operating segments are identified as components of an enterprise for which separate discrete financial information is available for evaluation by the chief operating decision maker (the Company’s Chief Executive Officer or “CODM”) in making decisions on how to allocate resources and assess performance. The Company’s three operating segments are Video Solutions, Revenue Cycle Management, and Entertainment, each of which has specific personnel responsible for that business and reports to the CODM. Corporate expenses capture the Company’s corporate administrative activities and are also to be reported in the segment information.
Contingent Consideration	Contingent Consideration   In circumstances where an acquisition involves a contingent consideration arrangement that meets the definition of a liability under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity, the Company recognizes a liability equal to the fair value of the contingent payments the Company expects to make as of the acquisition date. The Company remeasures this liability each reporting period and records changes in the fair value through the consolidated statement of operations.
Non-Controlling Interests	Non-Controlling Interests   Non-controlling interests in the Company’s Consolidated Financial Statements represent the interest in subsidiaries held by our venture partner. The venture partner holds a noncontrolling interest in the Company’s consolidated subsidiary Nobility Healthcare, LLC. Since the Company consolidates the financial statements of all wholly-owned and majority owned subsidiaries, the noncontrolling owners’ share of each subsidiary’s results of operations are deducted and reported as net income or loss attributable to noncontrolling interest in the Consolidated Statements of Operations.
New Accounting Standards	New Accounting Standards   In November 2023, the FASB issued Accounting Standards Update No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The guidance is to be applied retrospectively to all prior periods presented in the financial statements. Upon transition, the segment expense categories and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in the period of adoption. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.   In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.

NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
SCHEDULE OF CONTRACT LIABILITIES	March 31, 2024       December 31, 2023     Additions/Reclass     Recognized Revenue     March 31, 2024   Contract liabilities, current   $ 2,937,168     $ 535,598     $ 173,052     $ 3,299,714   Contract liabilities, non-current     7,340,459       13,066       68,319       7,285,206                                         $ 10,277,627     $ 548,664     $ 241,371     $ 10,584,920         March 31, 2023       December 31, 2022     Additions/Reclass     Recognized Revenue     March 31, 2023   Contract liabilities, current   $ 2,154,874     $ 562,809     $ 92,813     $ 2,624,870   Contract liabilities, non-current     5,818,082       868,211       370,646       6,315,647                                         $ 7,972,956     $ 1,431,020     $ 463,459     $ 8,940,517
SCHEDULE OF SHORT TERM INVESTMENTS	Cash and cash equivalents include funds on hand, in bank and short-term investments with original maturities of ninety (90) days or less. The following table shows the Company’s cash and cash equivalents by significant investment category as of March 31, 2024 and December 31, 2023:        March 31, 2024       Adjusted Cost     Realized Gains     Realized Losses     Fair Value   Demand deposits   $ 769,982     $ —     $ —     $ 769,982   Short-term investments with original maturities of 90 days or less (Level 1):                                 Money market funds     157,879       —       —       157,879                                         $ 927,861     $ —     $ —     $ 927,861         December 31, 2023       Adjusted Cost     Realized Gains     Realized Losses     Fair Value   Demand deposits   $ 545,207     $ —     $ —     $ 545,207   Short-term investments with original maturities of 90 days or less (Level 1):                                 Money market funds     135,342       —       —       135,342                                         $ 680,549     $ —     $ —     $ 680,549
SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS	The following table provides a reconciliation of cash and cash equivalents in the consolidated balance sheets to cash, cash equivalents and restricted cash in the consolidated statements of cash flows:        March 31, 2024     December 31, 2023   Cash and cash equivalents   $ 927,861     $ 680,549   Long-term restricted cash included in other assets     97,600       97,600   Total cash, cash equivalents and restricted cash in the statements of cash flows   $ 1,025,461     $ 778,149

INVENTORIES (Tables)	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
SCHEDULE OF INVENTORIES	Inventories consisted of the following at March 31, 2024 and December 31, 2023:        March 31, 2024     December 31, 2023   Raw material and component parts– video solutions segment   $ 2,938,434     $ 3,044,653   Work-in-process– video solutions segment     26,091       20,396   Finished goods – video solutions segment     4,180,699       4,623,489   Finished goods – entertainment segment     489,854       699,204   Subtotal     7,635,078       8,387,742   Reserve for excess and obsolete inventory– video solutions segment     (4,315,132 )     (4,355,666 ) Reserve for excess and obsolete inventory – entertainment segment     (171,257 )     (186,795 ) Total inventories   $ 3,148,689     $ 3,845,281

DEBT OBLIGATIONS (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
SUMMARY OF DEBT OBLIGATIONS	Debt obligations is comprised of the following:         March 31, 2024     December 31, 2023   Economic injury disaster loan (EIDL)   $ 146,971     $ 147,781   Contingent consideration promissory note – Nobility Healthcare Division Acquisition     64,826       129,651   Contingent consideration promissory note – Nobility Healthcare Division Acquisition     29,409       58,819   Revolving Loan Agreement     4,880,000       4,880,000   Commercial Extension of Credit- Entertainment Segment     69,643       87,928   Merchant Advances – Video Solutions Segment     1,348,000       1,350,000   Merchant Advances – Entertainment Segment     1,425,000       —   Unamortized debt issuance costs     (684,989 )     (540,429 ) Debt obligations     7,278,860       6,113,750   Less: current maturities of debt obligations     2,403,029       1,260,513   Debt obligations, long-term   $ 4,875,831     $ 4,853,237
SCHEDULE OF MATURITY OF DEBT OBLIGATIONS	Debt obligations mature as follows as of March 31, 2024:       March 31, 2024   2024   $ 2,402,188   2025     4,735,589   2026     3,542   2027     3,677   2028 and thereafter     133,864             Total   $ 7,278,860
SCHEDULE OF WARRANT TO PURCHASE COMMON STOCK GRANTED	Terms at April 5, 2023 (issuance date)   Volatility - range     106.0 % Risk-free rate     3.36 % Dividend     0 % Remaining contractual term     5.0 years   Exercise price   $ 5.50 – 7.50   Common stock issuable under the warrants     1,125,000

FAIR VALUE MEASUREMENT (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
SCHEDULE OF FINANCIAL ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON RECURRING BASIS	The following table represents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023:        March 31, 2024       Level 1     Level 2     Level 3     Total   Liabilities:                                 Warrant derivative liabilities   $ —     $ —     $ 1,718,629     $ 1,718,629   Contingent consideration promissory notes and contingent consideration earn-out agreement     —       —       94,235       94,235       $ —     $ —     $ 1,812,864     $ 1,812,864         December 31, 2023       Level 1     Level 2     Level 3     Total   Liabilities:                                 Warrant derivative liabilities   $ —     $ —     $ 1,369,738     $ 1,369,738   Contingent consideration promissory notes and contingent consideration earn-out agreement     —       —       188,470       188,470       $ —     $ —     $ 1,558,208     $ 1,558,208
SCHEDULE OF FAIR VALUE MEASUREMENTS CHANGE IN LEVEL 3 INPUTS	The following table represents the change in Level 3 tier value measurements for the three months ended March 31, 2024:        Contingent Consideration Promissory Notes and Earn-Out Agreement     Warrant Derivative Liabilities                 Balance, December 31, 2023   $ 188,470     $ 1,369,738                     Issuance of warrant derivative liabilities     —       —                     Change in fair value of warrant derivative liabilities     —       348,891                   Principal payments on contingent consideration promissory notes – Revenue Cycle Management Acquisitions     (94,235 )     —                     Change in fair value of contingent consideration promissory notes - Revenue Cycle Management Acquisitions     —       —                     Balance, March 31, 2024   $ 94,235     $ 1,718,629

ACCRUED EXPENSES (Tables)	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
SCHEDULE OF ACCRUED EXPENSES	Accrued expenses consisted of the following at March 31, 2024 and December 31, 2023:        March 31, 2024     December 31, 2023   Accrued warranty expense   $ 20,529     $ 17,699   Accrued litigation costs     2,040,292       2,040,292   Accrued sales commissions     40,000       87,421   Accrued payroll and related fringes     161,763       367,826   Accrued sales returns and allowances     93,170       117,713   Accrued taxes     66,114       150,981   Accrued interest - related party     187,346       95,031   Customer deposits     45,380       219,462   Other     482,550       172,905     $ 3,137,144     $ 3,269,330
SCHEDULE OF ACCRUED WARRANTY EXPENSE	Accrued warranty expense was comprised of the following for the three months ended March 31, 2024:    Beginning balance   $ 17,699   Provision for warranty expense     14,201   Charges applied to warranty reserve     (11,371 )           Ending balance   $ 20,529

PREPAID EXPENSES (Tables)	3 Months Ended
	Mar. 31, 2024
Prepaid Expenses
SCHEDULE OF PREPAID EXPENSE	Prepaid expenses were the following at March 31, 2024 and December 31, 2023:         March 31, 2024     December 31, 2023   Prepaid inventory   $ 5,570,087     $ 5,318,939   Prepaid advertising     485,429       612,292   Other     519,497       435,137   Total prepaid expenses   $ 6,575,013     $ 6,366,368

PROPERTY, PLANT AND EQUIPMENT (Tables)	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT	Property, plant and equipment consisted of the following at March 31, 2024 and December 31, 2023:        Estimated Useful Life   March 31, 2024     December 31, 2023   Building   25 years   $ 4,537,037     $ 4,537,037   Land   Infinite     739,734       739,734   Office furniture, fixtures, equipment, and aircraft   3-20 years     826,929       2,065,092   Warehouse and production equipment   3-7 years     239,055       29,055   Demonstration and tradeshow equipment   3-7 years     87,987       87,987   Building improvements   5-7 years     1,328,654       1,328,654   Total cost         7,759,396       8,787,559   Less: accumulated depreciation and amortization         (1,551,601 )     (1,503,857 )                       Net property, plant and equipment       $ 6,207,795     $ 7,283,702

OPERATING LEASE (Tables)	3 Months Ended
	Mar. 31, 2024
Operating Lease
SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES	The following sets forth the operating lease right of use assets and liabilities as of March 31, 2024:    Assets:         Operating lease right of use assets   $ 925,128             Liabilities:         Operating lease obligations-current portion   $ 225,960   Operating lease obligations-less current portion     749,718   Total operating lease obligations   $ 975,678
SCHEDULE OF LEASE EXPENSE	The components of lease expense were as follows for the three months ended March 31, 2024:   Selling, general and administrative expenses   $ 108,879
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS	Following are the minimum lease payments for each year and in total:    Year ending December 31:       2023 (April 1, to December 31, 2024)   $ 225,247   2024     288,720   2025     293,300   2026     117,492   Thereafter     235,020   Total undiscounted minimum future lease payments     1,159,779   Imputed interest     (184,101 ) Total operating lease liability   $ 975,678

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
SCHEDULE OF INTANGIBLE ASSETS	March 31, 2024     December 31, 2023       Gross value     Accumulated amortization     Net carrying value     Gross value     Accumulated amortization     Net carrying value   Amortized intangible assets:                                                 Licenses (video solutions segment)   $ 225,545     $ 92,525     $ 133,020     $ 225,545     $ 89,887     $ 135,658   Patents and trademarks (video solutions segment)     483,521       306,702       176,819       483,521       266,403       217,118   Sponsorship agreement network (entertainment segment)     5,600,000       2,893,333       2,706,667       5,600,000       2,613,333       2,986,667   SEO content (entertainment segment)     600,000       387,500       212,500       600,000       350,000       250,000   Personal seat licenses (entertainment segment)     87,679       7,542       80,137       180,081       14,004       166,077   Software     23,653       —       23,653                     Website enhancements (entertainment segment)     25,630       1,878       23,752       13,500       —       13,500   Client agreements (revenue cycle management segments)     999,034       251,744       747,290       999,034       226,768       772,266         8,045,062       3,941,224       4,103,838       8,101,681       3,560,395       4,541,286                                                     Indefinite life intangible assets:                                                 Goodwill (entertainment and revenue cycle management segments)     11,593,473       —       11,593,473       11,367,514       —       11,367,514   Trade name (entertainment segment)     900,000       —       900,000       600,000       —       600,000   Patents and trademarks pending (video solutions segment)     27,721       —       27,721       1,622       —       1,622                                                     Total   $ 20,566,256     $ 3,941,224     $ 16,625,032     $ 20,070,817     $ 3,560,395     $ 16,510,422
SCHEDULE OF ESTIMATED AMORTIZATION FOR INTANGIBLE ASSETS	Year ending December 31:       2024 (April 1, to December 31, 2024)   $ 1,117,290   2025     1,413,938   2026     909,400   2027     113,600   2028 and thereafter     549,610     $ 4,103,838

OTHER ASSETS (Tables)	3 Months Ended
	Mar. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
SCHEDULE OF OTHER ASSETS	Other assets were the following at March 31, 2024 and December 31, 2023:       March 31, 2024     December 31, 2023   Lease receivable   $ 5,880,809     $ 6,095,050   Restricted Cash     97,600       97,600   Other     354,776       404,382   Total other assets   $ 6,333,185     $ 6,597,032

STOCK-BASED COMPENSATION (Tables)	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
SUMMARY OF STOCK OPTIONS OUTSTANDING	A summary of all stock option activity under the Plans for the three months ended March 31, 2024 is as follows:    Options   Number of Shares     Weighted Average Exercise Price   Outstanding at December 31, 2023     53,600     $ 45.55   Granted     —       —   Exercised     —       —   Forfeited     —       —   Outstanding at March 31, 2024     53,600     $ 45.55   Exercisable at March 31, 2024     53,600     $ 45.55
SCHEDULE OF SHARES AUTHORIZED UNDER STOCK OPTION PLANS BY EXERCISE PRICE RANGE	The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of March 31, 2024:          Outstanding options   Exercisable options Exercise price range     Number of options     Weighted average remaining contractual life   Number of options     Weighted average remaining contractual life                         $ 0.01 to $49.99       37,000     6.4 years     37,000     6.4 years $ 50.00 to $69.99       15,100     4.2 years     15,100     4.2 years $ 70.00 to $89.99       1,500     2.1 years     1,500     2.1 years                                         53,600     5.6 years     53,600     5.6 years
SUMMARY OF RESTRICTED STOCK ACTIVITY	A summary of all restricted stock activity under the Plans for the three months ended March 31, 2024 is as follows:       Number of Restricted shares     Weighted average grant date fair value   Nonvested balance, December 31, 2023     53,875     $ 11.27   Granted     80,197       2.12   Vested     (30,750 )     10.06   Forfeited     (1,125 )     22.20   Nonvested balance, March 31, 2024     102,197     $ 4.34
SCHEDULE OF NON-VESTED BALANCE OF RESTRICTED STOCK	The nonvested balance of restricted stock vests as follows:   Years ended   Number of shares           2024 (April 1, 2024 through December 31, 2024)     1,500   2025     73,349   2026     18,349   2027     5,000   2028     4,000

COMMON STOCK PURCHASE WARRANTS (Tables)	3 Months Ended
	Mar. 31, 2024
Common Stock Purchase Warrants
SCHEDULE OF WARRANT MODIFICATION	Issuance date assumptions     March 31, 2024 assumptions   Volatility - range     106.0 %   $ 108.5 % Risk-free rate     3.36 %     4.21 % Dividend     0 %     0 % Remaining contractual term     5.0 years       4.0 years   Exercise price     5.50 – 7.50       5.50 – 7.50   Common stock issuable under the warrants     1,125,000       1,125,000
SUMMARY OF WARRANT ACTIVITY	The following table summarizes information about shares issuable under warrants outstanding during the three months ended March 31, 2024 and 2023:        Warrants     Weighted average exercise price   Vested Balance, December 31, 2023     1,125,000     $ 6.50   Granted     —       —   Exercised     —       —   Forfeited/cancelled     —       —   Vested Balance, March 31, 2024     1,125,000     $ 6.50
SUMMARY OF RANGE OF EXERCISE PRICES AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF WARRANTS	The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase shares of common stock as of March 31, 2024:         Outstanding and exercisable warrants Exercise price     Number of warrants     Weighted average remaining contractual life $ 5.50       375,000     4.0 years $ 6.50       375,000     4.0 years $ 7.50       375,000     4.0 years                             1,125,000     4.0 years

NET LOSS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
SCHEDULE OF WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING AND LOSS PER SHARE OUTSTANDING	The calculation of the weighted average number of shares outstanding and loss per share outstanding for the three months ended March 31, 2024 and 2023 are as follows:       Three months ended March 31,       2024     2023   Numerator for basic and diluted loss per share – Net loss attributable to common stockholders   $ (3,931,020 )   $ (6,105,818 )                   Denominator for basic loss per share – weighted average shares outstanding     2,861,229       2,751,662   Dilutive effect of shares issuable upon conversion of convertible debt and the exercise of stock options and warrants outstanding     —       —                     Denominator for diluted loss per share – adjusted weighted average shares outstanding     2,861,229       2,751,662                     Net loss per share:                 Basic   $ (1.37 )   $ (2.22 ) Diluted   $ (1.37 )   $ (2.22 )

COUNTRY STAMPEDE ACQUISITION (Tables)	3 Months Ended
	Mar. 31, 2024
Country Stampede Acquisition [Member]
Business Acquisition [Line Items]
SCHEDULE OF ESTIMATED FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED ACQUISITION	As allocated (Preliminary)   Description   March 1, 2024   Assets acquired (provisional):         Tangible assets acquired   $ 305,000   Identifiable intangible assets acquired (Trademarks and trade names)     300,000   Goodwill     225,959   Liabilities assumed     (288,000 ) Net assets acquired and liabilities assumed   $ 542,959   Consideration:         Cash paid at Country Stampede Acquisition date   $ 400,000   Cash paid subsequent to closing     142,959             Total Country Stampede Acquisition purchase price   $ 542,959

SEGMENT DATA (Tables)	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
SCHEDULE OF SEGMENT REPORTING	Summarized financial information for the Company’s reportable business segments is provided for the indicated periods and as of March 31, 2024, and March 31, 2023:       Three Months Ended March 31,       2024     2023   Net Revenues:                 Video Solutions   $ 1,718,293     $ 1,899,364   Revenue Cycle Management     1,434,598       1,781,590   Entertainment     2,376,460       4,016,236   Total Net Revenues   $ 5,529,351     $ 7,697,190                     Gross Profit:                 Video Solutions   $ 565,694     $ 534,195   Revenue Cycle Management     463,731       775,934   Entertainment     494,274       234,663   Total Gross Profit   $ 1,523,699     $ 1,544,792                     Operating Income (loss):                 Video Solutions   $ (891,588 )   $ (1,963,186 ) Revenue Cycle Management     (24,031 )     103,765   Entertainment     (642,219 )     (1,233,006 ) Corporate     (2,081,196 )     (3,080,379 ) Total Operating Loss   $ (3,639,034 )   $ (6,172,806 )                   Depreciation and Amortization:                 Video Solutions   $ 198,028     $ 198,122   Revenue Cycle Management     26,715       25,507   Entertainment     326,248       319,481   Total Depreciation and Amortization   $ 550,991     $ 543,110           March 31, 2024     December 31, 2023   Assets (net of eliminations):                 Video Solutions   $ 24,172,478     $ 26,396,559   Revenue Cycle Management     1,989,068       2,260,376   Entertainment     6,482,510       6,324,211   Corporate     12,520,139       12,047,663   Total Identifiable Assets   $ 45,164,195     $ 47,028,809

SCHEDULE OF CONTRACT LIABILITIES (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Contract liabilities, current, beginning	$ 2,937,168	$ 2,154,874
Contract liabilities, current, additions/reclass	535,598	562,809
Contract liabilities, current, revenue recognized	173,052	92,813
Contract liabilities, current, ending	3,299,714	2,624,870
Contract liabilities, non-current, beginning	7,340,459	5,818,082
Contract liabilities, non-current, additions/reclass	13,066	868,211
Contract liabilities, non-current, revenue recognized	68,319	370,646
Contract liabilities, non-current, ending	7,285,206	6,315,647
Contract liabilities, current, beginning	10,277,627	7,972,956
Contract liabilities, additions/reclass	548,664	1,431,020
Contract liabilities, revenue recognized	241,371	463,459
Contract liabilities, ending	$ 10,584,920	$ 8,940,517

SCHEDULE OF SHORT TERM INVESTMENTS (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Adjusted cost	$ 927,861	$ 680,549
Realized gains
Realized Losses
Fair value	927,861	680,549
Cash [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Adjusted cost	769,982	545,207
Realized gains
Realized Losses
Fair value	769,982	545,207
Money Market Funds [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Adjusted cost	157,879	135,342
Realized gains
Realized Losses
Fair value	$ 157,879	$ 135,342

SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and cash equivalents	$ 927,861	$ 680,549
Long-term restricted cash included in other assets	97,600	97,600
Total cash, cash equivalents and restricted cash in the statements of cash flows	$ 1,025,461	$ 778,149	$ 2,859,723	$ 3,532,199

NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)		3 Months Ended		12 Months Ended
	Feb. 06, 2023	Mar. 31, 2024 USD ($) Segments $ / shares	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($) $ / shares	Mar. 14, 2024 $ / shares	Aug. 23, 2022 $ / shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock, par value | $ / shares		$ 0.001		$ 0.001	$ 0.001
Reverse stock split	1-for-20 reverse stock split
Net loss		$ 3,931,020
Net cash used in operating activities		918,545	$ 1,216,876
Net cash used in investing activities		160,830	(70,645)
Net cash used in financing activities		1,005,027	615,045
Contract liabilities, revenue recognized		241,371	$ 463,459
Sales return and allowances		93,170		$ 117,713
Cash, FDIC insured amount		250,000
Uninsured balance		296,799		29,700
Restricted cash		$ 97,600		$ 97,600
Number of operating segments | Segments		3
Merger Agreement [Member] | Predecessor Common Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock, par value | $ / shares						$ 0.001
Merger Agreement [Member] | Registrant Common Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock, par value | $ / shares						$ 0.001

SCHEDULE OF INVENTORIES (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw material and component parts– video solutions segment	$ 2,938,434	$ 3,044,653
Work-in-process– video solutions segment	26,091	20,396
Finished goods – video solutions segment	4,180,699	4,623,489
Finished goods – entertainment segment	489,854	699,204
Subtotal	7,635,078	8,387,742
Reserve for excess and obsolete inventory– video solutions segment	(4,315,132)	(4,355,666)
Reserve for excess and obsolete inventory – entertainment segment	(171,257)	(186,795)
Total inventories	$ 3,148,689	$ 3,845,281

INVENTORIES (Details Narrative) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Inventory cost	$ 51,099	$ 42,797

SUMMARY OF DEBT OBLIGATIONS (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023	Jun. 02, 2023
Debt Disclosure [Abstract]
Economic injury disaster loan (EIDL)	$ 146,971	$ 147,781	$ 125,000
Contingent consideration promissory note – Nobility Healthcare Division Acquisition	64,826	129,651
Contingent consideration promissory note – Nobility Healthcare Division Acquisition	29,409	58,819
Revolving Loan Agreement	4,880,000	4,880,000
Commercial Extension of Credit- Entertainment Segment	69,643	87,928
Merchant Advances – Video Solutions Segment	1,348,000	1,350,000
Merchant Advances – Entertainment Segment	1,425,000
Unamortized debt issuance costs	(684,989)	(540,429)
Debt obligations	7,278,860	6,113,750
Less: current maturities of debt obligations	2,403,029	1,260,513
Debt obligations, long-term	$ 4,875,831	$ 4,853,237

SCHEDULE OF MATURITY OF DEBT OBLIGATIONS (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
2024	$ 2,402,188
2025	4,735,589
2026	3,542
2027	3,677
2028 and thereafter	133,864
Debt obligations	$ 7,278,860	$ 6,113,750

SCHEDULE OF WARRANT TO PURCHASE COMMON STOCK GRANTED (Details) - Warrant [Member] - $ / shares	Apr. 05, 2023	Mar. 31, 2024
Debt Instrument [Line Items]
Volatility - range	106.00%
Risk-free rate	3.36%
Dividend	0.00%
Remaining contractual term	5 years
Common stock issuable under the warrants	1,125,000	1,125,000
Minimum [Member]
Debt Instrument [Line Items]
Exercise price	$ 5.50
Maximum [Member]
Debt Instrument [Line Items]
Exercise price	$ 7.50

DEBT OBLIGATIONS (Details Narrative) - USD ($)											1 Months Ended	3 Months Ended
	Feb. 08, 2024	Jan. 22, 2024	Nov. 30, 2023	Oct. 26, 2023	Jun. 02, 2023	Apr. 05, 2023	Feb. 23, 2023	Aug. 31, 2021	Jun. 30, 2021	May 12, 2020	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023	Mar. 14, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Face value					$ 125,000						$ 146,971	$ 146,971			$ 147,781
Principal loan through remittances											$ 87,928	$ 87,928
Common stock, par value											$ 0.001	$ 0.001		$ 0.001	$ 0.001
Issuance of warrant derivative liabilities												$ 576,380
Loss on conversion of convertibleNote					$ 93,386
Debt issuance costs												188,255
Proceeds merchant advances												700,000
Merchant advances outstanding balance											$ 1,348,000	1,348,000			$ 1,350,000
Merchant advances entertainment segment outstanding balance											1,425,000	1,425,000
Merchant Cash Advances [Member]
Short-Term Debt [Line Items]
Amortization of debt discount												278,256
Short-term merchant advance			$ 1,050,000
Origination fees total			50,000
Net proceeds of origination fees			1,000,000
Short-term debt			$ 1,512,000
Loan interest rate			2.9
Repayments of short-term debt												702,000
Merchant Cash Advances Entertainment Segment [Member]
Short-Term Debt [Line Items]
Amortization of debt discount												63,750
Short-term merchant advance											1,000,000	1,000,000
Origination fees total												85,000
Net proceeds of origination fees												915,000
Short-term debt											$ 1,425,000	1,425,000
Loan interest rate											5.05
Revolving Loan Agreement [Member]
Short-Term Debt [Line Items]
Proceeds from secured convertible debt				$ 4,880,000
Proceeds from secured convertible debt				3,162,500
Principal amount outstanding of loans				4,880,000
Debt instrument, repaid, principal				$ 97,600
Loan agreement description				the Company issued the Revolving Note to Kompass whereby the Company and Digital Ally Healthcare jointly and severally promise to pay to the order of Kompass the lesser of (i) $4,880,000.00, or (ii) the aggregate principal amount of all Revolving Loans outstanding under and pursuant to the Loan Agreement at the maturity or maturities and in the amount or amounts stated on the records of Kompass, together with interest (computed on the actual number of days elapsed on the basis of a 360 day year) at a floating per annum rate equal to the greater of (i) the Prime Rate plus four percent or (ii) eight percent, on the aggregate principal amount of all Revolving Loans outstanding from time to time as provided in the Loan Agreement.
Amortization of debt discount												$ 23,435
Registration Rights Agreement [Member]
Short-Term Debt [Line Items]
Contractual interest rate											10.00%	10.00%
Purchaser percentage											2.00%	2.00%
Warrant [Member]
Short-Term Debt [Line Items]
Aggregate shares exercisable						1,125,000
Comprised shares						1,125,000					1,125,000	1,125,000
Warrant One [Member]
Short-Term Debt [Line Items]
Comprised shares						375,000
Warrant exercise price						$ 5.50
Common stock, par value						$ 0.001
Warrant Two [Member]
Short-Term Debt [Line Items]
Comprised shares						375,000
Warrant exercise price						$ 6.50
Warrant Three [Member]
Short-Term Debt [Line Items]
Comprised shares						375,000
Warrant exercise price						$ 7.50
Common Stock [Member]
Short-Term Debt [Line Items]
Common stock, convertible, conversion price, increase						$ 5.00
Debt instrument, redemption price, percentage						110.00%
Shares issued price per share					$ 5.00
Conversion of convertible securities, shares					25,000
Conversion of convertible securities					$ 119,750
2020 Small Business Administration Notes [Member]
Short-Term Debt [Line Items]
Proceeds from loans										$ 150,000
Face value										$ 150,000	$ 810	$ 810
Contractual interest rate										3.75%
principal payment										$ 731
Interest expense												1,383
June Contingent Payment Note [Member]
Short-Term Debt [Line Items]
Face value									$ 350,000
Contractual interest rate									3.00%
principal payment									$ 261,543
Principal amount									975,000
Debt instrument fair value									$ 350,000		29,409	29,409			29,409
August Contingent Payment Note [Member]
Short-Term Debt [Line Items]
Face value								$ 650,000
Contractual interest rate								3.00%
principal payment								$ 617,082
Principal amount								3,000,000
Debt instrument fair value								$ 650,000			$ 64,826	64,826
Increase in estimated fair value															$ 64,826
Twenty Twenty Three Commercial Extension Of Credit [Member]
Short-Term Debt [Line Items]
Line of credit							$ 1,000,000
Borrower percentage							25.00%
Credit facility description							The 25% withholding of the Borrower’s applicable remittance shall be deemed a “Payment” under the terms of this Note, and Payments shall continue until the earlier of (i) repayment of the Principal Sum, accrued Interest, and a fee of $35,000 or (ii) expiration of the Private Label Agreement on December 31, 2023.
2024 Commercial Extension Of Credit [Member]
Short-Term Debt [Line Items]
Line of credit	$ 75,000
Monthly advances	$ 100,000
Client fees		$ 25,000
Deposits received												275,000
Advance payments												205,357
Outstanding balance												$ 69,643
Securities Purchase Agreement [Member]
Short-Term Debt [Line Items]
Contractual interest rate						10.00%
Principal amount						$ 3,000,000
Proceeds from convertible debt						2,700,000
Principal amount						$ 3,000,000

SCHEDULE OF FINANCIAL ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON RECURRING BASIS (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value	$ 1,812,864	$ 1,558,208
Contingent Consideration Promissory Notes and Contingent Consideration Earn Out [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value	94,235	188,470
Warrant Derivative Liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value	1,718,629	1,369,738
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value
Fair Value, Inputs, Level 1 [Member] | Contingent Consideration Promissory Notes and Contingent Consideration Earn Out [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value
Fair Value, Inputs, Level 1 [Member] | Warrant Derivative Liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value
Fair Value, Inputs, Level 2 [Member] | Contingent Consideration Promissory Notes and Contingent Consideration Earn Out [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value
Fair Value, Inputs, Level 2 [Member] | Warrant Derivative Liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value	1,812,864	1,558,208
Fair Value, Inputs, Level 3 [Member] | Contingent Consideration Promissory Notes and Contingent Consideration Earn Out [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value	94,235	188,470
Fair Value, Inputs, Level 3 [Member] | Warrant Derivative Liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value	$ 1,718,629	$ 1,369,738

SCHEDULE OF FAIR VALUE MEASUREMENTS CHANGE IN LEVEL 3 INPUTS (Details)	3 Months Ended
	Mar. 31, 2024 USD ($)
Short-Term Debt [Line Items]
Beginning balance	$ 1,558,208
Issuance of warrant derivative liabilities	(576,380)
Ending balance	1,812,864
Contingent Consideration Promissory Note [Member]
Short-Term Debt [Line Items]
Beginning balance	188,470
Issuance of warrant derivative liabilities
Change in fair value of warrant derivative liabilities
Principal payments on contingent consideration promissory notes - Revenue Cycle Management Acquisitions	(94,235)
Change in fair value of contingent consideration promissory notes - Revenue Cycle Management Acquisitions
Ending balance	94,235
Warrant Derivative Liabilities [Member]
Short-Term Debt [Line Items]
Beginning balance	1,369,738
Issuance of warrant derivative liabilities
Change in fair value of warrant derivative liabilities	348,891
Principal payments on contingent consideration promissory notes - Revenue Cycle Management Acquisitions
Change in fair value of contingent consideration promissory notes - Revenue Cycle Management Acquisitions
Ending balance	$ 1,718,629

SCHEDULE OF ACCRUED EXPENSES (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued warranty expense	$ 20,529	$ 17,699
Accrued litigation costs	2,040,292	2,040,292
Accrued sales commissions	40,000	87,421
Accrued payroll and related fringes	161,763	367,826
Accrued sales returns and allowances	93,170	117,713
Accrued taxes	66,114	150,981
Accrued interest - related party	187,346	95,031
Customer deposits	45,380	219,462
Other	482,550	172,905
Total accrued expenses	$ 3,137,144	$ 3,269,330

SCHEDULE OF ACCRUED WARRANTY EXPENSE (Details)	3 Months Ended
	Mar. 31, 2024 USD ($)
Payables and Accruals [Abstract]
Beginning balance	$ 17,699
Provision for warranty expense	14,201
Charges applied to warranty reserve	(11,371)
Ending balance	$ 20,529

INCOME TAXES (Details Narrative) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Statutory rate valuation allowances	100.00%	100.00%
Deferred tax assets valuation allowance percentage	100.00%
Operating loss carryforwards	$ 140.9

SCHEDULE OF PREPAID EXPENSE (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Prepaid Expenses
Prepaid inventory	$ 5,570,087	$ 5,318,939
Prepaid advertising	485,429	612,292
Other	519,497	435,137
Total prepaid expenses	$ 6,575,013	$ 6,366,368

SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Building	$ 4,537,037	$ 4,537,037
Land	739,734	739,734
Office furniture, fixtures, equipment, and aircraft	826,929	2,065,092
Warehouse and production equipment	239,055	29,055
Demonstration and tradeshow equipment	87,987	87,987
Building improvements	1,328,654	1,328,654
Total cost	7,759,396	8,787,559
Less: accumulated depreciation and amortization	(1,551,601)	(1,503,857)
Net property, plant and equipment	$ 6,207,795	$ 7,283,702
Building [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life	25 years
Land [Member]
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]	us-gaap:UsefulLifeTermOfLeaseMember
Furniture and Fixtures [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life	3 years
Furniture and Fixtures [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life	20 years
Warehouse [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life	3 years
Warehouse [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life	7 years
Demonstration and Tradeshow Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life	3 years
Demonstration and Tradeshow Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life	7 years
Building Improvements [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life	5 years
Building Improvements [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life	7 years

PROPERTY, PLANT AND EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 162,712	$ 171,631
Sold aircraft	1,100,000
Closing cost	1,500
Carrying amount	1,141,661
Loss on sale of assets	(41,661)
Aircraft [Member]
Property, Plant and Equipment [Line Items]
Loss on sale of assets	$ 41,161

SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Operating Lease
Operating lease right of use assets	$ 925,128	$ 1,053,159
Operating lease obligations-current portion	225,960	279,538
Operating lease obligations-less current portion	749,718	$ 827,836
Total operating lease obligations	$ 975,678

SCHEDULE OF LEASE EXPENSE (Details)	3 Months Ended
	Mar. 31, 2024 USD ($)
Selling, General and Administrative Expenses [Member]
Selling, general and administrative expenses	$ 108,879

SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details)	Mar. 31, 2024 USD ($)
Operating Lease
2023 (April 1, to December 31, 2024)	$ 225,247
2024	288,720
2025	293,300
2026	117,492
Thereafter	235,020
Total undiscounted minimum future lease payments	1,159,779
Imputed interest	(184,101)
Total operating lease liability	$ 975,678

OPERATING LEASE (Details Narrative) - USD ($)					1 Months Ended		3 Months Ended
	Jan. 02, 2022	Sep. 01, 2021	Aug. 31, 2021	May 13, 2020	Oct. 31, 2023	Jun. 30, 2021	Mar. 31, 2024	Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted-average remaining lease term								4 years 6 months
Lease liability							$ 73,894	$ (517,039)
Second Medical Billing Company [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Lessor, operating lease, description			termination date in March 2030
Weighted-average remaining lease term							75 months
Goody Tickets, LLC and TicketSmarter, LLC [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Lessor, operating lease, description		termination date of December 2022
Private Medical Billing Company [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Lessor, operating lease, description	termination date of June 2025
Minimum [Member] | First Medical Billing Company [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Operating lease, payments						$ 2,648
Minimum [Member] | Second Medical Billing Company [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Operating lease, payments			$ 7,436
Minimum [Member] | Goody Tickets, LLC and TicketSmarter, LLC [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Operating lease, payments		$ 7,211
Minimum [Member] | Private Medical Billing Company [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Operating lease, payments	$ 4,233
Maximum [Member] | First Medical Billing Company [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Operating lease, payments						$ 2,774
Maximum [Member] | Second Medical Billing Company [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Operating lease, payments			$ 8,877
Maximum [Member] | Goody Tickets, LLC and TicketSmarter, LLC [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Operating lease, payments		$ 7,364
Maximum [Member] | Private Medical Billing Company [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Operating lease, payments	$ 4,626
October 2023 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Lease term					48 months
Operating lease, payments					$ 1,786
Warehouse And Office Space [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Lease term							36 months
Lessor, operating lease, description				termination date of December 2026.
Warehouse And Office Space [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Operating lease, payments				$ 12,398
Warehouse And Office Space [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Operating lease, payments				$ 14,741
Office Space and Copier [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Operating lease								$ 108,879
Discount rate							8.00%

SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross value	$ 20,566,256	$ 20,070,817
Accumulated amortization	3,941,224	3,560,395
Net carrying value	16,625,032	16,510,422
Amortized Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	8,045,062	8,101,681
Accumulated amortization	3,941,224	3,560,395
Net carrying value	4,103,838	4,541,286
Amortized Intangible Assets [Member] | Licenses [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	225,545	225,545
Accumulated amortization	92,525	89,887
Net carrying value	133,020	135,658
Amortized Intangible Assets [Member] | Patents and Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	483,521	483,521
Accumulated amortization	306,702	266,403
Net carrying value	176,819	217,118
Amortized Intangible Assets [Member] | Sponsorship Agreement Network [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	5,600,000	5,600,000
Accumulated amortization	2,893,333	2,613,333
Net carrying value	2,706,667	2,986,667
Amortized Intangible Assets [Member] | SEO Content [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	600,000	600,000
Accumulated amortization	387,500	350,000
Net carrying value	212,500	250,000
Amortized Intangible Assets [Member] | Personal Seat Licenses (Entertainment Segment) [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	87,679	180,081
Accumulated amortization	7,542	14,004
Net carrying value	80,137	166,077
Amortized Intangible Assets [Member] | Software [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	23,653
Accumulated amortization
Net carrying value	23,653
Amortized Intangible Assets [Member] | Website Enhancements Entertainment Segment [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	25,630	13,500
Accumulated amortization	1,878
Net carrying value	23,752	13,500
Amortized Intangible Assets [Member] | Client agreements (revenue cycle management segments) [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	999,034	999,034
Accumulated amortization	251,744	226,768
Net carrying value	747,290	772,266
Unamortized Intangible Assets [Member] | Goodwill [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	11,593,473	11,367,514
Accumulated amortization
Net carrying value	11,593,473	11,367,514
Unamortized Intangible Assets [Member] | Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	900,000	600,000
Accumulated amortization
Net carrying value	900,000	600,000
Unamortized Intangible Assets [Member] | Patents and Trademarks Pending [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	27,721	1,622
Accumulated amortization
Net carrying value	$ 27,721	$ 1,622

SCHEDULE OF ESTIMATED AMORTIZATION FOR INTANGIBLE ASSETS (Details)	Mar. 31, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2024 (April 1, to December 31, 2024)	$ 1,117,290
2025	1,413,938
2026	909,400
2027	113,600
2028 and thereafter	549,610
Total	$ 4,103,838

GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 388,278	$ 371,478

SCHEDULE OF OTHER ASSETS (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Lease receivable	$ 5,880,809	$ 6,095,050
Restricted Cash	97,600	97,600
Other	354,776	404,382
Total other assets	$ 6,333,185	$ 6,597,032

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) $ / shares in Units, $ in Millions	Mar. 31, 2024	Mar. 14, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Aggregate carrying amount of litigation loss	$ 1.8
Common stock, par value	$ 0.001	$ 0.001	$ 0.001

SUMMARY OF STOCK OPTIONS OUTSTANDING (Details) - Stock Options [Member]	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Options outstanding, beginning balance | shares	53,600
Weighted average exercise price, outstanding, beginning balance | $ / shares	$ 45.55
Options granted | shares
Weighted average exercise price, granted | $ / shares
Options exercised | shares
Weighted average exercise price, exercised | $ / shares
Options forfeited | shares
Weighted average exercise price, forfeited | $ / shares
Options outstanding, ending balance | shares	53,600
Weighted average exercise price, outstanding, ending balance | $ / shares	$ 45.55
Options exercisable, ending balance | shares	53,600
Weighted average exercise price, exercisable, ending balance | $ / shares	$ 45.55

SCHEDULE OF SHARES AUTHORIZED UNDER STOCK OPTION PLANS BY EXERCISE PRICE RANGE (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of options, outstanding	53,600
Weighted average remaining contractual life, outstanding options	5 years 7 months 6 days
Number of options, exercisable	53,600
Weighted average remaining contractual life, exercisable options	5 years 7 months 6 days
Range One [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price range, lower limit | $ / shares	$ 0.01
Exercise price range, upper limit | $ / shares	$ 49.99
Number of options, outstanding	37,000
Weighted average remaining contractual life, outstanding options	6 years 4 months 24 days
Number of options, exercisable	37,000
Weighted average remaining contractual life, exercisable options	6 years 4 months 24 days
Range Two [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price range, lower limit | $ / shares	$ 50.00
Exercise price range, upper limit | $ / shares	$ 69.99
Number of options, outstanding	15,100
Weighted average remaining contractual life, outstanding options	4 years 2 months 12 days
Number of options, exercisable	15,100
Weighted average remaining contractual life, exercisable options	4 years 2 months 12 days
Range Three [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price range, lower limit | $ / shares	$ 70.00
Exercise price range, upper limit | $ / shares	$ 89.99
Number of options, outstanding	1,500
Weighted average remaining contractual life, outstanding options	2 years 1 month 6 days
Number of options, exercisable	1,500
Weighted average remaining contractual life, exercisable options	2 years 1 month 6 days

SUMMARY OF RESTRICTED STOCK ACTIVITY (Details) - Restricted Stock [Member]	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of restricted shares, non-vested beginning balance | shares	53,875
Weighted average grant date fair value, non-vested beginning balance | $ / shares	$ 11.27
Number of restricted shares, granted | shares	80,197
Weighted average grant date fair value, granted | $ / shares	$ 2.12
Number of restricted shares, vested | shares	(30,750)
Weighted average grant date fair value, vested | $ / shares	$ 10.06
Number of restricted shares, forfeited | shares	(1,125)
Weighted average grant date fair value, forfeited | $ / shares	$ 22.20
Number of restricted shares, non-vested ending balance | shares	102,197
Weighted average grant date fair value, non-vested ending balance | $ / shares	$ 4.34

SCHEDULE OF NON-VESTED BALANCE OF RESTRICTED STOCK (Details)	Mar. 31, 2024 shares
Share-Based Payment Arrangement [Abstract]
2024 (April 1, 2024 through December 31, 2024)	1,500
2025	73,349
2026	18,349
2027	5,000
2028	4,000

STOCK-BASED COMPENSATION (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based payment arrangement, expense	$ 40,695	$ 114,848
Stock options or restricted stock granted	333,750
Options, available for grant	137,042
Aggregate intrinsic value	$ 0		$ 0
Aggregate intrinsic value of options exercisable	0		$ 0
Unrecognized portion of stock compensation expense	0
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unrecognized portion of stock compensation expense	$ 245,233
2005 Stock Option Plan [Member] | During 2015 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares unavailable for issuance	1,078
Shares unexercised and outstanding	284
2006 Stock Option Plan [Member] | During 2016 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares unavailable for issuance	2,739
Shares unexercised and outstanding	531
2007 Stock Option Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares unexercised and outstanding	0
2007 Stock Option Plan [Member] | During 2017 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares unavailable for issuance	4,733
2008 Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares unexercised and outstanding	0
2008 Plan [Member] | During 2018 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares unavailable for issuance	2,025

SCHEDULE OF WARRANT MODIFICATION (Details) - Warrant [Member]	Mar. 31, 2024 shares	Apr. 05, 2023 shares
Common stock issuable under the warrants	1,125,000	1,125,000
Measurement Input, Price Volatility [Member]
Warrants measurement input	108.5	106.0
Measurement Input, Risk Free Interest Rate [Member]
Warrants measurement input	4.21	3.36
Measurement Input, Expected Dividend Rate [Member]
Warrants measurement input	0	0
Measurement Input, Expected Term [Member]
Remaining contractual term	4 years	5 years
Measurement Input, Exercise Price [Member] | Minimum [Member]
Warrants measurement input	5.50	5.50
Measurement Input, Exercise Price [Member] | Maximum [Member]
Warrants measurement input	7.50	7.50

SUMMARY OF WARRANT ACTIVITY (Details) - Warrant [Member]	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Warrants, vested, beginning balance | shares	1,125,000
Weighted average exercise price, vested, beginning balance | $ / shares	$ 6.50
Warrants, granted | shares
Weighted average exercise price, granted | $ / shares
Warrants, exercised | shares
Weighted average exercise price, exercised | $ / shares
Warrants, forfeited/cancelled | shares
Weighted average exercise price, forfeited/cancelled | $ / shares
Warrants, vested, ending balance | shares	1,125,000
Weighted average exercise price, vested, ending balance | $ / shares	$ 6.50

SUMMARY OF RANGE OF EXERCISE PRICES AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF WARRANTS (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Outstanding and exercisable warrants, weighted average remaining contractual life	48 years 2 months 12 days
Warrant [Member]
Outstanding and exercisable warrants, number of warrants	1,125,000
Outstanding and exercisable warrants, weighted average remaining contractual life	4 years
Warrant [Member] | Range One [Member]
Outstanding and exercisable warrants, exercise price | $ / shares	$ 5.50
Outstanding and exercisable warrants, number of warrants	375,000
Outstanding and exercisable warrants, weighted average remaining contractual life	4 years
Warrant [Member] | Range Two [Member]
Outstanding and exercisable warrants, exercise price | $ / shares	$ 6.50
Outstanding and exercisable warrants, number of warrants	375,000
Outstanding and exercisable warrants, weighted average remaining contractual life	4 years
Warrant [Member] | Range Three [Member]
Outstanding and exercisable warrants, exercise price | $ / shares	$ 7.50
Outstanding and exercisable warrants, number of warrants	375,000
Outstanding and exercisable warrants, weighted average remaining contractual life	4 years

COMMON STOCK PURCHASE WARRANTS (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Apr. 05, 2023	Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding and exercisable warrants, weighted average remaining contractual life	48 years 2 months 12 days
Warrant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrant to purchase	1,125,000	1,125,000
Intrinsic value of outstanding warrants	$ 0		$ 0
Outstanding and exercisable warrants, weighted average remaining contractual life	4 years
2023 Purchase Warrants [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrant to purchase		1,125,000

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)			1 Months Ended	3 Months Ended
	Feb. 06, 2023	Jan. 10, 2023	Jan. 31, 2024	Mar. 31, 2024	Mar. 31, 2023
Cancellation of restricted stock, shares				1,125
Reverse stock split	1-for-20 reverse stock split
Net income (loss) attributable to noncontrolling interest				$ (12,248)	$ 126,239
Nobility Healthcare LLC [Member]
Subsidiary, ownership percentage, parent				49.00%
Net income (loss) attributable to noncontrolling interest				$ 12,248	$ 126,239
Nobility Healthcare LLC [Member]
Equity method investment, ownership percentage				51.00%
Officers [Member]
Common stock issuance granted		22,500	55,000
Vesting drescription		Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates	Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates
New Employees [Member]
Common stock issuance granted		12,500	25,197
New Employees [Member] | Minimum [Member]
Vesting period		1 year	1 year
New Employees [Member] | Maximum [Member]
Vesting period		2 years	2 years

SCHEDULE OF WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING AND LOSS PER SHARE OUTSTANDING (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Earnings Per Share [Abstract]
Numerator for basic income loss per share	$ (3,931,020)	$ (6,105,818)
Numerator for diluted loss per share	$ (3,931,020)	$ (6,105,818)
Denominator for basic loss per share – weighted average shares outstanding	2,861,229	2,751,662
Dilutive effect of shares issuable upon conversion of convertible debt and the exercise of stock options and warrants outstanding
Denominator for diluted loss per share – adjusted weighted average shares outstanding	2,861,229	2,751,662
Basic	$ (1.37)	$ (2.22)
Diluted	$ (1.37)	$ (2.22)

SCHEDULE OF ESTIMATED FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ASSUMED ACQUISITION (Details) - Country Stampede Acquisition [Member]	Mar. 01, 2024 USD ($)
Business Acquisition [Line Items]
Tangible assets acquired	$ 305,000
Identifiable intangible assets acquired (Trademarks and trade names)	300,000
Goodwill	225,959
Liabilities assumed pursuant to stock purchase agreement	(288,000)
Net assets acquired and liabilities assumed	542,959
Cash paid at Country Stampede Acquisition date	400,000
Cash paid subsequent to closing	142,959
Acquisition purchase price	$ 542,959

COUNTRY STAMPEDE ACQUISITION (Details Narrative) - USD ($)		3 Months Ended
	Mar. 01, 2024	Mar. 31, 2024	Mar. 31, 2023
Business Acquisition [Line Items]
Cash		$ 400,000
JC Entertainment LLC [Member]
Business Acquisition [Line Items]
Aggregate purchase price	$ 542,959
Cash	$ 400,000

SCHEDULE OF SEGMENT REPORTING (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Segment Reporting Information [Line Items]
Total Net Revenues	$ 5,529,351	$ 7,697,190
Total Gross Profit	1,523,699	1,544,792
Total Operating Loss	(3,639,034)	(6,172,806)
Total Depreciation and Amortization	550,991	543,110
Total identifiable assets	45,164,195		$ 47,028,809
Video Solutions [Member]
Segment Reporting Information [Line Items]
Total identifiable assets	24,172,478		26,396,559
Revenue Cycle Management [Member]
Segment Reporting Information [Line Items]
Total identifiable assets	1,989,068		2,260,376
Entertainment Segment [Member]
Segment Reporting Information [Line Items]
Total identifiable assets	6,482,510		6,324,211
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Total identifiable assets	12,520,139		$ 12,047,663
Operating Segments [Member]
Segment Reporting Information [Line Items]
Total Net Revenues	5,529,351	7,697,190
Total Gross Profit	1,523,699	1,544,792
Total Operating Loss	(3,639,034)	(6,172,806)
Total Depreciation and Amortization	550,991	543,110
Operating Segments [Member] | Video Solutions [Member]
Segment Reporting Information [Line Items]
Total Net Revenues	1,718,293	1,899,364
Total Gross Profit	565,694	534,195
Total Operating Loss	(891,588)	(1,963,186)
Total Depreciation and Amortization	198,028	198,122
Operating Segments [Member] | Revenue Cycle Management [Member]
Segment Reporting Information [Line Items]
Total Net Revenues	1,434,598	1,781,590
Total Gross Profit	463,731	775,934
Total Operating Loss	(24,031)	103,765
Total Depreciation and Amortization	26,715	25,507
Operating Segments [Member] | Entertainment Segment [Member]
Segment Reporting Information [Line Items]
Total Net Revenues	2,376,460	4,016,236
Total Gross Profit	494,274	234,663
Total Operating Loss	(642,219)	(1,233,006)
Total Depreciation and Amortization	326,248	319,481
Operating Segments [Member] | Corporate Segment [Member]
Segment Reporting Information [Line Items]
Total Operating Loss	$ (2,081,196)	$ (3,080,379)

SEGMENT DATA (Details Narrative)	3 Months Ended
	Mar. 31, 2024 USD ($) Segments
Segment Reporting Information [Line Items]
Number of operating segments | Segments	3
Video Solutions [Member]
Segment Reporting Information [Line Items]
Inventory reserve	$ 4,315,132
Entertainment Segment [Member]
Segment Reporting Information [Line Items]
Inventory reserve	$ 171,257

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Oct. 02, 2023	Sep. 22, 2023
Related Party Transaction [Line Items]
Notes payable current	$ 2,700,000		$ 2,700,000
Nobility LLC [Member]
Related Party Transaction [Line Items]
Accrued reimbursable expenses payable	576,690	$ 265,241
Nobility LLC [Member] | Operating Agreement [Member]
Related Party Transaction [Line Items]
Management fees	12,379	$ 32,181
Related Party [Member]
Related Party Transaction [Line Items]
Notes payable current	2,700,000				$ 2,325,000
Business combination, contingent consideration, asset				$ 375,000
Interest rate					13.25%
Accrued interest	$ 187,346

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended
	Apr. 30, 2024	Dec. 31, 2022	Apr. 05, 2024	Apr. 04, 2024
Subsequent Event [Member] | Merchant Cash Advances [Member]
Subsequent Event [Line Items]
Additional advance	$ 444,000
Inception total	2,144,000
Repayments of Debt	$ 2,880,000
Series A Convertible Redeemable Preferred Stock [Member]
Subsequent Event [Line Items]
Stock issued during period, shares, new issues		1,400,000
Series A Convertible Redeemable Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Preferred stock, par value			$ 0.001
Series B Convertible Redeemable Preferred Stock [Member]
Subsequent Event [Line Items]
Stock issued during period, shares, new issues		100,000
Series B Convertible Redeemable Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Preferred stock, par value			$ 0.001
Series A Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Preferred stock, shares authorized				1,400,000
Shares to be issued				0
Series B Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Preferred stock, shares authorized				100,000
Shares to be issued				0

---